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Abstract
Immune-Metabolic Regulation by the Transsulfuration Pathway
Aileen Heeyeon Lee
2021

Pro-longevity interventions such as caloric restriction (CR) and methionine
restriction (MR) can improve metabolic health. However, despite decades of extensive
studies, the mechanisms that underlie the benefits of these dietary interventions are still
being characterized. Particularly, the effect of these diets on immune cells in mediating
their metabolic benefits has been largely unexplored. This work aimed to expand our
understanding of how these dietary interventions may regulate immune responses and
identify novel immunomodulatory pathways that could be harnessed during inflammatory
and metabolic pathologies.
In line with other studies in animal models, we identified that the transsulfuration
pathway (TSP) was induced in humans with CR. The TSP controls the synthesis of cysteine
from methionine, and produces byproducts such as hydrogen sulfide (H2S). We find that
during MR, NLRP3 inflammasome-mediated inflammation can be inhibited by the
induction of autophagy due to low availability of sulfur-containing amino acids (SAA).
Additionally, the TSP can inhibit NLRP3 inflammasome through the production of H2S.
This highlights SAA availability mediated by the TSP as an immunoregulatory checkpoint
that may be harnessed to reduce inflammasome-mediated inflammation. However, MR
failed to reduce white adipose tissue inflammation in mouse models of acute endotoxemia,
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Muckle Wells Syndrome, and aging, suggesting that more direct interventions of specific
TSP metabolites may need to be explored.
In addition to regulation of inflammation, we have found that single amino acid
deficiencies can drive extreme thermogenesis in mice, and pathways that protect critical
amino acid levels such as the TSP can serve as important checkpoints to defend against
unchecked thermogenesis. We find that cysteine deficiency in mice lacking the TSP leads
to rapid loss of fat mass and robust adipose tissue browning. This is mediated by an increase
in sympathetic signaling in the adipose tissue, in part through a reduction in the expression
of catecholamine degrading enzymes in adipose tissue macrophages.
Altogether, this work highlights that regulation of cysteine availability through the
TSP serves as an important check point in metabolic and inflammatory homeostasis, and
may underlie many of the metabolic benefits during CR. Manipulation of cysteine
availability may thus potentiate novel therapeutic strategies for combating inflammatory
metabolic diseases such as aging and obesity.
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Chapter 1: Introduction
Aging is associated with systemic low-grade inflammation in the absence of apparent
infection, and is the single greatest risk factor for chronic diseases including cardiovascular
disease, type II diabetes, cancer, and neurodegenerative diseases. With the exception of
viral pandemics such as the current COVID-19 crisis, as the population of Americans over
the age of 65 has increased, there has been a shift in the leading causes of death from
infectious diseases and acute illness to non-communicable chronic diseases and
degenerative illnesses. By 2030, people aged 65 and older are projected to account for 20
percent of the total U.S. population, and by 2056, are projected to outnumber individuals
under the age of 18 (Colby and Ortman, 2014). Over the next 20-30 years, the number of
people over the age of 65 will double to ~80 million in the U.S. with healthcare costs
projected to be 2 trillion dollars (Ortman et al., 2014). In the 2013 report from the Centers
for Disease Control and Prevention, “The State of Aging in America 2013,” more than a
quarter of all Americans suffered from multiple chronic conditions, such as heart disease,
cancer, chronic lower respiratory diseases, Alzheimer’s disease, and diabetes, accounting
for 66% of the national health care burden (CDC, 2013). Furthermore, these age-related
conditions are also associated with high morbidity and mortality in the context of infectious
diseases, putting the elderly at even higher risks. Particularly, studies of the 2009 H1N1
pandemic, the MERS outbreak, and current COVID-19 pandemic have revealed that aging,
obesity, and diabetes to be high risk factors for disease severity and mortality (Drucker,
2020; Kulcsar et al., 2019; Pastor-Barriuso et al., 2020; Perez-Saez et al., 2020; Van
Kerkhove et al., 2011). It has thus become crucial to understand the process of aging and
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develop therapeutic interventions to increase heatlhspan and delay the onset of ageassociated disease.

Aging and Inflammation
While many facets contribute to the decline in health during aging, inflammation is
an important driver of most age-related diseases (Ferrucci et al., 2005; Franceschi and
Campisi, 2014). One contributor of chronic inflammation is the accumulation of damaged
macromolecules and cell debris that increase with age. These include damaged cellular
organelle components, reactive species from oxidative stress, and cellular components
indicative of dying cells such as extracellular ATP, ceramides, saturated fatty acids, urate
and cholesterol crystals, amyloid fibrils, succinate, and advanced glycation end products,
which act as danger associated molecular patterns (DAMPs); these DAMPs are sensed by
innate sensors called pathogen recognition receptors (PRRs) (Goldberg and Dixit, 2015;
Medzhitov, 2008). One such sensor of molecular DAMPs is the NACHT, LRR and PYD
domains containing protein 3 (NLRP3) inflammasome. While the NLRP3 inflammasome
normally plays an important role in defense against bacterial infections, sustained NLRP3
activation becomes a major driver of age-related inflammation. Consistently, ablation of
NLRP3 delays the onset of age associated diseases such as bone loss, thymic demise,
insulin insensitivity, development of cataracts, and memory loss (Youm et al., 2013).
Activation of the NLRP3 inflammasome is tightly regulated in a two-step process.
The first priming step involves sensing of cytokines or pathogen associated molecular
patterns (PAMPs) such as lipopolysaccharide (LPS) by PRRs, leading to NF-κB mediated
transcription of the NLRP3 inflammasome complex, including NLRP3, IL-1β, and IL-18
2

(Franchi et al., 2009; Tschopp and Schroder, 2010). Once the inflammasome is primed,
sensing of additional PAMPs or DAMPs such as extracellular ATP, microbial toxins, or
crystalline structures by NLPR3 acts as the second signal that leads to the assembly and
oligomerization of the inflammasome complex involving NLRP3, ASC, and caspase 1 (Cai
et al., 2014; Kanneganti and Dixit, 2012; Lu et al., 2014; Mangan et al., 2018). This
assembly initiates the proteolytic cleavage of pro-caspase 1 into its active form, which can
further process pro-IL-1β and pro-IL-18 into their biologically active forms that are
secreted out of the cell and mediate inflammation. Activation of the NLRP3 inflammasome
further leads to the activation of gasdermin D which mediates pyroptotic cell death, a rapid
inflammatory form of cell death (Aglietti et al., 2016; Shi et al., 2015). How the NLRP3
inflammasome can uniquely sense and respond to such a plethora of PAMPs and DAMPs
has been an outstanding question in the field. Studies have revealed that these stimuli
commonly induce cellular stress responses which lead to intracellular signaling events such
as potassium and chloride ion efflux, calcium ion influx, mitochondrial reactive oxygen
species (ROS) and DNA release, and lysosomal disruption which then drive NLRP3
inflammasome activation (Di et al., 2018; Domingo-Fernandez et al., 2017; Hornung et al.,
2008; Lee et al., 2012; Murakami et al., 2012; Zhang et al., 2010; Zhong et al., 2018; Zhou
et al., 2011). However, exactly how NLRP3 senses these diverse intracellular signaling
events is still unknown.
Activation of NLRP3 is particularly increased in the adipose during aging and
obesity (Vandanmagsar et al., 2011; Youm et al., 2013). Amongst myeloid cells,
macrophages are important regulators of adipose tissue homeostasis through NLRP3
inflammasome dependent regulation of insulin-action and lipolysis (Vandanmagsar et al.,
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2011). In healthy adipose tissue, macrophages are skewed towards an anti-inflammatory
phenotype and play important roles in the removal of dying adipocytes, lipid processing
and buffering, antigen presentation, modulating angiogenesis, and regulating sympathetic
tone (Camell et al., 2017; Haka et al., 2016; Hill et al., 2018; Jaitin et al., 2019; Lee et al.,
2013; Odegaard et al., 2007; Silva et al., 2019; Xu et al., 2013). But with obesity, an
increased infiltration of macrophages is accompanied by a switch towards a proinflammatory phenotype, expressing TNF-α, iNOS, and IL-6 (Weisberg et al., 2003).
Furthermore, NLRP3 activation by these inflammatory macrophages mediates subsequent
insulin resistance in obesity (Vandanmagsar et al., 2011). With aging, known activators of
the NLRP3 inflammasome such as reactive oxygen species, urate crystals, cholesterol
crystals, and saturated fatty acids are increased (Dostert et al., 2008; Duewell et al., 2010;
Martinon et al., 2006; Vandanmagsar et al., 2011). Transmission electron microscopy of
macrophages in the thymus, where adiposity is increased with age, have revealed that aged
macrophages accumulate these activators intracellularly in the form of large lipid droplets,
crystals, protein aggregates, and electron dense materials in the lysosome (Youm et al.,
2016). As such, ablation of NLRP3 reverses the metabolic defects in glycemic control in
aged mice (Youm et al., 2013). Conversely, growth hormone receptor knock out (GHRKO)
mice that are notable for their longevity, are characterized by reduced levels of NLRP3
activation (Spadaro et al., 2016). Importantly, analysis of multi-omics profiling of young
and older adult peripheral blood samples from the Stanford-Ellison longitudinal aging
study found an age-dependent increase in inflammasome gene modules; furthermore,
follow up of the study found the high expression of inflammasome modules was associated
with all-cause mortality (Furman et al., 2017).

4

More recent studies have found that activation of NLRP3 in adipose tissue
macrophages drives the expression of catecholamine degradation enzymes, causing the
lipolysis resistance that is characteristic of reduced metabolic function in age and obesity
(Camell et al., 2017; Pirzgalska et al., 2017). Additionally, NLRP3 activation in
macrophages further recruits and maintains B cells in tertiary lymphoid structures called
fat associated lymphoid clusters, and drive metabolic dysfunction exhibited as lipolysis
resistance and cold intolerance in aged animals (Camell et al., 2019). These with other
studies have highlighted a tight network of interactions that link metabolic function with
inflammatory processes. Further understanding of these interactions will allow for
therapeutic strategies to improve metabolically driven chronic diseases that occur with age.
This is particularly important because the prevalence of metabolic disorders such as obesity
and diabetes in adults aged 65 and over has increased continuously between 1999 and 2010
(Fakhouri et al., 2012).

Dietary Interventions can Extend Lifespan and Restrain Age-related Inflammation
One of the most successful interventions to delay aging and extend healthspan and
lifespan has been caloric restriction (CR). Since the first studies by Osborne et al. and
McCay et al. to show that decreasing food intake slowed growth and increased lifespan of
rats (McCay et al., 1935; Osborne et al., 1915), subsequent studies have demonstrated that
CR extends lifespan in many species including mice, yeast, fruit flies, nematodes, fish,
hamsters, and monkeys (Masoro, 2005; Sanchez-Roman and Barja, 2013). In addition to
increasing lifespan, CR has been shown to delay the onset of most age-associated diseases,
such as neoplastic disease, cardiomyopathy, degenerative diseases, and metabolic disorders
5

(Mattison et al., 2017; Ravussin et al., 2015; Sanchez-Roman and Barja, 2013). Besides
CR, other, more targeted dietary interventions such as restricting protein intake, or
restricting specific amino acids can also increase lifespan (Lee et al., 2008; Orentreich et
al., 1993; Richardson et al., 2021; Solon-Biet et al., 2014), suggesting the restriction of
protein derived macronutrients may be an important factor for their health benefits. Indeed,
protein quality and amino acid composition of diet have been more strongly associated
with metabolic and age associated health (Solon-Biet et al., 2014). Independently of caloric
intake, low protein and high carbohydrate diets were found to have the strongest extension
of lifespan in mice (Solon-Biet et al., 2014). In addition to dietary protein restriction (PR),
some studies suggest it is the restriction of essential amino acids (EAAs) that drive
beneficial effects, as supplementing dietary restriction with EAAs but not non-essential
amino acids were sufficient to reverse pro-longevity effects (Grandison et al., 2009;
Yoshida et al., 2018). Diets restricting specific EAAs have been extensively characterized
to increase metabolic homeostasis and promote healthy aging; these diets include the
restriction of sulfur amino acids (SAAs), methionine and cysteine, also known as
methionine restriction (MR), and restriction of the branched chain amino acids, leucine,
isoleucine, and valine, also known as branched chain amino acid restriction (BCAAR)
(Fontana et al., 2016; Lee et al., 2016; Solon-Biet et al., 2014). These dietary interventions
commonly lead to reduced adiposity and inflammation, increased insulin sensitivity and
lipolytic gene signatures, and reduction of lipogenesis in adipose tissue and liver (Kitada
et al., 2019). Although much less characterized, restriction of tryptophan can also lead to
increased lifespan and increases recovery to cold stress, suggesting an increase in
thermogenic capacity (Segall and Timiras, 1975, 1976; Zapata et al., 2018). Surprisingly,
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these studies indicate that deficiencies of specific essential amino acids drive
reprogramming of metabolic tissues to promote health. Despite numerous studies
investigating the mechanisms driving increased longevity during these dietary
interventions, there have been a lack of studies investigating the alterations to the immune
system and their role in tissue reprogramming.

Autophagy and Inflammation
One pathway that is increased during dietary protein and amino acid restriction is
the integrated stress response-mediated autophagy. The integrated stress response allows
for adaptive responses to various stresses such as starvation and ER stress. Stressors are
sensed by four different sensors: general control nonderepressible 2 (GCN2), protein
kinase R (PKR), heme-regulated inhibitor (HRI), and PKR like endoplasmic reticulum
kinase (PERK) (Pakos-Zebrucka et al., 2016). GCN2 senses amino acid depletion by
sensing the accumulation of uncharged tRNAs (Gallinetti et al., 2013). HRI recognizes
heme deficiency, while PKR senses viral infection through activation by double stranded
RNA (Pakos-Zebrucka et al., 2016). Finally, PERK is activated by ER stress (PakosZebrucka et al., 2016). Activation of these sensors are integrated by the activation and
phosphorylation of eIF2ɑ leading to global translational arrest (Pakos-Zebrucka et al.,
2016). One central component of the integrated stress response is autophagy (Kroemer et
al., 2010). Autophagy, which literally means “self-eating” in Greek, is a process that
delivers cellular components such as organelles and proteins to lysosomes for degradation
and recycling of amino acids. This process is mediated by a broad network of proteins,
many of which are called autophagy related genes (ATGs) (Tsukada and Ohsumi, 1993).
7

The most well characterized initiator of autophagy is deprivation of amino acids. In
addition to GCN2-sensing of uncharged tRNAs, depletion of EAAs leads to interaction of
their specific sensors such as SAMTOR (SAM sensor), sestrin 2 (leucine sensor), and
CASTOR (arginine sensor) with GATOR1 or GATOR2 to prevent mTORC1 activation
(Kim and Guan, 2019). The inhibition of mTORC1 leads to the dissociation of ULK1 from
mTORC1 (Hosokawa et al., 2009). ULK1 then proceeds to phosphorylate itself and other
complex members such as ATG13 and FIP200, ultimately leading to the formation of the
phagophore that undergoes further expansion, maturation and fusion with the lysosome
(Dikic and Elazar, 2018).
As an ancient, evolutionarily conserved pathway, autophagy has been adapted to
mediate multiple critical functions. In addition to acting as a homeostatic process that is
activated to replenish amino acids during starvation, autophagy was more recently
discovered to play a cytoprotective role through the elimination of damaged and
dysfunctional organelles such as mitochondria and protein aggregates in a process called
selective autophagy (Rui et al., 2015). Selective autophagy is in part mediated by p62,
which is also known as sequestosome 1 (SQSTM1); p62 acts as an adaptor between LC3
and ubiquitin chains to allow for recruitment of specific targets that have been ubiquitinated
for autophagy (Bjorkoy et al., 2005; Narendra et al., 2010). In addition to p62, NDP52 can
also act as an adaptor protein that not only binds to ubiquitin chains, but also galectin-8,
which marks damaged endosomes and lysosomes (Thurston et al., 2012).
Autophagy can also act as a type of primitive immune response via another process
of selective autophagy called xenophagy, through the capture and degradation of
intracellular pathogens such as Mycobacterium tuberculosis, Shigella flexneri, and
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Salmonella typhimurium (Levine 2005). Conversely, autophagy can also regulate immune
function. Multiple groups have now shown that autophagy can inhibit inflammasome
activity through several mechanisms. Initially, Saitoh et al, showed that depletion of
autophagosome machinery such as ATG16L1, ATG7, or treatment with the autophagy
inhibitor, 3-methyladenine (3-MA), lead to increased production of IL-1β in response to
LPS (Saitoh et al., 2008), suggesting that autophagy negatively regulates inflammasome
activation. Follow up studies have found that autophagy can promote the labeling of
inflammasome components with ubiquitin by parkin for proteasomal degradation (Shi et
al., 2012). Autophagy was also found to promote mitophagy in a p62 dependent manner to
reduce mitochondrial ROS production and subsequent inflammasome activation (Zhong et
al., 2016; Zhou et al., 2011). These studies underscore amino acid starvation induced
autophagy as a potential mechanism to regulate inflammation to mediate the effects of
protein restricting interventions. In a model of colitis, PR and BCAAR reduced
inflammation through the inhibition of NLRP3 inflammasome and reduction of Th17
differentiation in the gut. This response was dependent on amino acid sensing through
GCN2 (Ravindran et al., 2016). Furthermore, treatment with halofuginone, which activates
starvation responses by inhibiting prolyl tRNA charging, also inhibits differentiation of
Th17 cells, which play pathogenic roles in a multitude of autoimmune diseases (Sundrud
et al., 2009). These studies highlight the induction of amino acid starvation responses in
immune cells as potential strategies against inflammation driven pathological states such
as obesity, aging, and autoimmunity.

9

The Transsulfuration Pathway as a Novel Immunomodulatory Metabolic Pathway
Another pathway that could potentially mediate the effects of these dietary
interventions is the transsulfuration pathway (TSP). Recent studies from our lab have
revealed that Cth expression, a gene that encodes for cystathionine-γ lyase (CSE) and is
part of the TSP, is induced in the adipose tissue of humans that underwent 14% CR over
two years (CALERIE II, Dixit lab, unpublished). The TSP involves the metabolism of
sulfur amino acids (SAAs), beginning with the catabolism of methionine to generate
intermediates

such

as

the

methyl

donor

S-adenosylmethionine

(SAM),

S-

adenosylhomocysteine (SAH), homocysteine, and cystathionine. Additionally, TSP also
allows for the generation of cysteine through the action of CSE which can further provide
important metabolites and byproducts such as glutathione, taurine, pyruvate, and hydrogen
sulfide (H2S). Interestingly, recent studies have linked the TSP to longevity. The lifespan
extension induced by CR in Drosophila was abolished when treated with the inhibitor of
CSE, propargylglycine (PPG) (Kabil et al., 2011), and overexpression of another TSP
enzyme, cystathionine β-synthase (CBS) increased median lifespan in C. elegans (Hine et
al., 2015). Furthermore, a recent study evaluating the effects of CR across two different
mouse strains, and sex, found that 20% and 40% CR induces increased production of H2S,
one of the end products of the TSP (Mitchell et al., 2016). Finally, treatment of yeast with
H2S donors, NaHS and GYY4137, is sufficient to extend median lifespan of yeast, i.e.
delay replicative senescence (Hine et al., 2015). These studies suggest that TSP mediated
H2S production is an important mediator of lifespan benefits.
H2S is a gas molecule that has recently gained attention as a physiologically
relevant signaling molecule. While the role of H2S in controlling vasodilation by its action
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on endothelial smooth muscle is the most established (Paul and Snyder, 2015), one study
reports that H2S treatment can induce suspended animation in mice, leading to reduced
metabolic rate and decreased body temperature (Blackstone et al., 2005). Other studies
have begun to uncover a role for H2S in immune processes. In T cells, H2S is required for
the differentiation of regulatory T cells by promoting demethylation at the Foxp3 locus by
Tet1 and Tet2 (Yang et al., 2015). An anti-inflammatory role for H2S has been implicated
by its action on NF-κB to augment its antiapoptotic transcriptional activity in macrophages
(Sen et al., 2012), and its action on antioxidant gene regulation (Yang et al., 2013). Given
that both regulatory T cells and anti-inflammatory macrophages play important roles in
promoting metabolic homeostasis of adipose tissue, the increased localized production of
H2S may play important roles in regulating immune cells to mediate the effects of dietary
interventions.

Harnessing Adaptive Thermogenesis
One other effect of pro-longevity dietary interventions is the activation of adipose
tissue thermogenesis (Kim et al., 2017; Wanders et al., 2017). Brown adipose tissue (BAT)
along with skeletal muscle are the main thermogenic organs in the body. BAT can generate
heat by inducing energy-consuming futile cycles. Brown adipocytes express high amounts
of mitochondria and the uncoupling protein 1 (UCP1) which allows the uncoupling of
mitochondrial oxidative phosphorylation (OXPHOS) to generate heat instead of ATP
(Kozak and Harper, 2000). BAT is mainly activated in response to cold, where sensory
neurons expressing transient receptor potential cation channel subfamily M member 8
(TRPM8) sense the cooling of the skin and signal to the central nervous system (CNS)
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(Bautista et al., 2007). Within the CNS, sensory signals are conveyed to the hypothalamus,
which integrates these signals to activate sympathetic signaling that directs
vasoconstriction of cutaneous blood vessels to reduce heat loss through the skin (Bini et
al., 1980), and subsequent activation of thermogenic organs to increase energy expenditure
and generate heat via non-shivering mechanisms (Nakamura and Morrison, 2007, 2008).
During early cold exposure, when non-shivering thermogenic mechanisms are insufficient
to maintain body temperature, shivering thermogenesis mediated by the involuntary
contraction of muscle primarily generates heat (Israel and Pozos, 1989). When cold
exposure becomes chronic, reliance on shivering mechanisms is reduced and an increase
in non-shivering thermogenic capacity by BAT and white adipose tissue (WAT) occurs
(Betz and Enerback, 2018; Foster and Frydman, 1979). Indeed, acclimatization to cold
increases the density of noradrenergic fibers to increase response to sympathetic signaling
in both BAT and WAT (Chi et al., 2018; Murano et al., 2009). Furthermore, recent studies
have reminded the field that current standard housing conditions for mice at 20-22°C are
lower than their thermoneutral temperatures (28-33°C), such that mice are constantly in a
state of chronic cold stress and activate adaptive thermogenesis (Gaskill et al., 2009).
Accordingly, housing mice at 30°C reduces the activation of non-shivering thermogenesis,
and comparison of housing at 20°C vs. 30°C suggests that nearly half of the total energy
expenditure of mice at 20°C is utilized to maintain core body temperature (Skop et al.,
2020). In this way, BAT and WAT acts as adaptive thermogenic organs that allows
maintenance of core body temperature in response to environmental temperatures.
BAT is highly innervated by sympathetic nerve fibers and highly vascularized,
allowing for its rapid activation by the CNS and dispersion of heat throughout the body via
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the circulation (Rosell and Belfrage, 1979). In contrast to white adipocytes, brown
adipocytes store lipids in multiple smaller lipid droplets and harbor a large number of
mitochondria. While in rodents, BAT is prominently found in the interscapular region, in
response to long term or repeated cold exposure, additional brown-like adipocytes called
‘beige adipocytes’ are induced in the WAT, particularly in subcutaneous white adipose
tissues (SFAT) (Wu et al., 2012). This process where there is an increase in thermogenic
capacity of the SFAT is called ‘browning’ or ‘beiging’. UCP1 is uniquely expressed within
the inner mitochondrial membrane of brown and beige adipocytes, and forms a channel
allowing protons to flow into the mitochondrial matrix from the cytosol (Kozak and
Harper, 2000). This uncouples the proton gradient of the electron transport chain, allowing
for uncoupling of OXPHOS from ATP generation, ultimately converting energy stored as
triglycerides into heat (Kozak and Harper, 2000). Activation of UCP1 begins with the
stimulation of β3-adrenergic receptors on adipocytes by catecholamines released by
sympathetic nerves (Jimenez et al., 2003). This leads to the upregulation of the thermogenic
program including UCP1, and mitochondrial biogenesis by induction of peroxisome
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) in a p38 mitogenactivated protein kinase (MAPK) dependent manner (Cao et al., 2001). β3-adrenergic
signaling also activates lipolysis through the action of protein kinase A (PKA), a cyclic
AMP activated protein kinase (Fricke et al., 2004). PKA phosphorylates perilipin A and
hormone-sensitive lipase (HSL), where phosphorylated perilipin A dissociates with lipid
droplets and acts as a scaffold for the phosphorylation of HSL, which is involved in the
cleavage of stored triglycerides into fatty acids and glycerol. Another adipose tissue lipase,
adipose tissue triglyceride lipase (ATGL) also induces lipolysis semi-independently of
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PKA, through its interaction with CGI-58 and perilipin 5 (Lass et al., 2006; Wang et al.,
2011a). ATGL favors triglycerides as substrates as it catalyzes the first rate-limiting step
of lipolysis, whereas HSL is thought to primarily function more downstream as a
diacylglycerol lipase (Bezaire et al., 2009; Haemmerle et al., 2002; Holst et al., 1996;
Zimmermann et al., 2004). The released free fatty acids (FFAs) are then utilized as fuels
for beta oxidation and to increase flux through the electron transport chain. As UCP1 acts
as a long chain fatty acid (LCFA)/proton symporter, the release of long chain fatty acid
anions and their association with UCP1 drives stable uncoupling of the electron transport
chain (Fedorenko et al., 2012). And in a futile cycle as ATP production becomes
uncoupled, accumulation of ADP continues to drive the activation of OXPHOS, further
increasing heat production (Wikstrom and Springett, 2020).
While UCP1 was long thought to be the primary mediator of non-shivering
thermogenesis, the discovery that Ucp1-/- mice are able to adapt to long term cold exposure
uncovered the possibility of alternative thermogenic mechanisms independent of UCP1
(Ukropec et al., 2006). One such mechanism is through creatine futile cycling. Utilizing
Ucp1 deficient animals, Kazak and colleagues identified increased levels of mitochondrial
creatine kinases, CKMT1 and CKMT2, upon acute cold exposure, specifically in the beige
adipocytes of browning WAT (Kazak et al., 2015). Blocking the transport of creatine
reduced oxygen consumption in both human and Ucp1-deficient beige adipocytes,
suggesting that mobilization of creatine in and out of the mitochondria were important for
thermogenic respiration (Kazak et al., 2015). The conceptual framework behind the futile
creatine cycle is as follows: mitochondrial creatine kinases are positioned within the inner
mitochondrial membrane so that they can immediately utilize the ATP produced from
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OXPHOS to phosphorylate creatine and generate phosphocreatine and ADP. However,
through increased creatine transport, increased CKMT1 and CKMT2 activity drive an
excess of ADP over ATP, driving increased respiration to produce additional ATP in a
futile cycle (Kazak et al., 2015). While limited expression of CKMT1 and CKMT2 to
beige adipocytes might have suggested that creatine futile cycling was limited to browning
WAT, recently, another mitochondrial creatine kinase, creatine kinase B (CKB) was found
to drive creatine cycling in the BAT as well (Rahbani et al., 2021). Other studies have
begun to identify roles for non-shivering thermogenesis in muscle resulting from calcium
cycling by sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) where sarcolipin
uncouples the hydrolysis of ATP from Ca2+ transport (Bal et al., 2012; Smith et al., 2002),
or its expression of UCP1 and UCP3 (Riley et al., 2016). While UCP1-independent
thermogenic mechanisms are still being discovered and verified, their redundancy
highlights the importance of mechanisms to maintain and defend core body temperature.
Given that cold-induced thermogenesis essentially increases energy expenditure by
burning fat, there has been great interest in whether these pathways can be harnessed as
therapeutic strategies in the context of obesity. Until the last decade, the presence of BAT
in human adults had been controversial. However, once the existence of BAT was
confirmed by multiple studies in 2009 (Cypess et al., 2009; Saito et al., 2009; van Marken
Lichtenbelt et al., 2009; Virtanen et al., 2009), the therapeutic prospect of increasing
browning processes as a means to reduce fat mass and improve metabolic homeostasis has
gained much excitement. Given that human BAT exhibits more heterogeneous molecular
signatures resembling both classic and beige adipocytes of mice (Sun et al., 2020),
understanding the mechanisms that activate not only BAT, but also browning of WAT will
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be important in developing novel therapeutic strategies. BAT function decreases in rats as
well as in humans with age and obesity (Cypess et al., 2009; McDonald and Horwitz, 1999;
Pfannenberg et al., 2010; Saitoh et al., 2008; Vijgen et al., 2011). This decrease in
thermogenic capacity with age is in part mediated by the NLRP3 inflammasome (Camell
et al., 2019; Camell et al., 2017). Interestingly CR and MR delays the loss of BAT that
occurs during aging and promotes thermogenesis of WAT (Valle et al., 2008; Wanders et
al., 2015). Additionally, intermittent fasting of animals even on a high fat diet (HFD),
where mice were fed HFD 2 days and fasted for 1day, increased WAT browning to improve
metabolic homeostasis (Kim et al., 2017). The fact that thermogenesis is increased in the
context of MR where mice are reported to increase their food intake may suggest that a
decrease in caloric intake is not the driver of the shift from energy storage towards energy
expenditure (Hasek et al., 2010). How and why these dietary perturbations lead to increased
thermogenesis is poorly understood. Understanding the mechanisms that drive this
response may lead to novel therapeutic strategies that can be targeted in lieu of undergoing
broad dietary restrictions that are difficult to maintain.

Immune Cells in Regulating Thermogenesis
One emerging area of organismal regulation of thermogenesis is the crosstalk of
different resident tissue cell types within the adipose tissues. As the homeostatic role of
immune cells in adipose tissue have been continually characterized, some studies have
revealed a role for immune cells in regulating thermogenic processes. For example,
macrophages in close contact with the numerous sympathetic nerves that densely innervate
the BAT and SFAT can control thermogenesis by controlling the bioavailability of
16

catecholamines (Camell et al., 2017; Chi et al., 2018; Pirzgalska et al., 2017). Inhibition of
monoamine oxidase A (MAOA), an enzyme that degrades catecholamines such as
norepinephrine (NE) and serotonin in macrophages, increased local NE content in adipose
tissue, leading to increased lipolysis and thermogenesis by upregulation of UCP1 (Camell
et al., 2017). Moreover, type 2 innate lymphoid cells (ILC2s), eosinophils, invariant natural
killer (iNK) T and γδ T cells have also been implicated in increasing energy expenditure
and UCP1 (Brestoff et al., 2015; Hu et al., 2020; Lynch et al., 2016; Qiu et al., 2014).
Notably, FGF21, which gets induced during dietary restriction, can promote the expression
of CCL11 by adipocytes to recruit eosinophils, suggesting that immune cells are actively
recruited and regulated during adaptive adipose tissue remodeling (Huang et al., 2017).
Conversely, a recent study has identified lymphocyte derived IL-10 to inhibit
thermogenesis (Rajbhandari et al., 2019). Further studies are required to determine how
exactly specific immune cells affect UCP1 and alternative thermogenic pathways; whether
they act directly on adipocytes, or regulate other niche compartments such as the
sympathetic nervous system or vasculature to control heat production are still unknown.
Identification of such mechanisms may reveal strategies to divert the fate of dietary lipids
from storage to heat production through increased mitochondrial uncoupling, thus reducing
metabolic diseases emanating from lipotoxicity and obesity.

FGF21 Integrates Amino Acid Starvation, ER Stress, and Metabolic Adaptations
Changes in organismal nutritional state, such as starvation, ketogenic diet, or low
protein diets drive the expression of FGF21, an endocrine fibroblast growth factor (FGF)
(De Sousa-Coelho et al., 2013; Fazeli et al., 2015; Laeger et al., 2014; Reitman, 2007).
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FGF21 is expressed in many organs, but the liver is the main contributor to circulating
levels of FGF21 (Nishimura et al., 2000). Unlike other members in the FGF family, FGF21
has reduced affinity for heparin sulfate, allowing for it to disperse and act systemically as
an endocrine factor and integrate metabolic responses across multiple tissues including the
liver, adipose tissue, skeletal muscle, pancreas, and the brain (Kharitonenkov et al., 2005).
FGF21 controls glucose and lipid metabolism via binding to its receptor, β-Klotho in
complex with its co-receptors FGFR1C, FGFR2C, and FGFR3C (Ogawa et al., 2007). In
adipose tissue, FGF21 increases response to insulin by increasing the expression of glucose
transporter GLUT1 (Ge et al., 2011), while also increasing energy expenditure through
induction of PGC-1α and UCP1 (Fisher et al., 2012; Kwon et al., 2015). More specifically,
FGF21 acts through β-Klotho receptors in the central nervous system to induce sympathetic
activation of brown adipose tissue in a neuropeptide corticotropin-releasing factor (CRF)dependent manner (Bookout et al., 2013; Owen et al., 2014). In addition, FGF21
administration in UCP1 KO mice revealed that FGF21 can promote weight loss and
improve glycemic control in a UCP1 independent manner by reducing food intake (Samms
et al., 2015).
In line with the increased expression of FGF21 during pro-longevity dietary
interventions CR, PR, and MR, transgenic overexpression of FGF21 in mice leads to a 50%
increase in median lifespan (Zhang et al., 2012). Interestingly, FGF21 seems to be
responding specifically to restriction of protein intake, independently of energy intake, as
CR diets and ketogenic diets supplemented with isocaloric amounts of protein blocked the
induction of FGF21 (Laeger et al., 2014). More specifically, restriction of specific essential
amino acids, as such in MR diets, is sufficient to drive robust expression of FGF21
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(Wanders et al., 2017). Indeed, studies utilizing deprivation of leucine induced FGF21
expression in a GCN2 and ATF4 dependent manner (De Sousa-Coelho et al., 2013).
However, unlike leucine or BCAAR diets, MR also induces hepatic FGF21 and lipolytic
gene signatures independently of GCN2 (Lees et al., 2017). Instead, MR specific hepatic
changes are driven by PERK and glutathione depletion (Wanders et al., 2016), suggesting
that besides GCN2-mediated ISR, endoplasmic reticulum (ER) stress and oxidative stress
may play key roles in regulating FGF21 during amino acid starvation responses.
ER stress activates the unfolded protein response (UPR) which can signal through
three separate branches, each representing distinct ER membrane proteins: PERK and
ATF4, IRE1α and XBP1, and ATF6. These branches become activated when unfolded or
misfolded proteins accumulate within the ER. Activation of PERK results in the
phosphorylation of eIF2α and global translational arrest, leading to the activation of ATF4,
which regulates the expression of genes involved in amino acid metabolism and antioxidant defense (Pakos-Zebrucka et al., 2016). IRE1α activation leads to the transcription
of the potently active form of XBP1, which drives the expression of genes involved in ER
biogenesis and turnover (Iwakoshi et al., 2003; Yoshida et al., 2001). Finally, activation of
ATF6 leads to its relocation to the Golgi where it is cleaved and is involved in the
expression of chaperones (Adachi et al., 2008; Shen et al., 2002). Schaap and colleagues
first showed that ER stress stimuli as well as overexpression of ATF4 can induce the
expression of FGF21 in hepatocytes, identifying two ATF4 binding sites in the FGF21
promoter (Schaap et al., 2013). This study suggested that FGF21 may be a downstream
mediator of the PERK/ATF4/eIF2α branch of the ER stress-driven ISR. Indeed, FGF21
deficient mice exhibited increased hepatic ER stress in response to postprandial and
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tunicamycin-induced stress, indicating that FGF21 also directly plays a role in ameliorating
ER stress (Maruyama et al., 2018). However, ATF4 is a broad effector of ISRs and also
acts downstream of GCN2 mediated amino acid starvation responses (Harding et al., 2000).
In addition to ATF4 driven FGF21, Jiang and colleagues found that IRE1α was required
for the induction of FGF21 in the context of tunicamycin-induced ER stress as IRE1α KO
mice had reduced FGF21 levels without altering ATF4 expression (Jiang et al., 2014).
Furthermore, FGF21 directed ERK activation to suppress eIF2α-ATF4-CHOP, indicating
that FGF21 can reduce ER stress and subsequent activation of alternative branches of the
UPR program (Jiang et al., 2014). The fact that FGF21 is controlled by at least two
branches of the UPR supports a role for FGF21 as a mediator of the UPR. Understanding
the effector function of FGF21 within the context of ER stress response during prolongevity diets that have underlying amino acid restriction may lead to the discovery of
novel physiological phenomena.

Summary and Perspectives
Dietary interventions such as CR, PR, and MR extend lifespan and healthspan to
delay the onset of age-associated chronic diseases and metabolic dysfunction. However,
practicing these dietary interventions in daily life can be extremely difficult. Studying the
mechanisms that drive the effects of these pro-longevity interventions can allow for the
identification of novel therapeutic targets specific for different aspects of aging such as
inflammation, metabolic perturbations, and immune dysfunction. In particular, the study
of MR allows for a simplified model of amino acid restriction that still exhibits the benefits
of the broader dietary restriction regimes such as CR and PR. Many of the metabolic
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perturbations with age stem from alterations to adipose biology in part caused by increased
chronic, low-grade inflammation. Investigating how different responses to pro-longevity
dietary restrictions are integrated within the adipose tissue may yield the discovery of novel
immunomodulatory metabolic pathways. In this study, we identify the induction of the
TSP, a pathway involved in the catabolism of methionine to generate cysteine, as an
intriguing node that may play an important role in modulating the effects observed during
pro-longevity interventions. This project investigates the role of the TSP in regulating
inflammation in the context of MR and aging (Chapter 2), and its action in regulating amino
acid metabolism to maintain adipose tissue homeostasis (Chapter 3).

21

Chapter 2: Regulation of Inflammation by the Transsulfuration
Pathway
Introduction
Despite methionine being an essential amino acid, studies by the Orentreich
Foundation surprisingly found that restriction of methionine from 0.86% to 0.17% of the
diet increased lifespan by up to 45% in rats (Orentreich et al., 1993). Many follow-up
studies have further established the effects of methionine restriction (MR) diet in delaying
the onset of age-associated diseases, even when started in adult animals (Ables et al., 2012;
Lees et al., 2014; Miller et al., 2005; Richie et al., 1994). However, there has been a lack
of studies exploring the role of MR in regulating inflammation to mediate its effects as a
pro-longevity intervention. Large scale transcriptomics analysis comparing 20 months
caloric restriction (CR) and MR across subcutaneous fat (SFAT), brown adipose tissue
(BAT), liver, and skeletal muscle in mice suggested proinflammatory signaling pathways
were down-regulated in the SFAT and liver of MR mice (Ghosh et al., 2014; Wanders et
al., 2014). However, these studies were mostly limited to highlighting pathways involved
with immune recruitment, accumulation, and activation, rather than actual inflammatory
signatures, and subsequent follow-up studies have failed to confirm and identify clear
mechanisms that regulate this reduction in inflammatory profile (Sharma et al., 2019).
One important driver of inflammation in the context of age and metabolic diseases
such as obesity and atherosclerosis is the NLRP3 inflammasome (Duewell et al., 2010;
Vandanmagsar et al., 2011; Youm et al., 2013). Whether MR can regulate NLRP3
inflammasome activation has not been established. Methionine restriction in rats and mice
decreases serum methionine and cysteine levels (Elshorbagy et al., 2010; Mentch et al.,
2015). Methionine is an essential amino acid (EAA) that generates s-adenosyl methionine
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(SAM), homocysteine, cysteine, creatine, carnitine, and succinyl-coA. Accordingly, MR
driven autophagy has been found to be required for lifespan extension in yeast
(Ruckenstuhl et al., 2014). Autophagy is a known negative regulator of NLRP3
inflammasome. Zhou et al initially showed that mitochondrial ROS drives increased
NLRP3 activation, and disruption of autophagy led to the accumulation of damaged
mitochondria and mitochondrial ROS (Zhou et al., 2011). In addition to mitochondrial
ROS, DNA released for damaged mitochondria also activates the NLRP3 inflammasome
(Nakahira et al., 2011). During NLRP3 inflammasome activation, damaged mitochondria
get ubiquitinated by the E3 ubiquitin ligase Parkin, and removed in a p62 dependent
manner by selective autophagy (Zhong et al., 2016). Besides damaged mitochondria,
NLRP3 inflammasome components can also be directly targeted for degradation. NLRP3
complexes co-localize with autophagosomes, and ASC in the context of the AIM2
inflammasome complex has been shown to be ubiquitinated, and removed in a p62
dependent manner (Shi et al., 2012). This interaction of the NLRP3 complex with p62 via
ASC has been suggested to be dependent on phosphorylation of NLRP3, as NLRP3 lacking
the phosphorylation site does not interact with p62 and subsequently does not get
sequestered into the phagosome (Spalinger et al., 2016). These studies have established
that autophagy of NLRP3 inflammasome components and activators such as damaged
mitochondria serve as a negative feedback mechanism to prevent excessive inflammation.
Whether these pathways play a role in regulating inflammation during MR remains to be
investigated.
Alternatively, the transsulfuration pathway (TSP) also gets induced during MR
(Hine et al., 2015; Wang et al., 2019b). The transsulfuration pathway allows for the
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synthesis of cysteine from methionine (Jackson and Block, 1931). During MR, circulating
cysteine levels are reduced, and the TSP likely gets activated to generate cysteine
(Elshorbagy et al., 2010). One of the byproducts of TSP activation is hydrogen sulfide
(H2S), a gaseous molecule. H2S is produced by cystathionine β-synthase (CBS), and
cystathionine γ-lyase (CSE), cysteine aminotransferase (CAT), and 3-mercaptopyruvate
sulfurtransferase (MPST) (Moore et al., 2003). While a role for H2S has been studied in
various contexts of inflammatory diseases, there have been mixed reports of the role of
H2S in either inducing or reducing inflammation in the context of pancreatitis, endotoxemia
and sepsis, edema, colitis, and burn induced injury (Bhatia, 2015). Given that the role of
H2S in regulating macrophage mediated inflammation was largely unexplored at the start
of this project, we aimed to explore the role of TSP and H2S in regulating NLRP3 mediated
inflammation.
Cryopyrin-associated

periodic

syndromes

(CAPS)

are

rare

hereditary

autoinflammatory conditions, clinically characterized by fever and systemic inflammation
of the subcutaneous skin, joints, the musculoskeletal system, and the central nervous
system. These conditions are caused by autosomal dominant mutations in the NLRP3 gene
(Cuisset et al., 1999; Sarrauste de Menthiere et al., 2003). These mutations are mostly
located within the NACHT domain (Dode et al., 2002), which includes a nucleotide
binding domain (NBD) (MacDonald et al., 2013). There is a spectrum of NLRP3 driven
autoinflammatory diseases including familial cold autoinflammatory syndrome (FCAS),
Muckle-Wells syndrome (MWS), and neonatal-onset multisystem inflammatory disease
syndrome (NOMID), with FCAS being the least severe, and NOMID being the most severe
in neonates and young children (Neven et al., 2008). MWS patients present with clinical
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features similar to FCAS, with periodic fever, chills, and severe fatigue and arthritis,
oftentimes being diagnosed when they develop hearing loss. In MWS patients, gain of
function mutations in the NACHT domain of the NLRP3 gene leads to excessive activation
of the NLRP3 inflammasome (Agostini et al., 2004; Chae et al., 2011). How downstream
negative regulatory loops are regulated in CAPS patients not well established. Moreover,
during sepsis and endotoxemia, overwhelming proinflammatory responses drive
multiorgan damage or failure. This proinflammatory response is driven by the concerted
action of numerous immune cells and involves NLRP3 inflammasome activation (Anand
et al., 2011; Danielski et al., 2020). In this chapter, we aim to understand whether MR
regulates inflammation, specifically mediated by the NLRP3 inflammasome, and whether
MR can be harnessed to ameliorate NLRP3 mediated diseases such as MWS and sepsis
associated endotoxemia.

Results

P62 independent autophagy inhibits inflammasome activation during methionine and
cysteine restriction.
To test whether reduction in systemic SAAs could influence inflammasome mediated
inflammation, bone marrow derived macrophages (BMDMs) were cultured in media
lacking methionine and cysteine. Using LPS as the priming signal 1 that drives
transcription of the inflammasome complex, and ATP as the DAMP that serves as signal 2
that drives the assembly of the NLRP3 inflammasome, we observed a decrease in
inflammasome activation observed by reduced IL-1β and caspase-1 (casp-1) cleavage
when methionine and cysteine were restricted acutely at the time of LPS treatment (Fig
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2.1A). Given that methionine is an essential amino acid that cannot be synthesized, and
cysteine is a conditional essential amino acid that is synthesized from methionine and
serine, macrophages rely on the import of SAAs via SLC7A5 and SLC7A11 (Sato et al.,
1999; Yoon et al., 2018). To understand whether induction of autophagy induced by the
lack of environmental EAAs was mediating the reduction in inflammasome activation,
BMDMs were treated with the class III phosphatidylinositol 3-kinase autophagy inhibitor
3-methyladenine (3-MA) during methionine and cysteine restriction. Indeed, inhibition of
autophagy reversed the reduction of inflammasome activation, suggesting that autophagy
is mediating the anti-inflammatory effects of methionine and cysteine restriction (Fig
2.1B). Some of the effects of autophagy on inflammasome mediated inflammation are
dependent on mitochondrial removal (Harris et al., 2011; Zhong et al., 2016). NLRP3
inflammasome activation leads to the accumulation of defective mitochondria and
increased mitochondrial ROS production and DNA release, which gets removed by p62
mediated mitophagy to prevent excessive inflammasome activation (Nakahira et al., 2011;
Zhong et al., 2016; Zhou et al., 2011). To understand whether methionine and cysteine
restriction induced p62 mediated mitophagy to reduce inflammation, the NLRP3
inflammasome was activated in BMDMs lacking p62 in the presence or absence of SAAs.
Interestingly, despite an increase in inflammasome activation caused by p62 deficiency
alone, methionine and cysteine restriction still reduced inflammasome activation in p62
deficient macrophages, suggesting that the methionine and cysteine restriction was
independent of p62 driven mitophagy (Fig 2.1B). Furthermore, methionine and cysteine
restriction did not alter potassium efflux, suggesting that the autophagy mediated effects
were downstream of the inflammasome assembly trigger, potassium efflux (Fig 2.1 C). We
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next tested the impact of methionine and cysteine restriction in a mouse model of
constitutively active NLRP3, where a mutation found in MWS patients was knocked into
the Nlrp3 gene (Nlrp3A350VneoR) (Brydges et al., 2009). The mutation found in the NACHT
region of the Nlrp3 gene, causes auto-assembly of the inflammasome once it is expressed,
even in the absence of a signal 2 trigger. We found that culturing BMDMs from
Nlrp3A350VneoR mice in the absence of methionine and cysteine restriction still reduced
inflammasome activation, observed by decreased IL-1β cleavage and secretion (Fig 2.1 D).
Since the Nlrp3A350VneoR mutation leads to auto-assembly of the inflammasome complex
even in the absence of any secondary signals, methionine and restriction driven autophagy
likely reduces inflammasome activation by increasing the clearance of NLRP3 complex
components.

Exogenous hydrogen sulfide inhibits inflammasome activation
In addition to autophagy, the TSP is increased in the liver during MR, specifically by an
increase in the expression of CSE (Fig 2.4A). To understand whether intrinsic TSP might
directly regulate inflammasome activation, we first explored whether macrophages express
CSE, the enzyme required for the last step of cysteine production within the TSP. Although,
some studies suggest that CSE is induced in macrophages in the context of bacterial
infection (Gobert et al., 2019), we find that BMDMs in M1 (LPS + IFNγ) or M2 (IL-4)
polarization conditions do not express CSE (Fig 2.2A). Preliminary experiments in
peritoneal macrophages had suggested that CSE may be induced with thioglycollate
stimulation (Fig 2.3A). However, confirmation with Cth-/- mice revealed that these bands
were nonspecific (Fig 2.2B). Gene expression analysis of PBS or thioglycolate induced
peritoneal macrophages did not detect Cth or Cbs expression (data not shown).
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Furthermore, published RNA-seq data sets from the ImmGen consortium suggest little to
no expression of Cth in various tissue macrophages (Fig 2.3C) (Heng et al., 2008). These
analyses establish that macrophages lack cysteine synthesis machinery, and likely import
cysteine/cystine extracellularly to maintain cellular homeostasis. Given the lack of CSE
expression in macrophages, we explored the effects of exogenously provided H2S in
regulating inflammasome activation. We found that treatment with sodium hydrosulfide
(NaHS), a H2S donor, reduced Il-1β secretion in a dose dependent manner (Fig 2.2B).
Given reports that H2S can modify NF-κB to regulate its role in the transcription of
antiapoptotic pathways (Sen et al., 2012), and the role of NF-κB in priming inflammasome
activation by transcription of NLRP3 components, Nlrp3, Il1b, and Il18, we investigated
whether transcription of NF-κB targets were altered. However, we find that transcription
of Nlrp3, Il1b, or Il18 is not changed by exogenous H2S during inflammasome activation
(Fig 2.2C). Additionally, potassium efflux is not affected with H2S treatment, suggesting
that detection of secondary DAMP signals is not altered by H2S (Fig 2.2 D). Interestingly,
H2S treatment is unable to reduce inflammation in Nlrp3A350VneoR BMDMs, suggesting that
H2S may be acting during the assembly of the NLRP3 inflammasome complex.

Methionine restriction improves metabolic health and reduces inflammation during
aging
To investigate the effects of MR in vivo, we fed young, 8-week-old mice and old, 18month-old mice MR diet for three months. We find that MR prevents weight gain in both
young and old animals (Fig 2.4 A-B). This reduction in weight gain aligns with a reduction
in adiposity, with reduced subcutaneous fat (SFAT) mass (Fig 2.4C), visceral epididymal
fat (EFAT) mass (Fig 2.4D), and lipid content in the liver (Fig 2.4G). Additionally, MR
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animals had improved glucose and insulin sensitivity (Fig 2.4E-F), suggesting that MR can
improve metabolic health, even when started in already aged animals. Consistent with prior
studies that have shown that macrophages are the main drivers of inflammation in adipose
tissue of aged mice (Camell et al., 2017; Lumeng et al., 2011; Wu et al., 2007), MR reduced
EFAT macrophages in both young and old animals, while to a lesser degree, macrophages
were reduced in the SFAT in young animals with MR (Fig 2.4H-I). Additionally,
transcription of inflammatory cytokines, IL-1β and IL-6 were reduced in the retroperitoneal
fat (RPFAT), a visceral adipose depot, with 3 months MR (Fig 2.4J). Similarly, gene
expression of NLRP3 inflammasome components, Il1b, Nlrp3, and Il6 is also reduced in
the SFAT of animals that underwent PR (Fig 2.4K). However, reduction in inflammation
was only observed in the RPFAT of young animals, but not old animals (Fig 2.4J, 2.5E).
To understand these results, we investigated the expression of the TSP in young and old
animals. We find that regulation of the TSP during MR is tissue dependent. CSE is most
highly expressed in the liver and kidney in mice (Fig 3.3C). In response to MR, CSE is
induced specifically in the liver but not the kidney (Fig 2.5A-B). In the RPFAT, expression
of CSE is not changed, but MR increases the expression of CBS, another TSP enzyme that
can generate H2S, in young animals, but not old animals (Fig 2.5C-D). This specific
increase in the expression of TSP in young animals is consistent with the decreased
expression of inflammatory cytokines in young animals. Additionally, though RPFAT is a
visceral adipose depot, the contribution of inflammation in RPFAT towards systemic
metabolism has not been well characterized. How inflammation and TSP is being regulated
in other visceral adipose depots such as EFAT, and liver during MR in young and old
animals may be more relevant to the systemic metabolic changes that are observed.
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Methionine restriction fails to reduce inflammation in models of NLRP3
inflammasome activation
In order to determine whether MR can reduce inflammation in pathological states we
turned to in vivo models of MWS and acute endotoxemia. Inducible Nlrp3A350VneoR/+ CAGcre mice were fed MR diet 1 week prior to tamoxifen treatment. Mice were injected with
tamoxifen once daily for two days. Nlrp3A350VneoR/+ CAG-cre mice begin to lose weight
rapidly and in severe cases begin to die (Fig 2.6A). There was no difference in weight loss
between CTRL and MR fed animals (Fig 2.6A). Despite reduced splenomegaly due to
inflammation in MR fed animals (Fig 2.6B), parameters of inflammation such as gene
expression of NLRP3, Casp-1, IFN-γ, TNFα, and IL-18 were not decreased in the spleen,
and if anything, IL-1β was increased with MR (Fig 2.6C). Furthermore, there were no
differences in serum levels of IL-1β, IL-6, TNF, and MCP-1 between CTRL and MR fed
animals (Fig 2.6D). We next tested the impact of MR in a model of acute endotoxemia,
where young WT mice were injected intraperitoneally (i.p.) with lipopolysaccharide (LPS)
for four hours after being on CTRL or MR diet for three months. Compared to CTRL diet
fed animals, MR fed mice showed no differences in metabolic parameters such as decreases
in blood glucose (Fig 2.6E), core body temperature (CBT) (Fig 2.6F), or systemic
inflammation, measured by serum IL-1β, IL-6, TNF, and MCP-1 (Fig 2.6G). These results
suggest that short- and long-term MR may be insufficient to reduce inflammation in
NLRP3 inflammasome mediated pathological states.
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Summary and Discussion
Through in vitro studies utilizing BMDMs, we find that MR can reduce NLRP3
inflammasome mediated inflammation through two separate mechanisms: the first through
induction of autophagy due to decreases in systemic SAAs. This induction of autophagy is
independent of p62 mitophagy, suggesting that SAA restriction may reduce mitochondrial
ROS through alternative mechanisms. SAA restriction can reduce NLRP3 mediated
inflammation even in a MWS model of constitutively active NLRP3, indicating that SAA
restriction mediated autophagy may act downstream of inflammasome assembly,
potentially through increased degradation of inflammasome components. Some groups
have shown that pro-IL-1β can be degraded intracellularly by autophagy and proteosomes
to reduce IL-1β release (Ainscough et al., 2014; Harris et al., 2011). Indeed, pro IL-1β is
reduced with SAA restriction in an autophagy dependent manner (Fig 2.1B), suggesting
that increased degradation of pro-IL-1β can also be playing a role in the reduction of
inflammasome activation during SAA restriction.
Besides the activation of autophagy to reduce NLRP3 mediated inflammation, we
find that exogenously produced H2S can act on macrophages to reduce inflammasome
activation. This action of H2S is independent of the transcriptional activity of NF-κB in
response to signal 1, unlike what has previously been shown about the action of H2S on
NF-κB regulation of antiapoptotic pathways in response to inflammation (Sen et al., 2012).
Instead, the action of H2S seems to be downstream of sensing of signal 2 and potassium
efflux, potentially regulating the assembly of the inflammasome complex. H2S can act
regulate enzymatic activity by posttranslational modification of reactive cysteine thiol
groups in a process called sulfhydration (Paul and Snyder, 2015). Particularly of interest,
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many different posttranslational modifications (PTMs) have been detected in NLRP3 and
have been found to play important roles in NLRP3 inflammasome activation (Shim and
Lee, 2018). Besides PTMs involved in the phosphorylation and ubiquitination of NLRP3,
other known PTMs involve modifications of cysteine thiol groups. One of these PTMs
include alkylation, which was first reported by Juliana et al where inhibitors such as Bay117082 acted through direct alkylation of NLRP3 (Juliana et al., 2010). Cys419, which
resides in the ATPase catalytic pocket of NLRP3 has been predicted as a potential
alkylation site (Cocco et al., 2016), which is consistent with reduced ATP binding affinity
and reduced ATPase activity of NLRP3 post-alkylation (He et al., 2014; Juliana et al.,
2010). This ATPase activity is important for the oligomerization of NLRP3 with itself as
well as with ASC (Duncan et al., 2007). More recently, diarylsulfonylurea NLRP3
inhibitors such as MCC950/CRID3 was shown to bind to the ATP binding pocket of the
NACHT domain (Walle et al., 2019). Subsequently, MCC950/CRID3 was unable to reduce
circulating IL-1β and IL-18 in CAPS models of mice where there are mutations in the
NACHT domain (Walle et al., 2019). Given that H2S was unable to reduce inflammasome
activation in BMDMs modeling MWS (Nlrp3A350VneoR), H2S may similarly be acting in the
ATP binding pocket to regulate ATPase activity and assembly of inflammasome. More
recently, the itaconate derivative, 4-OI was shown to alkylate NLRP3 to block interaction
with NEK7, and could reduce inflammasome activation in human CAPS peripheral blood
mononuclear cells (PBMCs) (Hooftman et al., 2020). Unlike H2S, 4-OI is much larger, and
likely creates steric hindrance to prevent NLRP3 binding with its binding partners.
In addition to our work, other groups have independently found a role for H2S in
regulating NLRP3 inflammasome activation. Castelblanco et al. found in BMDMs and
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THP1 cells that H2S treatment via sodium thiosulfate or GYY4137 inhibited MSU or
nigericin induced inflammasome via blocking ASC oligomerization (Castelblanco et al.,
2018). However, another study investigating H2S action on human PBMCs and THP1 cells
found that NaHS treatment contrarily increased the production of IL-1β and IL-18 (Basic
et al., 2017). This last study treated cells with 1mM NaHS which is an extremely high dose
of H2S. And while physiological and toxic levels of H2S have been controversial given
the volatile nature of H2S, making it difficult to accurately measure, these studies
reinforce the notion that a tight balance of H2S is required to modulate inflammation and
studies manipulating H2S intrinsically, rather than the use of extrinsic donors, will be
important to understand the role of H2S physiologically.
In line with the in vitro results identifying potential pathways to regulate
inflammation during MR, we found improved metabolic health in both young and old
animals that underwent 3 months MR. In the adipose tissue, there was a reduction of
macrophages, the major expressors of NLRP3 inflammasome with MR and a reduction in
the expression of NLRP3 mediated inflammatory components in adipose tissue with MR
and PR. However, this reduction in adipose tissue inflammation was limited to young
animals and not old animals when the RPFAT was examined. Consistently, TSP was only
upregulated in the RPFAT of young animals with MR, suggesting that local production of
H2S may have mediated the specific reduction of inflammation in young animals.
However, old animals expressed higher basal levels of CBS in the RPFAT on CTRL diet,
indicating that absolute expression of TSP genes alone cannot predict inflammatory status
in adipose tissue. Importantly, we were unable to evaluate inflammation and the TSP in
gonadal visceral tissues in this study, which play important roles in metabolic decline with
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age (Camell et al., 2019; Camell et al., 2017; Lumeng et al., 2011; Morris et al., 2013).
Whether MR can reduce inflammation in tissues that are associated with systemic
metabolic homeostasis such as EFAT and liver to mediate the improved metabolic
parameters in aged animals needs to be further investigated.
Finally, short- and long-term MR diet was unable to reduce inflammation in the in
vivo models of MWS-NLRP3 inflammasome activation and endotoxemia. Both of these
models involve acute activation of the NLRP3 inflammasome, whereas aging is
characterized by more chronic low-grade inflammation. Thus, MR as an intervention may
not be able to induce autophagy and TSP to levels required to restrict large scale acute
inflammation.
In conclusion, we find that pro-longevity interventions such as MR has the potential
to reduce NLRP3 inflammasome activation through induction of autophagy and the TSP.
MR and PR can indeed reduce NLRP3 associated cytokines, IL-1β and IL-6 in the adipose
tissue of young animals, and improve metabolic parameters, even when started at an old
age, when age-associated inflammation and metabolic deterioration has already begun.
However, MR is unable to reduce inflammation in the context of acute strong inflammatory
stimuli such as CAPS and endotoxemia. Whether the pathways identified from our in vitro
studies can be further harnessed to reduce inflammation in a broader context of
inflammatory disease needs to be further investigated.
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Figures

Figure 2. 1 Methionine and cysteine restriction drives autophagy to reduce
inflammasome activation.
A) Differentiated BMDMs were switched to culture media containing or lacking methionine and cysteine
and stimulated with LPS for 4 hours and ATP for an additional 1 hour. Caspase 1 and IL-1β were detected
by western blot of lysate and supernatant. B) WT and p62 KO BMDMs were switched to culture media
containing or lacking methionine and cysteine and stimulated with LPS for 4 hours and ATP for an
additional 1 hour with or without the treatment of 3-MA. IL-1β cleavage was detected in the lysates by
western blot. C) Intracellular potassium levels were detected in BMDMs cultured with or without
methionine and cysteine during LPS and ATP mediated inflammasome activation. D) Nlrp3A350VneoR
Cag-cre BMDMs were activated with 4-OHT (Tam) and cultured in the presence or absence of
methionine and cysteine during LPS and ATP mediated inflammasome activation. IL-1β was detected
in lysates and supernatant by western blot. Data representative of at least 3 independent experiments,
with the exception of p62 KO BMDM experiments, which was only repeated twice. C) Data expressed
as mean±SEM. Statistical differences were calculated by unpaired t-test. *p<0.05, **p<0.01, ***p<0.001
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Figure 2. 2 Exogenously produced hydrogen sulfide inhibits inflammasome
activation.
A) Differentiated BMDMs were untreated (M0), or polarized with LPS and IFNγ (M1), or IL-4 (M2) for
24 hours. CSE was detected by western blot, with liver lysate as a control. B) BMDMs were treated with
0, 10, 50, 100uM of NaHS with 4 hour LPS and 1 hour ATP stimulation. IL-1β was detected in lysate
and supernatant by western blots. C) BMDMs were treated with 0, 10, 50, 100uM NaHS and stimulated
with LPS for 4 hours. Inflammasome gene transcripts were quantified by qPCR with Gapdh as the
reference gene. D) Intracellular potassium levels were detected in BMDMs cultured with increasing
concentrations of NaHS during LPS and ATP stimulation. E) Nlrp3A350VneoR Cag-cre BMDMs were
activated with 4-OHT and cultured with increasing NaHS with LPS stimulation. IL-1β was detected in
lysates and supernatant by western blot. Data representative of at least 3 independent experiments. C-D)
Data expressed as mean±SEM. Statistical differences were calculated by unpaired t-test. *p<0.05,
**p<0.01, ***p<0.001
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Figure 2. 3 CSE is not expressed in macrophages
A) Expression of CSE in PBS and thioglycollate induced peritoneal macrophages
measured by western blot. B) Western blot expression of CSE in Cth+/+ and Cth-/- in
thioglycollate induced peritoneal macrophages shows band is nonspecific. C) RNAseq expression of Cth expression in various macrophage and stromal populations
from the ImmGen Consortium.
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Figure 2. 4 MR reduces inflammation in vivo.
A) Body weight curves of young and old mice on Ctrl or MR diets over 12 weeks (n=10,10,7,5/group).
B) Percent gain in body weight over 13.5 weeks quantified. Dissected C) SFAT and D) EFAT mass
normalized to body weight. E) GTT post 14 hours fasting and glucose bolus IP in young and old animals
after 12 weeks Ctrl or MR diet. F) ITT post 4 hour fast and insulin IP after 13 weeks Ctrl or MR diet.
G) H&E histology sections of liver in young and old animals fed 13.5 weeks CTRL or MR diet. White
scale bar represents 50um. H) Representative FACs panel of CD11b+ F4/80+ macrophages gated on
CD45+ CD3- B220- Siglec F- cells in EFAT. I) Macrophage populations gated as in H) quantified in
EFAT and SFAT. J) Inflammatory cytokines measured by qPCR in RPFAT in young animals fed 13.5
weeks Ctrl or MR diet. K) Inflammatory genes measured by qPCR in SFAT of animals after 6 months
PR. (I) Each data point is representative of 2 animals pooled. Data expressed as mean±SEM. Statistical
differences were calculated by (A, E-F) 2-way ANOVA with Sidak’s correction for multiple
comparisons and (B-D, I-K) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001
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Figure 2. 5 CSE expression during MR and inflammation in old adipose tissue.
A) Expression of CSE detected by western blot in liver of young and old animals fed Ctrl and MR diets
for 13.5 weeks. B) Expression of CSE detected by western blot in kidney of young and old animals fed
Ctrl and MR diets for 13.5 weeks. Expression of C) Cth and D) Cbs in RPFAT of young and old animals
fed Ctrl and MR diets for 13.5 weeks. E) Inflammatory cytokines measured by qPCR in RPFAT in old
animals fed 13.5 weeks Ctrl or MR diet. Data expressed as mean±SEM. Statistical differences were
calculated by unpaired t-test.
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Figure 2. 6 MR fails to reduce inflammation in models of MWS and LPS.
A) Body weight curves during daily tamoxifen injections after 1 week Ctrl or MR diet in Nlrp3A350VneoR
Cag-cre mice. B) Spleen weights in Nlrp3A350VneoR Cag-cre mice after 2 days of tamoxifen injections in
mice fed Ctrl or MR diet. C) Expression of inflammatory genes in the spleen of Nlrp3A350VneoR Cag-cre
mice measured by qPCR. D) Inflammatory cytokines measured by Luminex in the serum of
Nlrp3A350VneoR Cag-cre post tamoxifen injection. E) Percent changes in blood glucose levels after 4 hours
of PBS or LPS IP in mice fed Ctrl or MR diet for 3 months. F) Percent changes in core body temperature
after 4 hours of PBS or LPS IP in mice fed Ctrl or MR diet for 3 months. G) Inflammatory cytokines
measured by Luminex in the serum after 4hour PBS or LPS IP. Data expressed as mean±SEM. Statistical
differences were calculated by (A-B, D-G) 2-way ANOVA with Sidak’s correction for multiple
comparisons and (C) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001
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Chapter 3: Transsulfuration Pathway Mediated Cysteine Metabolism
and Thermogenesis
Introduction
The transsulfuration pathway (TSP) is induced during dietary interventions such as caloric
restriction (CR) and methionine restriction (MR) (Hine et al., 2015; Mitchell et al., 2016).
These diets are associated with improved metabolic health, increased energy expenditure
(EE), and reduced adiposity (Bruss et al., 2010; Hasek et al., 2010). While the effects of
one of the TSP byproducts, H2S, has garnered much attention as discussed in Chapter 2,
the molecular basis driving the induction of the TSP has not been studied. In this chapter,
we aim to investigate the basis for TSP induction, to further the understanding of
mechanisms that drive metabolic adaptations caused by sulfur amino acid (SAA) restriction
and its impact on organismal energy expenditure.

Results

Human calorie restriction induces the transsulfuration pathway in response to
reduced cysteine derived metabolites
To study the mechanisms that drive CR effects in human adipose, we analyzed the
subcutaneous adipose tissue (SFAT) of eight participants that maintained CR for 2 years
and provided biopsies at baseline, 12 months, and 24 months (Fig 3.1A). Transcriptomic
analyses of these tissues revealed that CR increased expression of CTH, which encodes for
the enzyme that catalyzes the synthesis of cysteine from cystathionine (called cystathionine
γ-lyase, or CSE) (Fig 3.1B). We observed a simultaneous reduction in the expression of
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BHMT, which encodes for betaine-homocysteine S-methyltransferase, and converts
homocysteine to methionine, away from cysteine production by the TSP (Fig 3.1B). This
suggested an activation of the transsulfuration pathway (TSP) to shift SAA metabolism
towards cysteine production (Fig3.1D). To understand the activation of the TSP during CR,
we analyzed the metabolites of SFAT after 12 months CR via metabolomics. In line with
the reduced expression of BHMT, we identified a reduction in dimethylglycine (DMG), a
byproduct of BHMT. Notably, while metabolites upstream of cysteine such as
cystathionine, homocysteine, S-adenosylhomocysteine (SAH), S-adenosylmethionine
(SAM), and methionine were not changed, we found that CR reduced cysteine derived
metabolites including cysteine, γ-glutamyl-cysteine (γ-Glu-Cys), glutathione (GSH), and
cysteinylglycine (Cys-Gly) (Fig3.1C). Collectively, these results suggest that sustained CR
in humans causes activation of the TSP as a metabolic response to maintain cysteine its
downstream metabolites (Fig 3.1.D).

Cysteine deficiency drives rapid loss of adipose tissue through an increase in energy
expenditure.
To assess whether cysteine depletion plays an integral role in driving CR effects,
we developed a model to induce cysteine deficiency in mice. Cysteine is a conditionally
essential amino acid, because cysteine can be generated by CSE. We developed Cth-/- mice
which lack CSE, and can therefore no longer produce cysteine, creating a model where
cysteine has to be sourced from the diet. Cysteine deficiency was thus induced by feeding
Cth-/- mice a custom amino acid diet that contains (CTRL diet) or lacks cystine (CysF diet)
as a dietary cysteine source (Appendix 1, Fig 3.2A). The CTRL and CysF diets are
isocaloric with almost equal ratios of macronutrients, and equal amounts of all other
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essential amino acids. Cystine was replaced with cornstarch in the CysF diet (Appendix 2),
but this replacement shifts the balance of calories between protein and carbohydrates by
less than 1%. Therefore, feeding Cth-/- a CysF diet produces a unique model of systemic
cysteine deficiency.
Utilizing this model, we found that mice with cysteine deficiency rapidly lost ~2530% body weight within 1 week compared to littermate Cth+/+ fed a CysF diet or Cth-/- fed
a CTRL diet (Fig 3.2B). Due to severe weight loss, mice are required to be euthanized
within one week. Despite rapid weight loss, mice remained active and did not display any
sickness behavior. This weight loss is associated with significant loss of fat mass relative
to lean mass (Fig 3.2C). This response is sex-independent, with female cysteine deficient
animals losing weight at equal rates to males (Fig 3.3, B). In wild type mice, Cth expression
is highest in the liver and kidney, with much lower expression found in the adipose tissues
and brain (Fig 3.3C). In order to determine whether tissue specific expression of Cth was
important to maintain systemic cysteine levels and prevent cysteine deficiency, we
generated Cthflox/flox animals (Fig 3.3D). Depletion specifically in the liver (Fig 3.3E-F), or
adipose tissue (Fig 3.3H-I) was insufficient to drive rapid weight loss, suggesting that the
expression of Cth in multiple tissues could compensate for a loss of Cth expression in a
specific tissue (Fig 3.3 G, J). In addition, Cth-/- animals co-housed together with Cth+/+
mice still maintained weight loss when fed a CysF diet, suggesting that microbiota is not
the driving factor of this weight loss (Fig 3.3K). In all, these results highlight that redundant
expression of Cth across multiple tissues defend systemic cysteine levels; loss of cysteine
maintenance causes severe weight and fat loss in a sex and microbiota-independent
manner.
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Consistent with a loss of fat mass, cysteine deficient animals increased their
normalized energy expenditure (EE) compared to CTRL diet fed animals, particularly
during the dark cycle (Fig 3. 2B). However, the representation of whole-body energy
expenditure has been highly debated within the metabolism field, and normalizing
metabolic rate to body mass has been criticized because it overcompensates for the mass
effect, leading to potential misinterpretation of actual biology (Tschop et al., 2011).
Instead, calculation of the analysis of covariance (ANCOVA) or representation of the data
as regression between energy expenditure and body mass, have been proposed as better
methods for comparing differences in metabolic rates (Tschop et al., 2011). However, these
methods have been shown to generate spurious results when mice display no overlap of
body weight between groups (Fernandez-Verdejo et al., 2019), such as is between the
Cth+/+ and Cth-/- mice fed CysF diet. Indeed, typical light and dark cycle EE averages for 2
days against body mass did not allow for proper comparison of the regression of the two
groups, due to a lack of overlap between the two data sets (Fig 3.4 C). Similarly, regression
of EE of the light cycle over 2 days against body mass is not significantly different between
Cth+/+ and Cth-/- mice (Fig 3.4A). But notably, comparison of the regression of EE during
the dark cycle between Cth+/+ or Cth-/- mice is significantly different, suggesting that EE is
indeed increased in cysteine deficient animals during the dark cycle (Fig 3.4B). These
results are consistent with normalized EE shown in Fig 3.2D-E. Careful examination of the
EE over the full week of CysF diet, clearly portrays that the whole EE curve slowly shifts
down in cysteine deficient animals that are continuously losing weight (Fig 3.4D). Even as
the absolute values of EE are decreasing as the mice lose weight, the amplitude of the peaks
remains consistent (Fig 3.4D). This unique, robust weight loss situation highlights the fact
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that body mass does indeed contribute to the absolute measurements of EE and may justify
the use of normalized EE in this context.
To assess whether the increase in energy expenditure was supported by increased
fat utilization, we examined the respiratory exchange ratio (RER). RER is measured by the
ratio between carbon dioxide production and oxygen consumption, and serves as an
indirect measurement of the respiratory quotient. The respiratory quotient during rest and
mild activity indicates the fuel preference that is being utilized for metabolism. An RER of
1.0 indicates a predominant utilization of carbohydrates as the fuel source whereas an RER
of 0.7 indicates fat as the predominant fuel source. When we measured RER in Cth+/+ and
Cth-/- mice fed CysF diet, we found that cysteine deficient animals had significant reduction
in RER through both the light and dark cycle (Fig 3.4E-F), indicating increased fat
utilization. This supports the decrease in fat mass and increase in EE in cysteine deficient
animals, as fat is a much more efficient fuel source than carbohydrates.
Regulation of total body weight is tightly controlled by mechanisms that maintain
the balance of energy intake and EE. The weight loss during cysteine deficiency could thus
be caused by a reduction in energy intake in addition to increased EE. When we compared
food intake of Cth+/+ or Cth-/- mice fed CysF diet, we found no significant differences in
accumulated food intake (Fig 3.4G). But accurate measurements of food intake were
difficult due to cysteine deficient animals having an increased propensity to play with their
food at later time points. To definitively determine the contribution of energy intake vs. EE
on weight loss, we conducted a paired food intake experiment using a relatively low
amount of food provided daily to ensure that all the mice finished the daily allotment of
diet. Given the slight caloric restriction this caused, there was a non-significant, but
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consistent decrease in body weight in pair fed animals compared to ad libitum fed animals
(Fig 3.4H). But despite eating the same amount of food, only cysteine deficient pair fed
animals lost significant body weight and fat mass (Fig 3.4H-I). This supports the notion
that an increase in EE, rather than a reduction in energy intake was driving the weight loss
in cysteine deficient animals.

Serum metabolite analysis confirms systemic cystine deficiency
We next conducted serum metabolomics to identify systemic changes in metabolite
profile during cysteine deficiency. Principle component analysis (PCA) displayed clear
separations of Cth+/+ and Cth-/- metabolite profiles with an additional separation between
Cth-/- CTRL and CysF fed animals (Fig 3.5A). Fig 3.5B displays the top 25 metabolites
changing in Cth-/- CysF animals compared to CTRL fed mice. One of these metabolites is
L-cystine, which is significantly reduced in Cth-/- CysF serum (Fig 3.5B, C). Cysteine and
its downstream metabolites, γ-Glu-Cys, and GSH are not altered, suggesting that cysteine
deficiency is really maintained by a reduction in systemic cystine levels (Fig 3.5C). This
makes sense, as cystine is the predominant form of cysteine in the circulation. Interestingly,
with the exception of cystathionine which is significantly increased in CysF diet fed Cth-/mice compared to CTRL fed animals, other SAA metabolites such as methionine, SAM,
SAH, and Hcys, are not significantly changed (Fig 3.5C). Instead, analogs of cysteine and
GSH associated metabolites, such as 2-aminobutyric acid (2AB) and ophthalmic acid (OA)
are increased in the serum of cysteine deficient mice (Fig 3.5C). OA is a GSH analog where
cysteine is replaced by 2AB, and this increased flux towards OA production vs GSH
production may be indicative of systemic cysteine deficiency (Fig 3.5D). We explored the
potential bioactivity of several metabolites increased with cysteine deficiency including
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OA, 2AB, and uridine in the context of lipid mobilization. To do this, we conducted an ex
vivo lipolysis assay on adipose explants. We were unable to find repeatable effects of these
metabolites in inducing lipolysis ex vivo, suggesting that these metabolites are not directly
involved in driving lipid mobilization through action on adipocytes (data not shown).
Additional studies are required to definitively asses a functional role of these metabolites
in lipid metabolism. Regardless, serum metabolomics was able to identify that cysteine
deficiency was indeed being induced in this model, maintained by a decrease in circulating
cystine.

Cysteine deficiency drives thermogenesis of adipose tissue.
The decrease in fat mass during cysteine deficiency is driven by a loss of all major
adipose depots including subcutaneous fat (SFAT), visceral epididymal fat (EFAT), and
brown adipose tissue (BAT) (Fig3.6A). Histological analyses revealed this reduction in
adipose tissue size is associated with a complete transformation of white adipose depots
into a BAT-like appearance, with the formation of multilocular adipocytes and enlarged
nuclei, a phenomenon known as browning (Fig3.6B). Surprisingly, these morphological
changes were quite robust in the EFAT as well, which is normally not considered to be an
adipose depot amenable to browning (Fig3.6B). Given these robust changes in the adipose
tissues, we conducted total RNA-sequencing (RNA-seq) of the major adipose depots,
SFAT, EFAT, and BAT, to broadly asses the molecular basis of the changes occurring in
adipose tissue during cysteine deficiency. PCA analysis reveals that cysteine deficiency
drives clear transcriptomic changes in all three tissues (Fig 3.6C), with almost binary
transcriptional changes occurring in the SFAT and EFAT as displayed by heatmap (Fig
3.6D). Gene set enrichment analysis comparing Cth-/- CysF vs CysF CTRL identified that
47

the top downregulated pathways are involved in extracellular matrix and collagen
deposition, highlighting the broad remodeling of the adipose tissue that is also evident from
the histology (Fig 3.6E). In addition, multiple metabolic pathways appear to be regulated
by cysteine deficiency within the SFAT with ‘respiratory electron transport chain and heat
production’ as the top pathway induced during cysteine deficiency (Fig 3.6E).
Indeed, numerous genes identified by the ‘thermogenesis’ GO-term pathway are
differentially expressed comparing Cth-/- CTRL and CysF in the SFAT (Fig 3.7A). Brown
adipocytes are unique from white adipocytes in that they contain high density of
mitochondria, which are densely packed with cristae and increased respiratory-chain
components (Himms-Hagen and Desautels, 1978). This increased mitochondrial capacity,
along with the expression of UCP1, which uncouples oxidative phosphorylation, allows
for increased heat production. Compared to Cth-/- CTRL, Cth-/- CysF have increased
proportions of reads that map to the mitochondria in the SFAT, suggesting an increase in
mitochondrial content like brown adipocytes (Fig 3.7B). Additionally, UCP1, which is
normally not expressed in white adipose tissues, becomes widely expressed with cysteine
deficiency in both the SFAT and EFAT as measured by UCP1 staining in paraffin
embedded sections (Fig 3. 7C). This increase in UCP1 was confirmed by WB and qPCR
in the SFAT (Fig 3. 7D-E). The induction of numerous thermogenic genes that were
identified by RNA-seq including Cidea, Cox7a1, Cox8b, Dio2, Eva1, Pgc1, Elovl3, and
Slc27a2, was also verified by qPCR (Fig 3.7E-F). These results indicate that surprisingly,
cysteine availability acts as a thermogenic checkpoint.
To identify the metabolic pathways important for the tissue remodeling observed
during cysteine deficiency, we utilized GAM-clustering to identify pathways commonly
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changing in all three tissues. GAM-clustering is a recently developed, network-based
computational approach for unbiased identification of key metabolic subnetworks from
transcriptional profiles generated by RNA-seq. It was recently refined to allow for the
comparison of multiple groups (Gainullina et al., 2020). GAM-clustering applied to the
RNA-seq of all three tissues (SFAT, EFAT, and BAT) with all four sample conditions
(Cth+/+ and Cth-/- fed CTRL or CysF diet) identified 8 distinct metabolic modules (Fig
3.8A). Some of these modules identified tissue specific metabolic features, such as modules
1 and 2 which were more specific to BAT, whereas modules 3, 5, and 7 were more specific
to the white adipose depots, SFAT and EFAT. Within those white adipose tissue modules,
module 5 was most enriched in EFAT whereas module 3 was most enriched in SFAT (Fig
3.8A). Interestingly, module 2, which was strongly enriched in the BAT of all animals, was
also slightly enriched in the SFAT and EFAT of cysteine deficient animals specifically.
Given the browning of white adipocytes that occur with cysteine deficiency, this module
may highlight metabolic pathways directly related to thermogenic capacity. Pathways
enrichment analysis identified branched chain amino acid (BCAA) degradation, TCA
cycle, and fatty acid (FA) metabolism to be key features in module 2 (Fig 3.8B, E). The
enrichment of BCAA degradation is quite interesting, as a recent study found that BCAAs
were actively taken up by BAT upon cold exposure to fuel mitochondrial oxidation
(Yoneshiro et al., 2019). Similarly, during cysteine deficiency, increased BCAA
catabolism in the adipose tissues may support mitochondrial oxidation to drive
thermogenesis.
Module 4 represented metabolic features that were downregulated by cysteine
deficiency across all three tissues (Fig 3.8A, C). This module was characterized by steroid
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and cholesterol biosynthesis, suggesting that cholesterol biosynthesis is decreased in the
adipose tissues during cysteine deficiency (Fig 3.8 C, F). Conversely, module 6 represented
metabolic features that were increased by cysteine deficiency across all three tissues (Fig
3.8A, D). This module was specific to lipid metabolism (Fig 3.8D, G). These unbiased
analyses point towards increased changes in lipid metabolism and BCAA metabolism to
support increased mitochondrial oxidation and thermogenic capacity of adipose tissues
during cysteine deficiency.

Redox status of adipose tissue during cysteine deficiency
One important aspect of cysteine metabolism is its role in redox homeostasis.
Cysteine is a component of glutathione, one of the major antioxidants that neutralize
oxidative damage. Chouchani et al have demonstrated that mitochondrial ROS is acutely
increased during cold challenge, and is required for UCP1 activity. They showed that
sulfenylation of UCP1 due to increased mitochondrial ROS exposure is required to activate
UCP1 from its purine inhibited state (Chouchani et al., 2016). Similarly, forcing oxidative
redox state by treatment with a glutathione depleting agent, buthionine sulfoximine,
increases the expression of thermogenic programs in adipose tissue (Barbato et al., 2015).
These studies suggest that increased oxidative stress is an additional regulator of
thermogenesis in the adipose tissues. Given the requirement of cysteine for glutathione
synthesis, oxidative stress could be induced during cysteine deficiency. We performed
metabolomics in the SFAT to assess the impact of cysteine deficiency on glutathione and
cysteine metabolism in the adipose tissue undergoing a thermogenic response.
Surprisingly, we detected no differences in glutathione in its reduced form (GSH) by
orbitrap type mass spectrometry (Fig 3.9A). However, the oxidized form of glutathione
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(GSSG) was decreased in the SFAT, suggesting that oxidative status during cysteine
deficiency in the adipose tissue may actually be reduced (Fig 3.9A). Furthermore, cysteine
levels were increased while cystine levels in the adipose tissue are not altered, supporting
a lack of GSH depletion in adipose tissue and a less oxidative redox state (Fig 3.9B).
However, in contrast to our results where we do not find serum or tissue reductions of
GSH, other groups that have investigated cysteine deficiency, report reductions of GSH in
the plasma (Mani et al., 2011), and liver (Ishii et al., 2010; Mani et al., 2011). Further
evaluation of redox status by measuring ROS production and confirmation of GSH levels
through other methods may be important to make definitive conclusions of the redox status
in adipose tissues during cysteine deficiency. Ophthalmic acid (OA) has been suggested as
an oxidative stress biomarker indicative a hepatic GSH consumption (Soga et al., 2006).
In addition to serum OA, we find OA is increased in the SFAT during cysteine deficiency
(Fig 3.9D). Gene expression of enzymes involved in the synthesis of GSH and OA, Gclc
and Gss were elevated (Fig 3.9C), suggesting that there may indeed be increased pressures
to maintain GSH and OA during cysteine deficiency. However, cysteine deficiency also
increases threonine levels in the SFAT, which is an upstream metabolite that generates
2AB and OA (Fig 3.9D-E). Thus, substrate availability could drive the activation of this
pathway and OA production independently of glutathione synthesis. Collectively,
metabolomics of SFAT during cysteine deficiency suggests that redox homeostasis is
shifted towards a more reduced state, rather than oxidative state, and thus unlikely to be a
driving mechanism of thermogenesis in this context.
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scRNA-seq of SFAT stromal vascular fraction suggests increased mobilization of
preadipocytes.
To understand the cellular basis of adipose tissue remodeling during cysteine
deficiency, we isolated the SFAT stromal vascular fraction by enzymatic digestion and
conducted single cell RNA sequencing (scRNA-seq) by 10x Genomics. We isolated cells
from Cth+/+ and Cth-/- fed CTRL or CysF diet for 4 days to identify changes occurring
before full remodeling of the tissue, with each sample pooled from 4 animals (Fig 3.10A).
A total of 4,666 cells in Cth+/+ CTRL; 5,658 cells in Cth+/+ CysF; 4,756 cells in Cth-/- CTRL;
and 3,786 cells in Cth-/- CysF were analyzed for scRNA-seq (Fig 3.10D). By unbiased
clustering, we were able to identify a total of 15 cell populations, including 3 adipocyte
progenitor populations; endothelial and pericytes; mixed T cell populations including αβ T
cells, γδ T cells, ILC2s, and NK T cells; B cells; reticulocytes; mesothelial-like cells;
Schwann cells; and several myeloid clusters (Fig 3.10B-C). Comparison of Cth-/- CysF
with other groups revealed dramatic changes in cellular composition and transcriptional
state (Fig 3.10D).
Particularly, a significant loss of clusters 0, 1, and 2 were apparent during cysteine
deficiency (Fig 3.10D-E). Furthermore, these clusters contained the highest numbers of
differentially expressed genes (Fig 3.11E), highlighting them as important populations in
mediating the effects of cysteine deficiency. By expression of Pdgfra, we were able
identify these clusters as adipocyte progenitors (Fig 3.10C, F). To understand the
differential changes amongst these clusters, we conducted pseudotime analysis to place
these clusters on a trajectory to help allocate their cell lineage. Trajectory analysis based
on pseudotime suggested that cluster 2 differentiates into two separate preadipocyte
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clusters, cluster 0 and 1 (Fig 3.10G-H). Cth-/- CysF animals proportionally lost Clusters 0
and 1, while relatively maintaining cluster 2 compared to the other groups (Fig 3.10D-E),
suggesting that more differentiated preadipocytes were becoming mobilized and lost
during cysteine deficiency. Indeed, cluster 2 expressed Dpp4, an early progenitor marker
that has been shown to give rise to different committed preadipocytes (Merrick et al.,
2019)(Fig 3.10I). Cluster 0 was enriched for both Icam1 and F3, which have been shown
to be expressed by committed adipogenic, and antiadipogenic preadipocytes, respectively
(Hepler et al., 2018; Merrick et al., 2019)(Fig 3.10I). Cd9, a fibrogenic marker in
preadipocytes (Hepler et al., 2018; Marcelin et al., 2017), along with the collagen gene,
Col5a3, were broadly expressed across clusters 0 and 1, and was specifically lost by day 4
of inducing cysteine deficiency (Fig 3.10I). We next sought to identify beige/brown
adipocyte precursors in our scRNA-seq dataset to understand whether there was an
increased commitment towards brown adipocytes. To do this, we examined the expression
of a CL-316,243 β3-adrenergic receptor agonist-stimulated gene signature reported by Burl
et al, because β3-adrenergic signaling induces the differentiation of brown adipocytes (Burl
et al., 2018). We found that cluster 1 had the most pronounced expression of this gene
signature (Appendix 5, Fig 3.11B), and indeed Tagln, or Sm22, which have been
previously described in beige adipocytes (Berry et al., 2016; Long et al., 2014; Oguri et al.,
2020), is specifically expressed by a subset of cells in cluster 1 (Fig 3.10I). Interestingly,
these Tagln expressing cells are completely lost with cysteine deficiency (Fig 3.10I). Given
the strong browning phenotype observed at day 6, it is possible that these cells become
mobilized and differentiate early on during cysteine deficiency, leading to the absence of
these cells. Indeed, when we performed pathways analysis on cluster 1, comparing gene
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expression of Cth-/- CysF with Cth-/- CTRL, we found that one of the top upregulated
pathways was ‘adipogenesis’ (Fig 3.11C). Furthermore, when we examined the expression
of stem associated markers and mature adipocyte markers in the adipocyte progenitor
clusters, we observed a clear downregulation of stem markers and increase in mature
adipocyte markers, suggesting that cysteine deficiency was driving the maturation of
progenitor cells, which are not captured within the stromal vascular fraction (Fig 3.11A).
However, given the robust transformation of the adipose tissue during cysteine deficiency,
where significant portions of the white adipose tissue have become brown, it is unlikely
that mobilization of brown precursors alone is mediating this response. Transdifferentiation of mature white adipocytes into brown adipocytes can also contribute to the
browning of SFAT and needs to be further examined.

Cysteine deficiency increases lipolysis via activation of sympathetic nervous system
To determine the mechanism of adipose thermogenesis post-cysteine deficiency,
we next investigated the processes upstream of increased fatty acid oxidation. Activation
of the sympathetic nerves leads to release of catecholamines such as norepinephrine.
Norepinephrine acts on adipocytes through β3-adrenergic receptors and stored
triglycerides are hydrolyzed and converted to free fatty acids (FFAs) in a catabolic process
called lipolysis. These FFAs subsequently fuel mitochondrial respiration and ATP
production or uncoupling by UCP1 to generate heat (Fig 3.12A). Lipolysis is mainly
regulated by two lipases in white adipose tissue, hormone sensitive lipase (HSL) and
adipose triglyceride lipase (ATGL) (Zechner et al., 2009). When we measured the
activation of lipolysis in the SFAT by pHSL and ATGL by western blot, we found that
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cysteine deficiency increases ATGL expression without affecting pHSL levels (Fig 3.12B).
ATGL preferentially catalyzes the first step of triglyceride hydrolysis whereas HSL has a
much broader range of substrates with a preference for diacylglycerols and cholesteryl
esters (Haemmerle et al., 2002; Zimmermann et al., 2004). Our data suggests that
mobilization of lipids during cysteine deficiency is mainly mediated by ATGL, without
significant activation of HSL. Given a dramatic browning response in WAT during
cysteine deficiency, the increased ATGL expression is consistent with work that shows
BAT relies heavily on the action of ATGL to mobilize lipid substrates for uncoupling and
heat production (Morak et al., 2012).
Upstream of lipolysis, non-shivering thermogenesis is mainly activated by the
sympathetic nervous system and thyroid hormone. We find that norepinephrine levels are
significantly increased in Cth-/- CysF SFAT, compared to cysteine sufficient controls,
Cth+/+ CTRL, Cth+/+ CysF, and Cth-/- CTRL (Fig 3.12C), indicating that sympathetic
activation is significantly increased in the SFAT of cysteine deficient animals.
Furthermore, when we examined the RNA-seq of SFAT during cysteine deficiency, we
found that the expression of norepinephrine degradation enzymes, Comt and Maoa were
decreased in cysteine deficient mice (Fig 3.12D-E). Confirmation by qPCR revealed that
Maoa expression was indeed decreased (Fig 3.12G). However, the expression of Comt was
not consistently decreased in the SFAT with cysteine deficiency when measured by qPCR
(Fig 3.12F). Despite these disparities between different methods of accessing gene
expression of Comt, protein expression of COMT was lowered in cysteine deficient SFAT
when measured by western blot (Fig 3.12H). This reduction was more apparent in the
membrane bound form of COMT (MB-COMT). Furthermore, we found increased levels
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of S-adenosyl homocysteine (SAH) in the SFAT of cysteine deficiency, which can inhibit
the enzymatic activity of methyltransferases like COMT (Fig 3.12I). In all, these results
suggest the decreased degradation of norepinephrine during cysteine deficiency increases
catecholamine bioavailability together with sympathetic activation to promote lipolysis
and thermogenesis in SFAT (Fig 3.12J). Consistent with this, application of imaging mass
spectrometry to detect norepinephrine localization in BAT sections identified increased
concentrations and distribution of norepinephrine throughout the BAT tissue of cysteine
deficient animals (Fig 3.12K). These results suggest that cysteine deficiency drives
increased sympathetic activation, in part by a decrease in catecholamine degradation
enzymes. This increases lipolysis, mediated mainly by an increase in ATGL, which
provides the substrates required for mitochondrial respiration.

Cysteine deficiency leads to a loss of monocyte derived macrophages but enrichment
of resident macrophages.
Previously, it was shown that macrophages expressing catecholamine degradation
enzymes, COMT and MAOA, could regulate sympathetic activation in the context of aging
and obesity (Camell et al., 2017; Pirzgalska et al., 2017). Given the increased sympathetic
activation of SFAT and BAT during cysteine deficiency, we next aimed to understand
whether this process was being regulated by tissue resident macrophages. Besides a loss in
adipocyte progenitor populations, scRNA-seq of the stromal vascular fraction revealed a
decrease in multiple myeloid populations, such as cluster 8 and 11, as well as an enrichment
of a more resident macrophage population, cluster 4 (Fig 3.10E). Furthermore, in addition
to adipocyte progenitors, resident macrophages expressed a large number of differentially
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regulated genes, suggesting that they may play an important role in the remodeling of
adipose tissue during cysteine deficiency (Fig 3.11 E). When we examined macrophage
populations by flow cytometry, we were able to confirm a 50% reduction in macrophages
after 6 days of CysF diet in Cth-/- compared to Cth+/+ animals (Fig 3.13A).
To further understand the dynamic changes occurring in the macrophage
population, we performed scRNA-seq of resident myeloid cells after induction of cysteine
deficiency. Given that cysteine deficiency is accompanied by a loss of macrophages in an
already much smaller tissue, we chose a relatively early timepoint of 3 days of diet, and
pooled cells from 5 animals per group, to ensure we had enough cells for analysis. To target
resident cells within the tissue parenchyma, we utilized short-term intravenous (i.v.)
labeling of CD45 to exclude circulating cells, along with additional markers CD3, B220,
and Siglec F, to exclude T cells, B cells, and eosinophils, and CD11b that were stained
after single cell suspension to sort resident myeloid cells specifically (Fig 3.13B). We
performed scRNA-seq on a total of 7,877 cells from Cth+/+ and Cth-/- (Fig 3.13C), with
2,383 cells from Cth-/- CTRL and 2,679 cells from Cth-/- CysF (Fig 3.13D). Cth+/+
conditions were processed on a separate day from Cth-/- conditions, and we achieved much
fewer cells with 1,616 cells from the CTRL, and 1,199 cells in the CysF group (data not
shown). Of note, dendritic cell (DC) populations resembling conventional DCs, Cluster 5
and 6, were only identified in the Cth+/+ samples, suggesting potential inconsistencies in
the processing of these samples (Fig 3.13C). Due to the biases introduced by processing on
different days, we only show data from the Cth-/- from here onward.
In the scRNA-seq analysis of Cth-/- samples, we identified 5 other clusters of
macrophages, including (0) lipid associated macrophages that express high levels of Cd36;
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(1) Cd209 and Cd9 expressing macrophages/DCs; (2) Ly6c2 expressing monocyte derived
macrophages; (3) Lyve1 expressing resident macrophages; and (4) proliferating
macrophages (Fig 3.13C, 3.14A). Given our previous work identifying macrophages
tightly associating with nerve fibers and bundles (Camell et al., 2017), we hypothesized
that amongst the tissue resident macrophages, these nerve-associated macrophages
(NAMs) would play important roles in taking up and metabolizing catecholamines released
by sympathetic nerves to limit the availability of catecholamines to surrounding
adipocytes. Alterations to the function of NAMs may thus play important roles in
controlling sympathetic activation during cysteine deficiency. Currently, there are no
known markers for NAMs in the adipose tissue. To try to identify these macrophages in
our scRNA-seq datasets, we identified genes commonly expressed in NAMs of other
various tissues, such as the lung, gut, skin, and sciatic nerves (Chakarov et al., 2019;
Gabanyi et al., 2016; Kolter et al., 2019; Mueller et al., 2003; Pirzgalska et al., 2017; Ural
et al., 2020). When we overlayed this gene set (Appendix 6) onto our scRNA-seq data,
these genes were enriched in cluster 3 (Fig 3.13F). This cluster also specifically expressed
Maoa, one of the enzymes that degrade norepinephrine, supporting the notion that NAMs
are present within cluster 3 (Fig 3.13 G). Besides Maoa, cluster 3 macrophages also
expressed C1qa, Gas6, Mertk, and Lyve1 (Fig 3.13E, Fig 3.14A).
To verify an increase in NAMs during cysteine deficiency, we looked for cell
surface markers unique to cluster 3. We found that CD163 is highly expressed in cluster 3
(Fig 3.13H), and was able to verify an increase of CD163+ macrophages after 6 days of
inducing cysteine deficiency by flow cytometry (Fig 3.13I). However, it is important to
note that CD163 is not exclusively expressed in NAMs and can also be expressed by other
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resident macrophages in clusters 1 (Fig 13.H). In fact, transcriptionally, cluster 3 seemed
to be quite heterogeneous, with other markers such as Lyve1 present, which have been
described to be expressed in perivascular macrophages within the fat (Silva et al., 2019),
and Trem2 (Fig 14.A), which have been described in lipid associated macrophages that
increase in obesity (Jaitin et al., 2019). Indeed, when we examined the expression of
CD163 and Lyve1 by confocal whole mount imaging, we found that both CD163 and
Lyve1 were expressed by NAMs directly in contact with nerves, as well as parenchymal
macrophages that were further away from nerves (Fig 3.14B). Furthermore, the expression
of MAOA was detected in both NAMs as well as CD163+ macrophages that were
associated with adipocytes (Fig 3.14C-D). Collectively, these data suggest that
macrophages in the adipose tissue are not easily classified into distinct functional subsets
based on previously described markers. Nonetheless, the expression of Comt is widely
decreased in all macrophages with cysteine deficiency, suggesting that decreased
catecholamine degradation in macrophages may contribute to the increased sympathetic
tone in SFAT (Fig 3.13J).
To further understand the changes in the resident macrophage cluster where NAMlike macrophages appear to be enriched, we examined the pathway enrichment of
differentially regulated genes with cysteine deficiency in cluster 3 (Fig 3.14E). We found
that some of the top pathways increased in resident macrophages included
‘phosphodiesterases in neuronal function’ and ‘complement cascade’ (Fig 3.14E).
Particularly, recent work has found that microglia interact with neurons and synapses to
regulate neuronal function through the expression of complement and complement
receptors (Hong et al., 2016; Wang et al., 2020). Cluster 3 is indeed enriched in the
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expression of complement genes such as C1qa (Fig 3.14A). These pathways suggest
NAMs could be altering their interaction with nerves in the context of cysteine deficiency,
to support increased sympathetic activation (Fig 3.14 E).

UCP1 is not necessary for thermogenesis during cysteine deficiency
Given the robust activation of thermogenic pathways during cysteine deficiency,
we next investigated whether cysteine deficiency triggers adaptive thermogenesis to defend
core body temperature. We first evaluated whether core body temperature was being
altered during cysteine deficiency. Utilizing temperature data loggers surgically implanted
into the peritoneal cavity, we measured core body temperature of Cth-/- mice on CTRL or
CysF diet over 6 days. We found that core body temperature was not significantly different
between the two groups (Fig 3.15A-B). A recent study investigating the thermoneutral
point in mice, found that after ambient temperatures reached the thermoneutral point for
mice, energy expenditure remained constant at higher temperatures (Skop et al., 2020).
Instead, the body temperature of the mice began to increase as ambient temperatures
increased beyond the thermoneutral point (Skop et al., 2020). This study suggests that once
core body temperature is defended, energy expenditure levels are maintained at a minimal
level for basic bodily functions independent of core body temperature maintenance in mice.
During cysteine deficiency, mice have increased energy expenditure, but not higher core
body temperatures, suggesting that the increased energy expenditure is being utilized to
generate heat and defend core body temperature. To confirm that energy expenditure was
actually being utilized to generate heat, we utilized a magnetic resonance imaging (MRI)
method called BIRDS (Biosensor Imaging of Redundant Deviation in Shifts) to measure
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temperatures of BAT in Cth+/+ and Cth-/- animals after 6 days of CysF diet (Fig 3.15C).
This method relies on differing relaxation times of the non-exchanging protons of an
exogenous contrast agent, thulium and macrocyclic chelate, which becomes altered by
temperature. The chemical shifts that occur paramagnetically are detected by BIRDS and
converted into physicochemical parameters to obtain absolute temperatures with high
sensitivity (Coman et al., 2013; Coman et al., 2010). We adapted this method to measure
in vivo temperature differences of BAT in the context of cysteine deficiency. We found
that the relative temperature of the BAT compared to its surrounding tissue was higher in
Cth-/- mice compared to Cth+/+ mice (Fig 3.15C-D), suggesting that the adipose tissue was
increasing energy expenditure to indeed generate heat and defend core body temperature.
Cysteine deficiency seems to increase susceptibility to cold such that it is required
to increase heat production to maintain core body temperature. Considering that in animal
facilities, mice are normally housed at temperatures below their thermoneutral zone, mice
are constantly under thermogenic stress. To further confirm that mice were indeed inducing
thermogenesis to defend core body temperature due to increased susceptibility to cold, we
housed mice at 30°C in addition to 22°C. We found that housing at 30°C reduced the
browning phenotype of SFAT when cysteine deficiency was induced by 6 days of CysF
diet (Fig 3.15E-F). In addition, gene expression of Ucp1, required for uncoupling mediated
heat production, was reduced when housed at 30°C (Fig 3.15G), suggesting that indeed a
need to generate heat significantly drove thermogenic browning of the SFAT. However,
surprisingly, despite reduced fat mobilization and heat production, cysteine deficient
animals still significantly lost weight at 30°C (Fig 3.15E). Furthermore, transcriptional
expression of some mitochondrial enzymes involved in fatty acid oxidation such as Acadm
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and Cox8b were even further increased at 30°C with cysteine deficiency (Fig 3.15G),
suggesting that the browning responses are only attenuated and additional pressures to
mobilize fat metabolism and weight loss may be present during cysteine deficiency.
Given that these results suggested that cysteine deficiency somehow increased
pressures to defend core body temperature, we next tested whether UCP1 was required to
maintain core body temperature during cysteine deficiency. To do this, we generated Cth/-

Ucp1-/- double KO (DKO) mice. Interestingly, we found that Cth-/- Ucp1-/- DKO mice lost

weight at a similar rate to its Cth-/- littermates on a CysF diet (Fig 3.16A), but had increased
fat mass, suggesting that less lipids were being mobilized and utilized for heat production
in the Cth-/- Ucp1-/- DKO animals (Fig 3.16B). This increase in fat mass particularly came
from the SFAT and BAT, whereas loss of visceral gonadal peri-uterine/ovarian fat
(Ut/OvFAT) was not significantly different (Fig 3.16C). This reduction in browning is
evident from histology, where the SFAT from Cth-/- Ucp1-/- DKO post 6 days of CysF diet
shows slightly larger lipid droplets compared to the Cth-/- mice (Fig3.16D). However,
robust browning of the SFAT is still observed by the formation of multilocular adipocytes
in Cth-/- Ucp1-/- DKO on CysF diet (Fig 3.16D), suggesting that lipid mobilization is still
highly activated even in the absence of UCP1 during cysteine deficiency. In line with the
amelioration of fat loss in the Cth-/- Ucp1-/- DKO mice compared to Cth-/-, Cth-/- Ucp1-/DKO have reduced energy expenditures measured by indirect calorimetry in metabolic
chambers (Fig 3.16E-F). Given the similar body weights in these animals, it was possible
to represent the data without normalization, as is the gold standard (Fig 3.16E), and conduct
linear regression analysis of EE against body mass to show significant decreased EE in
Cth-/- Ucp1-/- DKO compared to Cth-/- animals (Fig 3.16F). Despite this reduction in EE of
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Cth-/- Ucp1-/-, surprisingly, Cth-/- Ucp1-/- mice were able to maintain core body temperature
identically to the Cth-/- mice on CysF diet (Fig 3.16G). This indicated that UCP1 was not
required for the maintenance of core body temperature.
Furthermore, RER dropped similarly over time in both Cth-/- and Cth-/- Ucp1-/DKO, indicating that they both increased utilization of fat as the major fuel source for
metabolism during cysteine deficiency (Fig 3.17A). If anything, Cth-/- Ucp1-/- DKO had
even lower RER on the very last dark cycle on the diet, suggesting greater fat utilization
(Fig 3.17B). Consistent with this lower RER, Cth-/- Ucp1-/- DKO mice expressed higher
levels of ATGL and tyrosine hydroxylase (TH) measured by western blot in the SFAT (Fig
3.17C-E). These results suggest that Cth-/- Ucp1-/- DKO mice increase their mobilization of
lipids through increased lipolysis. TH is the rate limiting enzyme for norepinephrine
production and is predominantly expressed in sympathetic nerves innervating the adipose
tissue. Increased TH expression suggests that Cth-/- Ucp1-/- DKO may potentially have
increased sympathetic activation compared to Cth-/- at 6 days post-cysteine deficiency.
However, TH is also increased in Ucp1-/- independently of cysteine deficiency (data not
shown), and further evaluation of sympathetic tone by measuring catecholamines is
required.
Despite a lack of UCP1, gene expression of activators of the thermogenic program
such as Ppargc1, Cidea, Cpt1 are significantly increased in Cth-/- Ucp1-/- DKO compared
to Cth-/- in the BAT after 6 days of CysF diet (Fig 3.17F). Furthermore, gene expression of
other mediators of the thermogenic program such as Acadm, Cox7a1, Elovl3, and Slc27a
are also significantly increased in Cth-/- Ucp1-/- DKO mice compared to Cth-/- (Fig 3.17F).
These data suggest that Cth-/- Ucp1-/- DKO mice are increasing their mobilization of lipids
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for mitochondrial respiration, even more so than the Cth-/-, which already rely on
significantly elevated mitochondrial respiration in response to cysteine deficiency. The
lack of UCP1 may force Cth-/- Ucp1-/- DKO mice to rely on less efficient mechanisms of
thermogenesis, which could potentially explain the increase in FA metabolism and
mitochondrial respiration.
Several UCP1 independent thermogenic mechanisms have been identified in recent
years. We evaluated one such mechanism, creatine futile cycling, by measuring gene
expression of the enzymes involved in this process, Gatm, Gamt, Ckmt1, Ckmt2, and
Slc6a8. While the expression of creatine synthesis genes, Gatm and Gamt were not
differentially induced with cysteine deficiency in Cth-/- Ucp1-/- DKO mice compared to Cth/-

animals, the expression of one of the creatine kinases that utilize ATP, Ckmt2, was

significantly increased and the transporter for creatine, Slc6a8, albeit not significantly, was
slightly increased in the BAT (Fig 3.17G). These results indicate that creatine futile cycling
may be one mechanism that becomes activated to generate heat in the absence of UCP1 in
Cth-/- Ucp1-/- DKO mice. In all, it seems that UCP1 is not strictly necessary to maintain
core body temperature during cysteine deficiency. However, the reduction in energy
expenditure despite increased activation of FA metabolism leaves many questions
unanswered. Furthermore, weight loss is maintained even when energy expenditure is
reduced. More studies will be necessary to fully understand the dynamic metabolic changes
occurring during cysteine deficiency.
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Summary & Discussion
We find that during CR, the TSP is induced to defend against reduced cysteine
levels. We developed a model to study the effects of cysteine deficiency by knocking out
the gene, Cth, to force a requirement for cysteine from the diet. Surprisingly, we discovered
that cysteine deficiency drives rapid mobilization and utilization of lipids in adipose tissues
to increase heat production via browning of SFAT and EFAT. Activation of browning in
these white adipose depots is mediated through an increase in sympathetic signaling that
drives increased lipolysis in the SFAT and BAT. We find that increased sympathetic
activation is in part mediated by a decrease in degradation of norepinephrine; the
expression of COMT and MAOA is decreased in the adipose tissues. Particularly, COMT
expression is decreased in resident macrophages during cysteine deficiency.
Whether macrophages are indeed playing a critical role in regulating sympathetic
tone and browning during cysteine deficiency still needs to be verified. And if so, whether
specific populations of macrophages are mediating its effects is unclear. Recent studies
have begun to redefine macrophages within the adipose tissue. While early studies had
purely divided macrophages into proinflammatory and anti-inflammatory macrophages
(Lumeng et al., 2007a; Weisberg et al., 2003), more recent studies utilizing scRNAsequencing have started to categorize adipose macrophages according to their function and
niche (further discussed in Chapter 4). Given an increase in sympathetic activity, we
aimed to study whether NAMs mediate neuro-immune crosstalk to impact adipose
metabolism during cysteine deficiency. Indeed, our data demonstrates that residential
macrophages were enriched during cysteine deficiency in the SFAT, and their expression
of Comt was decreased. However, due to the heterogeneity within cluster 3, and limitations
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of sensitivity of scRNA-seq, we were unable to identify exclusive iron-clad markers for
NAMs in the SFAT. Instead, we found that this population of resident macrophages were
likely a mixed population, including perivascular macrophages, parenchymal adipocyte
adjacent macrophages, and nerve associated macrophages, and thus may be acting through
several different mechanisms. This heterogeneity of residential macrophages in adipose
tissue may highlight the complexity of the adipose tissue niche, where nerves and blood
vessels have been found to be highly integrated with adipocytes, and nearly every
adipocyte has been suggested to be in close contact with a nerve (Cao et al., 2018; Chi et
al., 2018; Wolf et al., 2017). We plan to further investigate whether these macrophages are
important in mediating the remodeling of adipose tissue during cysteine deficiency by
depleting macrophages using clodronate liposomes. Recently, a study found that adipose
tissue macrophages were important in mediating a model of thermogenesis where
adipocytes were deficient in fatty acid synthase (Henriques et al., 2020). This study
suggested that macrophages can promote browning independently of mediating
sympathetic activation, and additional detailed studies are required to determine if indeed
NAMs or parenchymal residential macrophages can regulate the thermogenic response in
the context of cysteine deficiency.
Given the significant decrease in monocyte derived macrophages in addition to the
enrichment of residential macrophages during cysteine deficiency, loss of specific adipose
tissue macrophages could also play a role in adipose tissue remodeling. Ideally, depletion
of resident macrophages specifically would delineate the role of enriched resident
macrophages vs the loss of monocyte derived macrophages during cysteine deficiency.
Pilot studies attempting to deplete adipose resident macrophages utilizing CD169-cre
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iDTR mice in our lab have not been successful and require further optimization to
successfully deplete resident macrophages in the adipose tissue. However, if macrophage
depletion by clodronate liposomes further enhances weight loss during cysteine deficiency,
it may suggest that alternatively, macrophages, including monocyte-derived macrophages
are required to maintain adiposity, and loss of these macrophages during cysteine
deficiency promote unchecked thermogenesis.
Our results suggest that cysteine is an important metabolite in maintaining core
body temperature, and loss of mechanisms to maintain cysteine levels severely challenges
homeostatic thermoregulation. While it is still unclear why cysteine deficiency requires the
activation of thermogenic processes, it appears that thermogenesis can be successfully
maintained even in the absence of UCP1. Moreover, it appears that even when fat mass
loss is ameliorated by housing at thermoneutrality, weight loss is still maintained,
suggesting that lean mass is significantly lost during cysteine deficiency as well. In
agreement with our cysteine deficiency studies, recently, a group studying the effects of
protein content in diet ranging from 20% to 1%, found that mice preferentially lost adipose
depots including subcutaneous adipose, epididymal adipose, mesenteric adipose,
retroperitoneal adipose, and brown adipose in response to low protein diet (Wu et al.,
2021). They also report that mice on low protein diets lost the mass of reproductive organs,
pancreas, and liver while other lean organs such as the brain, lungs, heart, kidneys, and
spleen were protected (Wu et al., 2021). And while this study did not measure skeletal
muscle, in a study that deleted Cth in a 129/SvJ mouse background, mice fed a low cysteine
diet before adulthood (3 weeks of age), prevented developmental growth, and developed
severe paralysis of the lower extremities after one week (Ishii et al., 2010). This paralysis
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was caused by increase autophagy in the skeletal muscle, suggesting that cysteine
deficiency during development promoted degradation or atrophy of the skeletal muscle
(Ishii et al., 2010). Evaluating how these different lean organs are changing during cysteine
deficiency in adult mice may help us understand the biology driving weight loss and
adipose thermogenesis.
Particularly, the increase in BCAA degradation pathways in the adipose tissue is
intriguing. Normally, BCAAs are primarily oxidized in the skeletal muscle. However,
recent studies utilizing mouse models lacking BAT (UCP1-cre x PPARγ) found that in
addition to skeletal muscle, BAT plays an active role in clearing BCAAs from the
circulation (Yoneshiro et al., 2019). Clearance of BCAAs from the circulation is important,
as buildup of these amino acids and byproducts are toxic to the brain and other organs, and
can lead to serious health problems associated with maple syrup urine disease (Dancis et
al., 1960; Menkes et al., 1954). Because we do not actually detect differences in BCAAs
in the serum of cysteine deficient mice, investigation of adaptations in the skeletal muscle,
such as protein turnover and autophagy may provide important clues to how and why
BCAA metabolism gets enriched in adipose tissue. Similarly, we observe an increased flux
towards OA production in the SFAT during cysteine deficiency. While this could be
interpreted as an increased pressure to generate glutathione, we also observe increased
levels of threonine in the adipose tissues, which give rise to 2-oxybutric acid and
subsequently 2AB. Thus, rather than regulation of glutathione production, the induction of
this pathway may serve as a mechanism to clear amino acids that have been released by
skeletal muscle.
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In conclusion, our data demonstrates that cysteine availability is a previously
unidentified key checkpoint in maintaining core body temperature. Through the generation
of CSE deficient animal fed a cysteine free diet, we show that when cysteine levels are not
maintained, thermogenic pathways are activated in the adipose tissues, leading to rapid
weight loss to the point of mortality, as mice are required to be euthanized at 30% weight
loss. This response is mediated by an increase in sympathetic signaling in the adipose
tissue. How this metabolic response in the adipose tissue is being integrated by adaptations
of other metabolic organs such as the skeletal muscle, liver, and hypothalamus remains to
be characterized and may provide further understanding of how cysteine metabolism
guards thermogenic homeostasis.
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Figures

Figure 3. 1 Human calorie restriction activates the transsulfuration pathway
A) Schematic of human CALERIE II study. Participants provided subcutaneous adipose (SFAT) biopsies
at baseline, 12 months, and 24months of CR for RNA-seq and metabolomics (n=8 per timepoint). B)
Normalized expression of changing transsulfuration pathway genes CTH, and BHMT in human SFAT at
baseline, 12 months, and 24 months CR. Adjusted p-values (padj) were calculated in the differential gene
expression analysis (n=8). C) Selected metabolites involved in cysteine metabolism measured by MS/MS
in human SFAT at baseline and 12 months CR. Significance was calculated using paired t-tests. *p<0.05,
**p<0.01, ***p<0.001. D) Schematic summary of changing TSP genes and metabolites from baseline to
12 months CR that were measured in human SFAT. Green lines represent measured, but unchanging
metabolites, blue arrows indicate significantly decreasing, and red arrows indicate significantly
increasing metabolites or genes via paired t-test (p<0.05).
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Figure 3. 2 Cysteine deficiency in mice drives rapid fat loss
A) Schematic of mouse model used to achieve cysteine deficiency utilizing Cth-/- fed a Cystine free
(CysF) diet. B-C) Male Cth+/+ and Cth-/- were fed CTRL or CysF diets for 6 days (n=5 Cth+/+ CTRL,
n=12 Cth+/+ CysF, n=8 Cth-/- CTRL, n=17 Cth-/- CysF, 3 expts pooled). B) Percent body weight over 6
days of diet. C) Fat mass and lean mass measured by EchoMRI at day 6 of diet. D) Energy expenditure
measured in metabolic cages at day 4 and 5 of diet and E) quantified day and night averages, normalized
by daily body weight (n=10 Cth+/+ CysF, n=12 Cth-/- CysF, 3 expts pooled). Data expressed as
mean±SEM. Statistical differences were calculated by (B,D,E) 2-way ANOVA with Sidak’s correction
for multiple comparisons and (C) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001
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Figure 3. 3 Whole body depletion of Cth is required for cysteine deficiency response
A-B) Female Cth+/+ and Cth-/- were fed CTRL or CysF diets for 6 days (n=5 Cth+/+ CTRL, n=5 Cth+/+
CysF, n=6 Cth-/- CTRL, n=8 Cth-/- CysF, 2 expts represented). A) Body weight curve and B) fat mass
and lean mass measured by EchoMRI at day 6 of diet. C) Expression of Cth in various tissues of WT
mice (n=3). D) Schematic of Cthf/f mice generation used to cross to either Alb-cre or Adipoq-cre. Protein
expression of CSE in Alb-cre Cthf/f and Cthf/f mice measured by western blot in E) liver and F) kidney to
confirm deletion. G) Body weight over 6 days of CTRL or CysF diet in Alb-cre Cthf/f and Cthf/f mice. H)
Protein expression of CSE in Adipoq-cre Cthf/f and Cthf/f mice measured by western blot in H) SFAT and
I) liver to confirm deletion. J) Body weight over 6 days of CTRL or CysF diet in Adipoq-cre Cthf/f and
Cthf/f mice. K) Body weight over 6 days of CysF diet in co-housed Cth+/+ and Cth-/- mice (n=4/group, 2
expts represented). Data expressed as mean±SEM. Statistical differences were calculated by (B) unpaired
t-test. *p<0.05, **p<0.01, ***p<0.001.
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Figure 3. 4 Metabolic parameters during cysteine deficiency
A-G) Metabolic cage data of Cth+/+ and Cth-/- on 6 days of CysF diet after 3 days acclimation (n=10 Cth+/+,
n=12 and Cth-/-). Linear regression analysis of unnormalized average energy expenditure measured by
indirect calorimetry against body mass in Cth+/+ and Cth-/- on days 4 and 5 of CysF diet A) for the light
cycle, B) dark cycle, and c) light and dark cycle combined. D) Unnormalized EE over the full course of 6
days on CysF diet. E) RER over the full course of 6 days on CysF diet. F) Area under the curve quantified
for RER. G) Accumulated food intake over the full course of 6 days. H-I) Cth+/+ and Cth-/-pair fed CTRL or
CysF diet over 6 days (n=4 Cth+/+CysF ad lib, n=4 Cth+/+CysF pair fed, n=6 Cth-/- CTRL pair fed, n=5 Cth/CysF pair fed). H) Percent body weight over 6 days, and I) fat mass and lean mass measured by EchoMRI
on day 6. Data expressed as mean±SEM. Statistical differences were calculated by (B) linear regression
analysis, by (H) 2-way ANOVA with Sidak’s correction for multiple comparisons, and by (F, I) unpaired ttest. *p<0.05, **p<0.01, ***p<0.001.
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Figure 3. 5 Serum metabolomics of Cth+/+ and Cth-/- mice fed CTRL or CysF diet
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A) Principal component analysis (PCA) of serum metabolomic profile measured by orbitrap MS/MS in
Cth+/+ or Cth-/- mice fed CTRL or CysF diet for 6 days (n=5 Cth+/+ CTRL, n=6 Cth+/+ CysF, n=4 Cth-/CTRL, n=5 Cth-/- CysF). B) Normalized heat map of top 25 metabolites changing in the serum of Cth-/mice fed CTRL or CysF diet for 6 days. C) Box plots of select metabolites involved in TSP from serum
of Cth-/- mice fed CTRL or CysF diet for 6 days. D) Schematic summary of changing metabolites in the
serum of Cth-/- mice fed CTRL or CysF diet for 6 days. Green lines represent measured, but unchanging
metabolites, blue arrows indicate significantly decreasing, and red arrows indicate significantly
increasing metabolites. Statistical differences were calculated by unpaired t-test. *p<0.05, **p<0.01,
***p<0.001.

Figure 3. 6 Transcriptional response of adipose tissues to cysteine deficiency
A) Representative subcutaneous, visceral, and brown adipose depots of Cth+/+ and Cth-/- post 6 days of
CysF diet. B) Representative H&E histology images of SFAT and EFAT of Cth-/- mice fed CTRL or
CysF diet for 6 days. C-D) Whole tissue RNA-seq of SFAT, EFAT, and BAT of Cth+/+ and Cth-/- fed 6
days of CTRL or CysF diet (n=4/group). C) PCA and D) heat map highlighting changes specifically
occurring in cysteine deficiency. E) Select top pathways being up- and down-regulated in Cth-/- CysF vs
CTRL in the SFAT.
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Figure 3. 7 Cysteine deficiency induces thermogenesis in white adipose tissue
A) Heatmap of representative genes involved in thermogenesis that are differentially regulated by
cysteine deficiency in the SFAT detected by RNA-seq (n=4/group). B) Percentage of reads coming from
nuclear and mitochondrial transcripts. C) Representative images of SFAT and EFAT stained for UCP1
from Cth-/- mice fed CTRL or CysF diet at day 6. D) Western blot detection of UCP1 in the SFAT of
Cth-/- mice fed CTRL or CysF diet at day 6. E-F) qPCR analysis of SFAT expression of thermogenic
genes after 6 days of CTRL or CysF diet. Statistical differences were calculated by unpaired t-test.
*p<0.05, **p<0.01, ***p<0.001.
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Figure 3. 8 GAM-clustering analysis of RNA-seq
77

A-D) High expression is represented as red, low expression is represented as blue. Each column
represents a different sample. A) GAM-clustering algorithm was applied to RNA-seq data of BAT,
EFAT, and SFAT. 8 different metabolic modules were identified. B) Highlight of subnetworks within
module 2 by pathways enrichment analysis. Heat map of representative genes within BCAA degradation,
TCA cycle, and FA metabolism are shown. C) Module 4 pathways enrichment analysis identifies
cholesterol/steroid biosynthesis as top correlated pathway. Heat map of representative genes within
cholesterol biosynthesis are shown. D) Module 6 pathways enrichment analysis identifies lipid
metabolism as top correlated pathway. Heatmap of representative genes within lipid metabolism are
shown. E-G) Corresponding subnetwork schematic diagrams for Modules 2, 4, and 6. Edges of modules
are attributed with color according to correlation of its enzyme’s gene expression to this particular
module pattern, and thickness according to its score. Red represents high correlation and green represents
low correlation. E) Subnetwork generated for module 2 highlighting several different metabolic nodes
such as amino acid metabolism, TCA cycle, FA metabolism. F) Subnetwork generated for module 4,
highlighting cholesterol and steroid biosynthesis. G) Subnetwork generated for module 6, highlighting
lipid metabolism. (BCAA: Branched chain amino acids; TCA: Tricarboxylic acid cycle; FA: Fatty acid;
SAA: Sulfur amino acids; PIP3:Phosphatidylinositol 3,4,5 triphosphate)
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Figure 3. 9 Increased production of ophthalmic acid in the SFAT during cysteine
deficiency.
A, B, D) Metabolites measured by Orbitrap type mass spectrometry in the SFAT of Cth-/- CTRL and Cth/CysF (n=6/group). Arbitrary units represent area under peak/internal standard/tissue weight. A)
Measurements of GSH and GSSG in the SFAT of Cth-/- CTRL and Cth-/- CysF. B) Measurements of
cysteine and cystine in the SFAT of Cth-/- CTRL and Cth-/- CysF. C) RNA-seq expression of Got1, Gclc,
and Gss in the SFAT of Cth-/- CTRL and Cth-/- CysF. (n=4/group) D) Measurements of OA, 2AB, and
threonine in the SFAT of Cth-/- CTRL and Cth-/- CysF. D) Schematic showing changes in gene and
metabolite expression in glutathione and ophthalmic acid synthesis pathway. Significantly increased
have red arrows, significantly decreased have blue arrows, and unchanging have green dashes. Each dot
represents a single mouse. Statistical differences were calculated by unpaired t-test. *p<0.05, **p<0.01,
***p<0.001. (2OB: 2-oxalobutyric acid; 2AB: 2-aminobutryic acid; Cys: Cysteine; OA: ophthalmic acid;
GSH: Glutathione (reduced); GSSG: Glutathione (oxidized); γGlu-Cys: γ-Glutamyl-Cysteine; γGlu2AB: γ-Glutamyl-2-Aminobutyric acid; AST: Aspartate transaminase (Got1); γGCS: GammaGlutamylcysteine synthetase (Gclc); GS: Glutathione synthetase (Gss)).
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Figure 3. 10 scRNA-seq of stromal vascular fraction SFAT during cysteine
deficiency.
A) Schematic of cell processing of SFAT stromal vascular fraction (SVF) for scRNA-seq. B) t-SNE plot
of SFAT stromal vascular fraction with cluster identities. C) Heat map of normalized gene expression of
select markers to identify major cell lineages. D) t-SNE plot showing SVF of Cth+/+ CTRL, Cth+/+ CysF,
Cth-/- CTRL, and Cth-/- CysF diet. Population statistics of select clusters have been overlayed. E) Bar
chart showing population fold changes in relative abundance of each cluster comparing Cth-/- CysF vs.
Cth+/+ CysF. F) t-SNE plot displaying Pdgfra expression in red across all populations. G) Monocle
analysis clusters 0, 1, and 2, with coloring by pseudotime to show right most cluster giving rise to two
separate clusters. H) Monocle analysis with each cluster represented by color in Cth-/- CTRL, and Cth-/CysF. I) t-SNE plots displaying Dpp4, Cd9, Icam1, Col5a3, F3, and Tagln expression in red across all
populations in Cth-/- CTRL, and Cth-/- CysF samples.
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Figure 3. 11 scRNAseq of stromal vascular fraction of SFAT during cysteine
deficiency.
A) Heatmap of gene expression of select stem and mature adipocyte genes in cells of clusters 0, 1, and
2 in all samples. B) Enrichment of CL-316,243 activated gene set overlaid on all populations in all
samples. C) Select top pathways from gene set enrichment comparing Cth-/- CysF vs. Cth+/+ CysF in
cluster 1. D) Volcano plot of differentially expressed genes (DEGs) comparing Cth-/- CysF vs. Cth+/+
CysF in cluster 1. E) Table of number of DEGs per cluster when compared to Cth-/- CysF.
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Figure 3. 12 Cysteine deficiency increases sympathetic tone by reducing degradation
of norepinephrine.
A) Schematic showing activation of browning in adipose tissue via sympathetic activation and lipolysis.
B) Western blot analysis of lipolytic proteins, pHSL and ATGL, in SFAT of Cth-/- mice fed CTRL or
CysF diet at day 6. C) Measurement of norepinephrine by orbitrap MS/MS in the SFAT of Cth+/+ and
Cth-/- fed 6 days CTRL or CysF diet (n=5 Cth+/+ CTRL, n=5 Cth+/+ CysF, n=6 Cth-/- CTRL, n=6 Cth-/CysF). Boxplots of D) Comt and E) Maoa FPKMs from RNA-seq of SFAT (n=4/group). Gene expression
of F) Comt and G) Maoa in the SFAT measured by qPCR (n=8 Cth+/+ CysF, n=10 Cth-/- CysF). H)
Measurement of COMT by western blot in SFAT. I)SAH measured by orpitrap MS/MS J) Schematic of
norepinephrine degradation K) imaging mass spec of norepinephrine in the BAT. Data expressed as
mean±SEM. Statistical differences were calculated unpaired t-test. *p<0.05, **p<0.01, ***p<0.001.
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Figure 3. 13 scRNA-seq of SFAT residential myeloid cells during cysteine deficiency.
A) Schematic depicting cell sorting strategy of SFAT resident myeloid cells for scRNA-seq. B) t-SNE
plot of SFAT resident myeloid cells with cluster identities of Cth+/+ CTRL, Cth+/+ CysF, Cth-/- CTRL,
and Cth-/- CysF. B) t-SNE plots of resident myeloid cells from Cth-/- CTRL and Cth-/- CysF with
proportional population statistics displayed for each cluster. D) Heat map of normalized gene expression
of select markers to identify major cell lineages. E) Enrichment NAM gene signature overlaid on all
populations in all samples. F) t-SNE plot displaying Maoa expression in all samples. G) t-SNE plot
displaying Cd163 expression in Cth-/- CTRL and Cth-/- CysF. Representative FACS plot of H) CD11b+
F4/80+ macrophages with quantification and I) CD163+ macrophages with quantification. J) Violin plots
of Comt expression within all cells from each group.
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Figure 3. 14 Analysis of resident macrophage cluster in SFAT during cysteine
deficiency.
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A) t-SNE plots showing expression of genes enriched in each cluster B) Volcano plot of DEGs comparing
Cth-/- CysF vs. Cth-/- CTRL in cluster 3. C) Selected top pathways identified by pathways enrichment
analysis of cluster 1, comparing Cth-/- CysF vs. Cth-/- CTRL. D-F) Representative confocal image of wild
type -whole mount SFAT, stained for CD163 (yellow), Tubb3 (green), Lyve1 (red), and MAOA (blue).
D) NAMs and adipose tissue macrophages near a nerve. Yellow arrow indicates CD163+ adipose
macrophage that is not a NAM. White arrows indicate NAMs that stain both CD163 and Lyve1. Red
arrow indicates a Lyve1+ macrophage away from the nerve. E) NAM expressing CD163, Lyve1, and
intracellular MAOA. F) Adipose tissue macrophage expressing CD163 and Lyve1, and intracellular
MAOA. B-D) Image was generously provided by Elsie Gonzalez-Hurtado
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Figure 3. 15 Thermogenesis is induced to maintain core body temperature.
A) Core body temperatures (CBT) measured in the peritoneal cavity by implantation of Star oddi loggers
over 6 days of diet in male Cth-/- mice fed CTRL or CysF diet. Recordings were taken every 30min (n=11
Cth-/- CTRL, n=12 Cth-/- CysF, 3 expts represented). B) Average day and night temperatures quantified.
C) Measurement of BAT temperature, utilizing MRI imaging technique, BIRDS and D) quantification.
E-F) Cth+/+ and Cth-/- housed at 22°C or 30°C while on CysF diet for six days. E) Percent body weight
curves. F) Representative H&E histology images of SFAT at day6 of CysF diet. G) Expression of
thermogenic genes measured by qPCR. Data expressed as mean±SEM. Statistical differences were
calculated by (B,E,D) 2-way ANOVA with Sidak’s correction for multiple comparisons, and by (D)
unpaired t-test. *p<0.05, **p<0.01, ***p<0.001.
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Figure 3. 16 Cth-/- Ucp1-/- induce reduced thermogenesis in response to cysteine
deficiency.
A-D) Female Cth-/- and Cth-/- Ucp1-/- fed a CysF diet for 6 days (n=8 Cth-/-, n=8 Cth-/- Ucp1-/-). A) Percent
body weight, and B) fat mass measured by echoMRI. C) Dissected gonadal, subcutaneous, and brown
adipose tissue weights. D) Representative H&E histology images of SFAT after 6 days of diet. E) EE
measured in metabolic cages on day 4-5 of CysF diet ((n=8 Cth-/-, n=8 Cth-/- Ucp1-/-) and F) linear
regression analysis of average EE day4-5 against body mass. G) Core body temperatures (CBT)
measured in the peritoneal cavity by implantation of Star oddi loggers over 6 days of diet in male Cth-/mice fed CTRL or CysF diet. Recordings were taken every 30min and representative day 4 shown (n=7
Cth-/-, n=5 Cth-/- Ucp1-/-). Data expressed as mean±SEM. Statistical differences were calculated by (A,
G) 2-way ANOVA with Sidak’s correction for multiple comparisons, by linear regression analysis (F),
and by (B, C) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001.
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Figure 3. 17 Cth-/- Ucp1-/- display increased lipolytic and creatine futile cycling
signature
A) RER measured in metabolic cages over 6 days of CysF diet (n=8 Cth-/-, n=8 Cth-/- Ucp1-/-) and B)
day and night averages quantified. C) Western blot analysis of ATGL, TH, and UCP1 in BAT of Cth-/and Cth-/- Ucp1-/- fed a CysF diet for 6 days and D) quantified against tubulin. F) Gene expression
analysis of thermogenic genes in BAT of Cth-/- Ucp1-/- fed a CysF diet for 6 days, measured by qPCR.
G) Gene expression analysis of creatine futile cycling genes in BAT of Cth-/- Ucp1-/- fed a CysF diet for
6 days, measured by qPCR (n=8 Cth-/-, n=10 Cth-/- Ucp1-/-). Data expressed as mean±SEM. Statistical
differences were calculated by (B, F, G) 2-way ANOVA with Sidak’s correction for multiple
comparisons, and by (D, E) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001.
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Chapter 4: Dietary regulation of Immunity
The following chapter was published as a review in Volume 53, Issue 3 in Immunity, 2020
(Lee and Dixit, 2020). This review was written together with Vishwa D. Dixit.

Figure 4. 1 Dietary Regulation of Immunity
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SUMMARY
Integrated immunometabolic responses link dietary intake, energy utilization, and storage
to immune regulation of tissue function and is therefore essential for the maintenance and
restoration of homeostasis.

Adipose resident leukocytes have non-traditional

immunological functions that regulate organismal metabolism by controlling insulinaction, lipolysis, and mitochondrial respiration to control the usage of substrates for
production of heat versus ATP.

Energetically expensive vital functions such as

immunological responses may have thus evolved to respond accordingly to dietary surplus
and deficit of macronutrient intake. Notably, chronic positive energy balance manifested
as obesity compromises immunity, increasing morbidity and mortality from infections
including Covid-19. Conversely, negative energy balance induced by glucose deprivation
leads to fatty acid utilization and ketogenesis, promoting longevity and reducing disease
burden. Here, we discuss the immunometabolic checkpoints that promote healthspan and
highlight how dietary fate and regulation of glucose, fat, and protein metabolism may
impact immunity.

Introduction
The hominids that were destined to become humans evolved with larger and intensive
energetic demands for brain function. Host survival thus required mechanisms that balance
the energetic costs of essential functions such as successful immune response against
infections and tissue repair.

Accordingly, humans have developed an integrated

immunometabolic response (IIMR) that involves sensing of nutrient balance by neuronal
(sympathetic and sensory innervation) and humoral signals (e.g., hormones like insulin,
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incretins, FGF21, GDF15, ghrelin and leptin) between the hypothalamus and peripheral
tissues to allow the host to prioritize storage and/or utilize substrates for tissue growth,
maintenance and immune responses. The evolutionary pressure to maintain healthy
adiposity concurrently with tissue protective inflammatory responses to injuries and
infections are important drivers of IIMR. It has been hypothesized that because energy rich
nutrients have been scarce throughout most of human evolution, dominant genetic
pathways evolved to favor increasing intake of calorie rich diets and storage of energy as
triglycerides in adipose tissue.

Within this evolutionary pressure to store calories,

consumption of energy rich diets in the modern world has given rise to obesity. Excessive
adiposity or obesity with a body mass index (BMI) of > 30, is a multisystem disorder
resulting from chronic caloric intake and perturbation of IIMR. A large body of literature
suggests that altered IIMR in obesity causes a chronic proinflammatory state that is linked
to diseases such as Type-2 diabetes, non-alcoholic steatohepatitis, and cardiovascular
disease (Christ et al., 2019). In addition, obesity impairs adaptive immune responses and
is a major risk factor for mortality and morbidity from H1N1 influenza (Van Kerkhove et
al., 2011).
In opposition to obesity, negative energy balance without malnutrition is induced
by restriction of calories, and is one of the most effective means for lifespan and healthspan
extension in multiple species (Anderson et al., 2017; Weindruch and Sohal, 1997). Caloric
restriction (CR) limits glucose availability and therefore the host must engage fatty acid
oxidation to generate ATP. The effector immune functions that rely on glucose as their
primary substrates are likely modulated by such dietary interventions and such
interventions could be promising avenues to prevent or treat diseases that involve
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hyperinflammatory responses. It is recognized that severe reduction in nutrient and energy
intake may cause tradeoffs in non-essential functions. As posited by the disposable soma
theory, this involves diversion of resources from host growth and reproduction toward
cellular maintenance, with the evolutionary rationale that when nutrients become available
again, the conserved pathways dedicated for host defense are preserved and can be reengaged (Kirkwood et al., 2000). Which scenarios induce such a tradeoff and whether the
immune system is indeed dispensable when energy is limiting are open questions.
However, emerging evidence suggest that immune response to infectious challenges is
maintained during moderate dietary restriction (Collins et al., 2019; Jordan et al., 2019;
Nagai et al., 2019) and is boosted when carbohydrate deficient, high fat diet intake induces
ketogenesis (Goldberg et al., 2019). Surprisingly, restriction of proteins, including the
restriction of essential amino acid methionine in adult life extends lifespan in rodents by
almost 40-50% (Orentreich et al., 1993; Solon-Biet et al., 2014). The biochemical
metabolic pathways engaged by such dietary alterations may hold the keys to identifying
as of yet unknown mechanisms that could be harnessed to control reparative responses,
inflammation, and immune-surveillance. In this review we discuss the interaction of dietary
intake of macronutrients and their metabolic fate on immune system including adipose
tissue resident leukocytes in regulation of inflammation and organismal metabolism.

Immune Defense in Diet Induced Obesity
Modern diets are rich in saturated fats and processed carbohydrates, such as high fructose
corn syrup, and are deficient in fiber, vitamins, and minerals, while containing high
levels of salt. These diets are a leading cause of the emergence of obesity associated
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chronic diseases, the majority of which are linked to chronic inflammation (Bray et al.,
2017). A vast number of studies have described a predominant role of inflammation,
originating from visceral adipose tissue and lipotoxicity, in engaging innate immune
cells that lead to development of type 2 diabetes through their production of TNFα, IL1β and IL-6 (Donath and Shoelson, 2011; Hotamisligil, 2006; Saltiel and Olefsky, 2017).
There is however, also increasing evidence of obesity as an independent risk factor for
dysregulated adaptive immune response against various infections. The retrospective
analyses post 2009 H1N1 pandemic across the globe revealed obesity to be comorbid
with influenza in nearly one-third of hospitalized patients with increased fatality post
infection (Van Kerkhove et al., 2011). The mechanism by which obesity disrupts
immune response and recovery from influenza are manifold and represent the impact of
chronic metabolic perturbation on multiple cell types. Diet-induced obese (DIO) mice
have reduced levels of H1N1-specific antibodies as well as lower neutralization response
during influenza infection (Honce et al., 2020). Whether obesity impacts germinal center
reactions, class-switching of antibodies, or the B cell repertoire remains unknown. There
are data that suggest that obesity restricts T cell receptor (TCR) repertoire diversity
(Yang et al., 2010) and decreases the number of T cell receptor excision circles (TRECs)
in blood of obese and diabetic individuals suggesting reduced thymic generation of naïve
T cells (Yang et al., 2009b).
In addition, the differentiation of naïve T cells (CD4 and CD8) into an effector state
upon antigen recognition is dependent on glucose and glutamine (Jacobs et al., 2008;
Michalek et al., 2011; Pearce et al., 2009; Wang et al., 2011b). It is thus likely that
hyperglycemia and dyslipidemia seen in obesity affects T cell immune activation against

93

influenza infection. Interestingly, high-fat diet feeding expands γδ T cells in lungs that are
IL-17 competent but lack a tissue protective transcriptional profile and fail to confer
protection against influenza (Goldberg et al., 2019). Whether altered lipid versus glucose
metabolism drives dysfunctional γδ T responses in obesity remains to be characterized.
Furthermore, effective memory T cell response relies on efficient transition from
glycolytic to a more oxidative metabolism (Pearce et al., 2009), although this distinction
may not be binary in vivo. Recent studies using

13

C-based stable isotope labeling

techniques in T cells highlight that glucose use by CD8+ cells is dynamically regulated
during the course of an immune response to Listeria infection and identified that glucose
dependent serine biosynthesis as a key metabolic program for optimal T cell expansion in
vivo (Ma et al., 2019). How diet-induced obesity impacts the metabolic reprogramming of
T cells in vivo in bacterial or viral infection requires further investigation. Initial analyses
suggest that indeed altered glycolytic and oxidative respiration in memory T cells of obese
animals is a likely mechanism influencing influenza disease susceptibility (Rebeles et al.,
2019). In addition, Mauro et al found that saturated fatty acid-induced metabolic stress
affects T cell differentiation and causes preferential trafficking of CD4+ T cells to nonlymphoid effector sites in obesity. Palmitate drove CD4+ T cells to acquire a specific
CD44hi CCR7lo CD62Llo CXCR3+ LFA1+ pro-inflammatory dysfunctional phenotype via
the activation of a PI3K p110δ-Akt-dependent pathway (Mauro et al., 2017). Interestingly,
adipose tissue serves as a reservoir of memory T cells specific to several viruses including
but not limited to lymphocytic choriomeningitis virus (LCMV) and HIV (Damouche et al.,
2015), as well as bacteria like Yersenia, and protozoa like Toxoplasma (Han et al., 2017).
It is possible that antigen-specific T cells may enter the adipose tissue to potentially resolve
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the infection but then remain as a memory population distinct from memory T cells in
classical sites of immune response. Formal studies would be required to test the hypothesis
that adipose microenvironment shapes the specific transcriptional signatures of memory
phenotype that is compromised in obesity. It is however known that in obese mice, upon
re-challenge to infection, adipose memory T cells upregulate lipases and cause severe
disease including calcification of adipose tissue, pancreatitis, and reduce survival (Misumi
et al., 2019). Concernedly, data from the COVID-19 pandemic has identified obesity and
diabetes as a major risk factor in disease severity and mortality (Drucker, 2020) (Box 1).
Given that in the US, over one third of adults are obese, urgent research efforts are required
to determine immunoregulatory mechanisms that impact immune response, disease
tolerance, treatment, and potential vaccination failure in this large high-risk population.
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Box1 Immunometabolic regulators of COVID-19 severity: In addition to old age,
metabolic syndrome, diabetes, and obesity are independent risk factors for increased
SARS-COV2 induced mortality and morbidity. Given the prevalence of obesity is
10% among younger adults aged 20-39, 45% among adults aged 40-59 years and 43%
among older adults aged 60 and over (Hales et al., 2020), there is urgent need for
studies that define the mechanism of aberrant immune response that promotes
predisposition to infection and disease. Recent analyses show that 47% of cases of
COVID-19 hospitalization represented obese patients with BMI >30. Moreover, 85%
of patients above the BMI of 35 developed hyperinflammatory response in lungs that
required mechanical ventilation to boost oxygen saturation (Simonnet et al., 2020).
Macrophage activation and neutrophil influx mediate hyperinflammatory response in
lungs in COVID-19 (Zhou et al., 2020). Given obesity’s known effects on increasing
inflammation, future studies will be required to determine the immunological
mechanism of diet driven complications of SARS-Cov2 viral infection. Of note,
NLRP3 inflammasome, a myeloid cell expressed multiprotein complex that senses
pathogen associated molecular patterns (PAMPS) and danger associated molecular
patterns (DAMPS) to cause IL-1β and IL-18 release, is activated in obesity, type-2
diabetes, atherosclerosis, and aging (Camell et al., 2015; Goldberg and Dixit, 2015).
There is increasing evidence that SARS-COV2 infection activates the NLRP3
inflammasome (Siu et al., 2019) with increased levels of IL-18 and lactate
dehydrogenase (LDH) levels due to inflammasome mediated pyroptotic cell death
(Lucas et al., 2020; Zhou et al., 2020). Interestingly, SARS-CoV open reading frame
3a (ORF3a) and ORF8b activates the NLRP3 inflammasome (Siu et al., 2019) by
inducing ER stress and lysosomal damage (Shi et al., 2019), mechanisms that are
independently shown to be elevated in obesity. It is now known that increased
glycolysis, which also induces transcriptional upregulation of inflammasome
machinery, causes aberrant activation of myeloid cells and worsens COVID-19 (Codo
et al., 2020). This raises the question whether dietary approaches that mimic a
glucoprivic state by feeding of a low carbohydrate, high fat diet, which necessitates
the switch from glycolysis to production of ketone metabolites, can be employed to
stave off COVID-19. Indeed, ketone bodies inhibits the Nlrp3 inflammasome (Youm
et al., 2015) and ketogenic diet protects against influenza-induced lethality in mice by
expanding γδ-T cells (Goldberg et al., 2019). Thus, raising the possibility that
harnessing specific immunometabolic checkpoints, such as glycolytic-to-ketogenic
switch maybe relevant to several infections, including SARS-COV2.

Adipose Tissue as an Immunological Organ
Of the metabolic organs responding in the IIMR during chronic positive energy balance
(Figure 4.2), adipose tissue has been best characterized and strongly contributes to the
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pathogenesis of obesity. Obese adipose contains approximately 2 to 5 million stromalvascular cells per gram, of which approximately 60-70% are immune cells. In severe
obesity, adipose tissue can expand to constitute up to 30-50% of total body mass
(Kanneganti and Dixit, 2012). Thus, the adipose tissue represents an underappreciated
immunological organ that harbors distinct subpopulations of immune cells that localize to
specific niches to perform potentially unique functions.
Even before it was recognized that immune function could be regulated by cellular
metabolism (Buck et al., 2015; Frauwirth et al., 2002; O'Neill et al., 2016), the discovery
that obesity-induced insulin resistance was directly caused by elevated TNF levels in
adipose tissues launched the field of immunometabolism, pioneering the association of the
immune system with metabolic processes (Hotamisligil et al., 1993). Although, initially
thought to be derived from adipocytes, later studies clarified that accumulation of
macrophages in the adipose were the main drivers of inflammatory cytokine production
(Lumeng et al., 2007b; Weisberg et al., 2003). It has now been elucidated that during
obesity, in addition to macrophages, there are large changes in the adipose immune
landscape as certain cells are recruited and activated while other cell types are depleted and
replaced, leading to a more proinflammatory environment that drives type 2 diabetes and
chronic disease progression (Figure 4.3). Mechanistically, proinflammatory cytokines such
as TNF, IL-6 and IL-1β have been shown to block insulin receptor signaling through
inhibition of insulin receptor substrates (IRSs), by increasing their serine phosphorylation
(Hotamisligil et al., 1996; Werner et al., 2004). Conversely, gain of function of IKKβ in
the liver was found to reduce ER stress by elevated XBP1 activity leading to an actual
improvement in insulin-sensitivity (Liu et al., 2016). Additional studies are required to
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determine the delicate balance of chronic pro- and anti-inflammatory cytokine signaling
required to repair and restore metabolic homeostasis.

Adipose Tissue Macrophages in Obesity
It is now understood that macrophages are resident immune cells found in almost every
tissue, and play key roles in maintaining homeostasis (Lavin et al., 2014; Okabe and
Medzhitov, 2014). In healthy adipose tissue, macrophages are thought to constitute about
10% of the hematopoietic cell composition. However, it is possible that enzymatic
digestion protocols of adipose tissue are not releasing all macrophages from their tissue
niches and thus current analyses may be underestimating the total quantity of cells residing
in fat. During obesity, an infiltration of monocytes and macrophages, local proliferation,
reduced egress, and increased cell longevity leads to a further accumulation of
macrophages (Amano et al., 2014; Hill et al., 2015; Nagareddy et al., 2014; Oh et al., 2012)
so that more than 50% of the cells in the fat depot can be made up of macrophages (Lumeng
et al., 2007b; Weisberg et al., 2003).
Proinflammatory ATMs drive obesity induced insulin resistance by activating
kinases such as IκB Kinase (IKK) and JNK (Arkan et al., 2005; Han et al., 2013; Solinas
et al., 2007). ATMs that accumulate at crown-like structures (CLSs) further secrete
exosomes containing miR155 that act on adipocytes to block insulin signaling (Ying et al.,
2017). Ablation of proinflammatory CD11c+ ATMS during DIO reduces local and
systemic proinflammatory cytokine levels, reduces CLSs and infiltrating macrophages, and
leads to rapid normalization of insulin sensitivity, thus highlighting the role of
inflammatory ATMs in driving metabolic disease (Patsouris et al., 2008). However, ATMs
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can be divided into various populations of diverse lineages and functionality that respond
dynamically to local metabolic cues within their unique niches. While these macrophage
subsets are still being defined, careful examination of the transcriptional profiles of
different ATM groups have clarified that there are numerous ways to define macrophage
subsets and most infiltrating macrophages in adipose tissue in chronic inflammation do not
fit a simple M1/M2 polarization model (Camell et al., 2017; Kratz et al., 2014).
In lean adipose tissue, macrophages are a mixed heterogeneous population of yolk
sac derived, self-maintaining macrophages and bone marrow (BM) derived monocytes and
macrophages that are continuously replenished (Amano et al., 2014; Hassnain Waqas et
al., 2017; Schulz et al., 2012; Silva et al., 2019). Silva et al have recently described 4
different groups of lean visceral ATMs. The group of macrophages which make up the
majority of ATMs in lean adipose tissue express high levels of CD206 and are CD11b+
MHCII+ Tim4+ (Silva et al., 2019). Through bone marrow chimera experiments, these
macrophages were found to be largely tissue resident with minimal replenishment from the
periphery (Amano et al., 2014; Silva et al., 2019). Surprisingly, these macrophages were
found to be laden with lipids even in the lean state (Silva et al., 2019). One of the roles of
macrophages in lean adipose is to clear dead adipocytes. ATMs form CLSs around dying
adipocytes to clear the dying cell and lipids in a contained manner (Murano et al., 2008).
Because adipocytes are too large to fully be engulfed by macrophages, ATMs release acidic
exosomes laden with lysosomal enzymes that can take up and degrade large adipocyte
fragments which can then be taken up by the macrophages in a process called exophagy
(Haka et al., 2016). This process allows for macrophages to internalize large amounts of
lipids. During obesity, this process becomes increasingly overburdened as there is an
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increase in the number of dying adipocytes and CLSs. The accumulation of macrophages
in response to high fat diet is mostly attributed to an influx of peripheral BM derived
monocytes that quickly differentiate and proliferate locally (Amano et al., 2014; Hill et al.,
2018; Jaitin et al., 2019; Nagareddy et al., 2014; Oh et al., 2012; Silva et al., 2019). The
macrophages that accumulate with obesity are also heterogeneous and further studies may
clarify the specific roles of each subset in disease progression (Hill et al., 2018; Jaitin et
al., 2019).
Most of the infiltrating macrophages are found at CLSs and proliferate locally.
They are largely CD9+ and are enriched with signatures for lipid metabolism, lysosomal
biosynthesis, and phagocytosis (Hill et al., 2018; Jaitin et al., 2019; Xu et al., 2013).
Transcriptomic profiling has identified that CD9+ macrophages that accumulate with dietinduced obesity also express CD163 and Trem2. Due to their association with enlarged
adipocytes at CLSs, these macrophages have been named lipid associated macrophages, or
LAMs (Jaitin et al., 2019). Depletion of TREM2+ LAMs led to reduced lipid uptake by
macrophages and increased adipocyte hypertrophy and weight gain, and a worsening of
glucose homeostasis, challenging the idea that infiltrating ATMs during obesity purely
cause disease progression, but also play critical protective roles in the adaptation to
metabolic stresses that occur during obesity (Jaitin et al., 2019).
Adipose tissue is highly vascularized. As adipocytes increase in size and number
via hypertrophy and hyperplasia to store excess calories as triglycerides, hypoxia ensues
as the diffusion limit of oxygen is reached. Pockets of local hypoxia leads to angiogenesis
to meet the oxygen demands required for hypertrophy and increased mitochondrial
respiration. Lyve1+ macrophages express MMP-7,-9, and -12 to remodel the ECM and
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promote angiogenesis (Cho et al., 2007). In lean adipose, macrophages are found tightly
wound around blood vessels as a subset of perivascular macrophages, or PVMs (Hilgendorf
et al., 2019; Silva et al., 2019). These self-maintaining PVMs that are in direct contact with
the vasculature make up a large proportion of macrophages in healthy adipose and express
high levels of CD206 (Silva et al., 2019). Surprisingly, PVMs store lipid droplets even in
the lean state, and rapidly take up dextran and OVA from the circulation, suggesting that
they are constantly surveilling and buffering lipids within the adipose circulation and may
play important roles in presenting antigen and maintaining T cells within the adipose tissue
(Silva et al., 2019). During obesity, PVMs change in morphology from an elongated shape
to a rounded shape and have a reduction in their capacity to take up dextran, suggesting
that their homeostatic functions are diminished in response to high-fat diet (Silva et al.,
2019). As PVMs may play important roles as APCs, how this may impact the interaction
of PVMs with other immune populations during DIO remains to be elucidated.
Adipose tissue is also densely innervated by both sympathetic and sensory nerves
which are important in controlling lipolysis and thermogenesis (Bartness et al., 2014; Chi
et al., 2018; Slavin and Ballard, 1978). Density of innervation varies amongst different fat
depots, with brown adipose having the most, then subcutaneous adipose depots, and
various visceral adipose tissues such as the mesenteric adipose and gonadal adipose tissues.
Release of catecholamines such as norepinephrine (NE) by sympathetic nerves is essential
for hydrolysis of triglycerides into fatty acids, a process called lipolysis that provides
substrates for energetic and synthetic purposes. (Bartness et al., 2010). Interestingly,
macrophages also reside on nerves in the adipose tissue as nerve associated macrophages,
or NAMs (Camell et al., 2017; Pirzgalska et al., 2017; Wolf et al., 2017). While a
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significant portion of brown adipose NAMs are self-maintaining, long lived resident
macrophages, white adipose NAMs are more frequently replenished by BM derived
macrophages (Pirzgalska et al., 2017; Wolf et al., 2017). NAMs lack tyrosine hydroxylase
and therefore do not produce catecholamines (Fischer et al 2017. Pirzgalska et al 2017,
Spadaro et al 2017). Instead, they express the canonical catecholamine transporter, Slc6a2,
allowing for the uptake of catecholamines from the local environment and express
catecholamine degradation enzymes such as monoamine oxidase A (MAOA) and catecholo-methyl transferase (COMT) to control local availability of catecholamines (Camell et al.,
2017; Pirzgalska et al., 2017). Furthermore, the expression of MAOA and COMT in NAMs
is upregulated by NLRP3 mediated inflammation during obesity and aging, leading to
increased catecholamine degradation by NAMs to contribute to metabolic dysregulation
(Camell et al., 2017). How NAMs integrate metabolic and immune sensing in adipose
tissue in response to diet is not well understood and is likely to reveal important nontraditional functions of macrophages in maintaining tissue homeostasis.

Impact of Diet Induced Obesity on Adipose Leukocytes
Besides macrophages, many other immune cell types have been described in
adipose tissue and in the context of obesity. Adipose tissue is relatively enriched with
innate lymphoid cells such as eosinophils, innate lymphoid cells (ILCs), iNKT cells, and
γδ T cells and have been well described in other reviews (Kane and Lynch, 2019; Mraz
and Haluzik, 2014). In brief, mast cells, ILC1s, γδ T cells, and neutrophils all increase in
adipose tissue with obesity and are associated with inflammation. Mast cells increase in
the visceral adipose tissue (VAT), particularly around CLSs and actively degranulate to
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release TNFα, IL-6, and IFNγ to promote obesity and diabetes (Altintas et al., 2011; Liu et
al., 2009). Recently, Zhang et al. have demonstrated that dietary cholesterol leads to
activation of mast cells, suggesting mast cells may be directly sensing and responding to
dysregulated metabolites (Zhang et al., 2019). Neutrophils are transiently increased during
obesity, and are one of the earliest cells to infiltrate adipose tissue and secrete elastase to
contribute to pathology (Elgazar-Carmon et al., 2008; Talukdar et al., 2012). ILC1s or NK
cells were found to contribute to obesity by producing IL-2 and IFNγ to promote M1
skewing in macrophages, and displayed higher killing activity towards M2 like
macrophages over M1 like macrophages (Boulenouar et al., 2017; O'Sullivan et al., 2016).
In humans, CD1c+, CD11c+CD83+ DCs increase in obese adipose and induce Th17
differentiation (Bertola et al., 2012).
γδ T cells are tissue resident and increase during diet induced obesity (Mehta et al.,
2015). Mice lacking γδ T cells have reduced accumulation of proinflammatory
macrophages and significant reductions in systemic insulin resistance, suggesting that γδ
T cells play a role in driving the proinflammatory response during diet induced obesity
(Mehta et al., 2015). However, γδ T cells may also serve homeostatic functions in healthy
adipose tissue as IL-17A production by γδ T cells stimulates the secretion of IL-33 in
stromal cells to maintain the expansion of Tregs in adipose tissue during development
(Kohlgruber et al., 2018). Conversely, iNKT cells, ILC2s, eosinophils are reduced in the
adipose tissue during obesity and their presence is associated with a reduction in metabolic
inflammation, increased insulin signaling and promotion of thermogenesis (Lynch et al.,
2016; Lynch et al., 2009; Molofsky et al., 2015; Wu et al., 2011).
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Besides innate immune cells, B and T cells also become dysregulated during
obesity. B cells in healthy adipose tissue are thought to express IL-10 to negatively control
adipose tissue inflammation (Nishimura et al., 2013). During obesity, although adipose B
are fewer than T cells, there overall numbers are increased and contribute to insulin
resistance by secreting autoreactive, pathogenic IgG antibodies and cytokines that drive
inflammatory macrophages, Th17 polarization, and CD8+ T cell cytotoxicity (DeFuria et
al., 2013; Duffaut et al., 2009; Winer et al., 2011). Cytotoxic CD8 T cells increase with
high fat diet even before macrophages accumulate (Rausch et al., 2008) and along with
increased Th1 cells contribute to insulin resistance during obesity (Nishimura et al., 2009;
Pacifico et al., 2006; Winer et al., 2009). The expansion of T cells before infiltration of
peripheral monocytes and macrophages occurs through antigen expression of resident
ATMs, especially within CLSs, but the increase in T cells may not be exclusively through
clonal expansion during obesity (Morris et al., 2013). Regulatory T cells and iNKT cells
largely contribute to the homeostasis of adipose tissue and produce anti-inflammatory
factors such as IL-10, IL-4, and TGF-β to promote metabolic homeostasis (Feuerer et al.,
2009; Lynch et al., 2012; Schipper et al., 2012). During obesity, both Tregs and iNKT cells
are reduced in adipose tissue (Feuerer et al., 2009; Lynch et al., 2009). How many of these
immune cells are sensing metabolic dysregulation and macronutrient availability remains
to be established.

Immune Cells Regulate Thermogenesis
Maintenance of core-body temperature in homeotherms through heat production is a high
priority metabolic event that is crucial for survival. The invaginations of the inner
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mitochondrial membrane that forms cristae are the sites of oxidative phosphorylation
(OXPHOS) complexes that generate ATP (Kozak and Harper, 2000). In addition to ATP
synthesis, mitochondrial OXPHOS generates heat as an energy byproduct. To enhance
adaptive thermogenesis, adipocytes upregulate the expression of UCP1 (uncoupling
protein 1) that forms pores in the inner mitochondrial membrane to allow protons to pass
through without producing ATP (Kozak and Harper, 2000). Therefore, in the uncoupled
mitochondria, the rate of OXPHOS is significantly boosted and releases heat instead of
ATP. While UCP1 was long thought to be the primary mediator of non-shivering
thermogenesis, the discovery that UCP1-/- mice are able to adapt to long term cold exposure
exposed the possibility of alternative thermogenic mechanisms independent of UCP1
(Ukropec et al., 2006). More recently, studies have revealed that other mechanisms such
as futile creatine cycling, sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) mediated
calcium cycling, and UCP3 can also contribute to fat thermogenesis (Ikeda et al., 2017;
Kazak et al., 2015; Riley et al., 2016).
Macrophages control thermogenesis by controlling the bioavailability of
catecholamines. Inhibition of MAOA in macrophages, increases NE content in adipose
tissue leading to increased lipolysis and thermogenesis by upregulation of UCP1 (Camell
et al., 2017). Moreover, ILC2s, eosinophils, iNK T and γδ T cells have also been implicated
in increasing thermogenesis and upregulating UCP1 (Brestoff et al., 2015; Hu et al., 2020;
Lynch et al., 2016; Qiu et al., 2014). Notably, FGF21, which gets induced during dietary
restriction, can promote the expression of CCL11 by adipocytes to recruit eosinophils,
suggesting that immune cells are actively regulated during adaptive adipose tissue
remodeling (Huang et al., 2017). Future studies are required to determine whether immune
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cells directly affect UCP1 and alternative thermogenic pathways, differentiation of de novo
brown/beige adipocytes, or regulate the sympathetic nervous system to control heat
production. Identification of such mechanisms may reveal strategies to divert the fate of
dietary lipids from storage to heat production through increased mitochondrial uncoupling,
thus reducing metabolic diseases emanating from lipotoxicity and obesity.

Inflammation and Adipose Tissue Fibrosis
Metabolic perturbations such as diet induced obesity or dietary restriction lead to rapid
remodeling of the adipose tissue, where alterations in extracellular matrix (ECM) proteins
play an important role in maintaining adipose tissue homeostasis. During obesity, there are
dynamic changes in the deposition of ECM components such as collagens, fibrillins,
proteoglycans, and specific matrix metalloproteases. While obesity is associated with an
excessive accumulation of hypoxia driven fibrosis that directly leads to poor metabolic
output (Halberg et al., 2009), the regulation and interaction of adipose ECM and the
immune system is still being established. Chronic inflammation had been thought to be the
main driver of fibrosis and metabolic dysfunction during obesity, but studies have revealed
that fibrosis may precede and occur independently of tissue inflammation (Halberg et al.,
2009). Furthermore, repression of fibrosis alone can improve metabolic parameters without
largely affecting inflammation (Hasegawa et al., 2018; Khan et al., 2009). However,
immune cells may contribute to the continued pathologic fibrosis during chronic obesity.
Wang and colleagues have demonstrated that IFNγ producing ILC1s can increase TGF-β
output by macrophages to increase fibrosis, while sensing of dying adipocytes and hypoxia
by Mincle and HIF1-α in macrophages within CLSs can further drive adipose tissue
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fibrosis (Henegar et al., 2008; Tanaka et al., 2014; Wang et al., 2019a). Recent studies
suggest that Mincle may potentially be sensing cholesterol moieties released by dying
adipocytes, as human Mincle can bind crystalline cholesterol and Mincle was shown to
sense cholesterol sulfate in mouse skin (Kiyotake et al., 2015; Kostarnoy et al., 2017).
Further understanding of how different ECM components interact with the immune system
to mediate adipose homeostasis and pathology remains to be elucidated.

Obesity is not accelerated aging of adipose resident immune system
Both obesity and aging are characterized by NLRP3 inflammasome driven low grade
chronic inflammation and metabolic dysregulation. Despite these shared similarities,
obesity is not an accelerated model of aging. While aging is commonly associated with
visceral obesity, there are distinct immunological changes that underlie the pathological
disease progression of each condition (Figure 4.3).
In adipose tissue, obesity leads to an increase in most of the defined macrophage
subsets (Jaitin et al., 2019; Silva et al., 2019). During aging, however, the opposite trend is
observed where macrophage numbers modestly decline (Camell et al., 2017; Lumeng et
al., 2011). Age associated VAT ATMs are enriched for NLRP3 dependent senescence and
catecholamine catabolism gene signatures, with GDF3 being the most highly upregulated
gene with age (Camell et al., 2017). While an accumulation of senescent pre-adipocytes,
endothelial cells, and T cells have been described with age in adipose tissue, these
signatures have yet to be highlighted in highly proliferative obese ATMs (Salvestrini et al.,
2019). Careful investigation of how these newly defined subsets of macrophages and their
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niches change with age may help identify therapeutic targets in ameliorating metabolic
pathogenesis in aging.
In contrast to the reduction of innate macrophage populations with aging, adaptive
B and T cells increase in fat with age (Camell et al., 2019; Lumeng et al., 2011). While
there is also an increase in T and B cells in obese adipose tissue, during aging these cells
accumulate in specific niches called fat associated lymphoid clusters (FALCs). Hence,
FALCs increase their size and number with age (Lumeng et al., 2011). FALCs are a form
of non-classical lymphoid structures that are not encapsulated like traditional lymph nodes
but can form germinal centers and respond to immunological challenges (Cruz-Migoni and
Caamano, 2016). While sterile peritoneal inflammation induced by zymosan increases the
size and numbers of FALCs in visceral adipose depots, an increase in FALC formation is
not associated with inflamed obese fat (Benezech et al., 2015). During aging, there is a
NLRP3 dependent accumulation of adipose tissue resident B cells within FALCs that
produce inflammatory mediators such as IL-1β and CCL2. Depletion of adipose B cells in
aged mice improves lipolytic signaling and insulin sensitivity, identifying aged adipose B
cells as important mediators of age associated insulin resistance, lipolysis resistance, and
adipose dysfunction (Camell et al., 2019).
Tregs play important regulatory roles in protecting metabolic homeostasis in the
adipose of young animals and their dramatic reduction during obesity contributes to
pathology (Feuerer et al., 2009). Conversely Tregs accumulate in adipose with age (Bapat
et al., 2015; Lumeng et al., 2011). Unlike young Tregs, the accumulation of aged adipose
Tregs drive insulin resistance and depletion of Tregs in aged animals improves metabolic
health (Bapat et al., 2015). However, when aged animals are challenged with HFD to
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induce obesity, metabolic homeostasis is not maintained by depletion of Tregs, confirming
that distinct mechanisms drive the pathophysiology of age and obesity associated insulin
resistance (Bapat et al., 2015).
Other adipose resident immune cells which have been characterized in healthy and
obese adipose tissue still require additional examination in the context of aging. While
eosinophils which are associated with promoting homeostasis in healthy adipose are
decreased in obese fat, there seem to be no substantial changes during aging (Bapat et al.,
2015; Wu et al., 2011). Innate T lymphocytes such as iNKT cells are decreased during
obesity whereas iNKTs significantly increase with age, and γδT cells increase during both
obesity and age in the visceral adipose tissue (Kohlgruber et al., 2018). Surprisingly, ILC2s
which reside in visceral adipose tissues, including in FALCs, and produce IL-5 and IL-13
to recruit and maintain eosinophils are also reduced with aging (Molofsky et al., 2015;
Moro and Koyasu, 2010). In fact, many of the age associated immunological changes that
drive metabolic pathology predominantly occur within the visceral adipose. While immune
composition remains to be characterized within the BAT, the depletion of macrophages,
and accumulation of FALCs and Tregs with age occur mainly in the visceral adipose
depots. Similarly, during obesity, changes in pro-inflammatory subsets such as
macrophages are much stronger in visceral adipose depots compared to subcutaneous
adipose tissue (Weisberg et al., 2003).These depot specific immune perturbations likely
drive tissue differences as visceral adiposity is strongly associated with increased risk for
metabolic dysfunction and disease whereas SFAT has been considered to be more
beneficial by acting as a metabolic sink that can buffer daily influx of nutrients to prevent
ectopic lipid storage in visceral organs (Chusyd et al., 2016). As the immune system within
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adipose continues to be explored, it is becoming clear there are complex crosstalk between
different immune cell types. How these homeostatic interactions become dysregulated
during obesity and aging, and their specific tissue niches, remain to be carefully
investigated.

Dietary Protein and Amino Acid Restriction
While the mechanisms of CR are not completely understood, protein quality and amino
acid composition of diet have been more strongly associated with metabolic and age
associated health. Independently of caloric intake, low protein and high carbohydrate diets
were found to have the strongest extension of lifespan (Solon-Biet et al., 2014). In addition
to dietary protein restriction (PR), some studies suggest it is the restriction of essential
amino acids (EAAs) that drive beneficial effects, as supplementing dietary restriction with
EAAs but not non-essential amino acids were sufficient to reverse prolongevity effects
(Grandison et al., 2009; Yoshida et al., 2018). Restriction of specific EAAs, such as the
restriction of sulfur-containing amino acids (SAAs), methionine and cysteine, or
methionine restriction (MR), and deficiency of the branched chain amino acids, leucine,
isoleucine, and valine, or branched chain amino acid restriction (BCAAR), have been
extensively characterized to increase metabolic homeostasis and promote healthy aging
(Fontana et al., 2016; Lee et al., 2016; Solon-Biet et al., 2014). These dietary interventions
commonly lead to reduced adiposity and inflammation, increased insulin sensitivity and
lipolytic gene signatures, and reduction of lipogenesis in adipose tissue and liver (Kitada
et al., 2019). Although much less characterized, restriction of tryptophan can also lead to
increased lifespan and increases recovery to cold stress, suggesting an increase in
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thermogenic capacity (Segall and Timiras, 1975, 1976; Zapata et al., 2018). Surprisingly,
these studies indicate that deficiencies of specific essential amino acids drive remodeling
and programming of metabolic tissues to promote health. Despite numerous studies
investigating the mechanisms driving increased longevity during these dietary
interventions, alterations to the immune system and their role in tissue reprogramming have
been lacking.
One of the pathways that are induced with CR, PR, and amino acid restriction, is
the transsulfuration pathway (TSP) (Hine et al., 2015; Mitchell et al., 2016). The TSP
involves the metabolism of SAAs and involves the catabolism of methionine to generate
intermediates

such

as

the

methyl

donor

S-adenosylmethionine

(SAM),

S-

Adenosylhomocysteine (SAH), homocysteine, and cystathionine. The TSP also allows for
the generation of cysteine through the action of cystathionine-γ lyase (CSE) which can
further provide important metabolites and byproducts such as glutathione, pyruvate, and
hydrogen sulfide (H2S) (Figure 4.4). Some TSP metabolites such as SAM and
homocysteine are increased with obesity and aging and have been implicated with
inflammation and disease risk (Elshorbagy et al., 2013; Obata and Miura, 2015; Rodriguez
et al., 2006; Vaya et al., 2012).
Another exciting, relevant byproduct of the TSP is H2S. Hydrogen sulfide is a
gaseous signaling molecule produced by three mammalian enzymes, cystathionine-gamma
lyase (CSE), cystathionine-beta synthase (CBS), and 3-mercaptopyruvate sulfurtransferase
(MPST), but some studies have shown that H2S may be produced via non enzymatic
reactions (Glorieux et al., 2020). Of note, lifespan extension induced by CR in Drosophila
was abolished when treated with the inhibitor of CSE, propargylglycine (PPG) (Kabil et
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al., 2011), and overexpression of another TSP enzyme, cystathionine β-synthase (CBS) or
treatment with H2S increased median lifespan in C. elegans and yeast respectively,
highlighting TSP mediated H2S production as an important mediator of dietary benefits
(Hine et al., 2015). Interestingly, a role for H2S in immune responses is emerging. In T
cells, H2S is required for the differentiation of regulatory T cells by promoting
demethylation at the Foxp3 locus by Tet1 and Tet2 (Yang et al., 2015). An antiinflammatory role for H2S has been implicated by its action on NF-κB to regulate its
transcriptional activity in macrophages (Sen et al., 2012), and its action on antioxidant gene
regulation (Yang et al., 2013). These studies highlight that H2S may generally promote a
more anti-inflammatory phenotype in immune cells. In myeloid cells, H2S can act
specifically to inhibit inflammasome activation (Castelblanco et al., 2018; Lin et al., 2018),
which may act as an important mechanism to reduce inflammation and initiate tissue
remodeling during dietary interventions. However, studies with H2S have been largely
limited to in vitro studies using H2S donors, inhibitors, or whole-body deletions of TSP
enzymes, particularly CSE. CBS deficiency in mice leads to neonatal lethality (Gupta et
al., 2009), further complicating the investigation of the role of H2S in immune cells. These
complications have led to numerous contradictory reports of the action of H2S on immune
cells, such as the action of H2S in regulating leukocyte adherence and tissue infiltration or
NLRP3 activation (Basic et al., 2017; Spiller et al., 2010; Zanardo et al., 2006). Cell
specific and tissue specific genetic deletion may allow for careful dissection of the role of
the TSP in modulating immune response in physiological contexts.
Another pathway that is increased during protein and amino acid restriction is
integrated stress response mediated autophagy. The integrated stress response allows for
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adaptive responses to various stresses such as starvation and ER stress. Stressors are sensed
by four different sensors: general control nonderepressible 2 (GCN2), protein kinase R
(PKR), haem-regulated inhibitor (HRI), and PKR like endoplasmic reticulum kinase
(PERK) (Pakos-Zebrucka et al., 2016). GCN2 senses amino acid depletion by sensing the
accumulation of uncharged tRNAs (Gallinetti et al., 2013). HRI recognizes heme
deficiency, while PKR senses viral infection through activation by double stranded RNA
(Pakos-Zebrucka et al., 2016). Finally, PERK is activated by ER stress (Pakos-Zebrucka et
al., 2016). Activation of these sensors are integrated by the activation and phosphorylation
of eIF2ɑ leading to global translational arrest (Pakos-Zebrucka et al., 2016). One central
component of the integrated stress response is autophagy (Kroemer et al., 2010). In
addition to GCN2 sensing of uncharged tRNAs, depletion of EAAs leads to interaction of
their specific sensors such as SAMTOR (SAM sensor), sestrin 2 (leucine sensor), and
CASTOR (arginine sensor) with GATOR1 or GATOR2 to prevent mTORC1 activation
and promote autophagy (Kim and Guan, 2019) (Figure 3). Interestingly, autophagy and
amino acid sensing also regulates immune function. It is now well established that
autophagy inhibits inflammasome activation (Sun et al., 2017). In a model of colitis, PR
and leucine restriction were able to reduce inflammation through the inhibition of NLRP3
inflammasome mediated inflammation and reduction of Th17 differentiation. This
response was dependent on amino acid sensing through GCN2 (Ravindran et al., 2016).
Furthermore, treatment with halofuginone, which activates starvation responses by
inhibiting prolyl tRNA charging, also inhibits Th17 cell differentiation (Sundrud et al.,
2009). These studies highlight the induction of amino acid starvation responses in immune
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cells as potential strategies against inflammation driven pathological states such as obesity,
aging, and autoimmunity.
While these different dietary amino acid restrictions may be inducing some
common pathways, specific amino acids may target different pathways. Unlike leucine or
BCAA restriction diets, MR also induces hepatic FGF21 and lipolytic gene signatures
independently of GCN2 (Lees et al., 2017). Instead, MR specific hepatic changes are driven
by PERK and glutathione depletion (Wanders et al., 2016). Thus, different mechanisms
may drive adaptations to specific amino acid deficiencies in tissues and immune cells
(Figure 3). Despite numerous studies investigating the broad metabolic adaptations that
occur during PR, how immune cell function is being altered have been lacking. A plethora
of early studies have investigated immune defense in the context of protein malnutrition,
suggesting alterations in both macrophage and lymphocytic responses to infection.
However, these studies were conducted prior to the classification of broad immune subsets
and advancement of technological tools and need to be revisited to properly understand
how the immune system may be responding during PR without malnutrition in the context
of both tissue adaptation and immune defense.

Integrated Immunometabolic Response to Carbohydrate and Caloric Restriction
In an event of low glucose availability, such as food restriction, the limited glycogen
reserves in the liver and muscle cannot sustain nonessential metabolic demand. Instead,
triglycerides undergo fatty acid oxidation, ketogenesis, and ketolysis to support ATP
production.
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It is known that long-term CR lowers inflammation and protects against thymic
lipoatrophy and maintains T cell repertoire during aging (Yang et al., 2009a). Intriguingly,
however, CR causes a major redistribution of circulating leukocytes. A two-year
multicenter randomized controlled trial where healthy humans achieved approximately
14% CR (CALERIE-II) provided evidence that CR reduces the number of circulating
lymphocytes and monocytes without compromising vaccine responses or increasing
susceptibility to infections (Meydani et al., 2016). Similarly, studies from Jordan et al
found that 19hr of fasting in humans led to reduction of monocytes and dendritic cells in
blood but instead increased retention of pro-inflammatory Ly6Chi monocytes in the BM
(Jordan et al., 2019). In agreement with prior studies (De Rosa et al., 2015) fasting reduced
systemic inflammation in a mouse model of multiple sclerosis. Importantly, monocytes
could still respond and control Listeria monocytogenes infection during fasting in a PPARα
dependent manner (Jordan et al., 2019). Similarly, negative energy balance mediated
reduction in mTOR also led to CXCL13 driven homing of naïve B cells from Peyer’s
patches to BM. Moreover, Collins et al found that mice subjected to 50% dietary restriction
for 3 weeks caused a loss of peripheral memory CD8 T cells and their surprising
accumulation in the BM. Markedly, this redistribution of B and memory T cells led to
enhanced protection against secondary bacterial infection (Collins et al., 2019). It is
intriguing that during energy deficit, memory T cells do not prefer adipose tissue that is
undergoing increased lipolysis with abundant fatty acids as energy substrates, and home
instead to BM. CR’s salutary effects on immune system and control of inflammation
require further characterization. From the current evidence, switch from glycolysis to fatty
acid oxidation appears to be an important immunometabolic checkpoint affected by CR.
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For example, production of ketone bodies like β-hydroxybutyrate downstream of fatty acid
oxidation, inhibits Nlrp3 inflammasome mediated inflammation and protects against
influenza infection by expanding tissue protective γδ T cells in lung and adipose tissue
(Goldberg et al 2019). Whether low carbohydrate high fat ketogenic diet that increases
fatty acid oxidation and BHB can be harnessed to protect against inflammatory damage, as
in

Covid-19

immunopathology,

requires

careful

testing.

The

endogenous

immunometabolic mediators that drive CR salutary effects thus offer a promising avenue
to regulate inflammation and enhance healthspan.

Concluding Remarks
Significant progress over the last decade has firmly established that reciprocal interactions
between immune and metabolic systems are required for the host to maintain homeostasis.
Immunometabolism, not only encompasses immune cell intrinsic regulation of glycolysis,
TCA cycle, pentose phosphate pathway, and fatty acid metabolism to impact inflammation
and effector functions, but also entails immune regulation of systemic whole-body
metabolism and coupling of positive and negative energy balance to successful immune
response. As outlined in this review, the integrated immunometabolic response is in fact
vital for regulation of organismal metabolism and host defense. A major influencer of IIMR
is the diet. It is evident that metabolic fate of fat, protein and carbohydrates is important
for immunologic function. However, how macronutrient intake elicits specific pathways in
a host to either induce disease or promote health and longevity is only beginning to be
understood. In addition, both immune response and metabolism are regulated by the
autonomic nervous system which are not under our conscious control. The neural
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regulation of immunometabolism, by which the autonomic nervous system integrates the
central nervous system, immune system, and metabolic organs to maintain essential
functions and prepare the host for surmounting stressful challenges, is not well understood.
Thus, study of Neuro-Immunometabolism may reveal new mechanisms to promote health
and understand disease. Identification of immune cells like macrophages in sympathetic
nerve niches in adipose tissue represents one mode of neuroimmunometabolic crosstalk
that controls inflammation and lipolysis setpoints. These advances have set the stage for
the next era of immunometabolism studies where regulation of diet driven metabolic
checkpoints are likely to be revealed and potentially implemented in clinical practice to
promote health.
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Figures

Figure 4. 2 Negative energy balance drives integrated immuno-metabolic responses
to counterbalance homeostatic processes to promote longevity.
Negative energy balance is achieved with energy consumed is less than energy expended. This drives
neuroendocrine hormone effectors such as ghrelin, FGF21, and GDF15, and the usage of alternative
metabolic fuels such as fatty acids and ketone bodies. These signals get integrated by organs such as the
brain, liver, adipose tissue, gut, and skeletal muscle with the immune system to promote metabolic
reprogramming that prioritizes fatty acid oxidation over glycolysis. These changes adjust the balance of
normal physiological processes such as body temperature, growth, reproduction, and immune response
in a way that promotes longevity and health.
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Figure 4. 3 Obesity and Aging lead to Distinct changes in the immune profile of adipose
tissue to drive inflammation and pathology.
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Healthy, lean adipose tissue is associated with anti-inflammatory immune subsets, such as CD206
expressing macrophage subsets (Adipose tissue macrophages (ATMs), nerve associated macrophages
(NAMs), and vascular associated macrophages (VAMs)), IL-4 expressing eosinophils, IL-10 expressing
iNKT cells, B cells, and Tregs, and IL-5 expressing ILC2s. Energy imbalance leads to a disruption of
immune and metabolic homeostasis, leading to an infiltration of inflammatory immune cells such as IL6 and TNFα producing lipid associated macrophages (LAM), elastase producing neutrophils, IgG2C
producing B cells, degranulating mast cells, IFNγ producing CD4 T cells, IL-17 producing γδ T cells,
and cytotoxic CD8 T cells. Accumulation of danger associated molecular patterns (DAMPs) such as free
fatty acids (FA), oxidized LDL (oxLDL), cholesterol crystals, and islet amyloid polypeptides (IAPP) in
obesity further drives the activation of NLRP3 inflammasome. These changes in immune mediated
inflammation drive pathologies such as insulin resistance, type II diabetes, cardiovascular disease, and
cancer, while weakening immune defense against pathogens, leading to higher risk for premature
death. Unlike obesity, which is characterized by an accumulation crown like structures (CLS) where
immune cells such as T cells and CD9+ macrophages, associated with increased lipid processing and
inflammation, accumulate to deal with dying adipocytes, aging sees a reduction of adipose tissue
macrophages, which instead increase GDF3 and catecholamine degradation enzymes such as MAOA and
COMT to promote lipolysis resistance. Aging also leads to an increase of fat associated lymphoid clusters
(FALCs) where B cells and T cells accumulate and contribute to dysregulated adipose homeostasis such
as reduced insulin signaling and thermogenesis. While γδ T cells increase with both age and obesity,
iNKT cells and Tregs increase with age and decrease with obesity, and while no marked changes in
eosinophils are reported in aged adipose, obesity is associated with significant decreases in eosinophil
populations. These differences in immune profiles and immune lymphoid structures during aging and
obesity suggest that distinct mechanisms contribute to the pathologies associated with each condition.
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Figure 4. 4 Protein and essential amino acid restriction induces the transsulfuration
pathway and the integrated stress response to regulate immune response.
Induction of the transsulfuration pathway leads to production of byproducts such as hydrogen sulfide,
which can reduce NLRP3 inflammasome mediated inflammation and promote and maintain regulatory
T cell differentiation. Low amino acid availability leads to the interaction of amino acid sensors such as
Sestrin 2 and SAMTOR with GATOR2 and GATOR1 respectively to restrict mTORC1 activation.
Furthermore, sensing of uncharged amino acids by GCN2 and lack of glutathione by PERK further
inhibits mTORC1 and leads to the activation of eIF2α, stress response genes, and autophagy, inhibiting
NLRP3 inflammasome mediated inflammation and Th17 responses.
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Chapter 5: Summary and Perspectives
This project began with the aim to identify novel mechanisms that mediated the
health benefits during caloric restriction (CR), a pro-longevity intervention. Specifically,
we sought to identify novel therapeutic targets to reduce inflammation and improve
metabolic health, because many chronic diseases associated with aging and obesity are
caused by inflammation-driven metabolic pathology. And while dietary interventions such
as CR or protein restriction are successful in reducing inflammation and promoting weight
loss and improved metabolic function, they are untested in humans and are extremely
difficult to implement in everyday life. We thus investigated transcriptional and metabolic
changes in adipose tissue from healthy adults that underwent 2 years of 14% CR (Ravussin
et al., 2015), Dixit, unpublished). Through investigation of human caloric restriction, our
studies identify that defense of cysteine availability by the transsulfuration pathway is a
critical immune-metabolic checkpoint. We find that during caloric restriction, the TSP is
induced in response to a depletion of cysteine and its downstream metabolites. Induction
of the TSP in turn, can reduce inflammation through the production of H2S. We show that
H2S can inhibit the activation of NLRP3 inflammasome, through inhibition of the assembly
of NLRP3 inflammasome complex. Furthermore, reduction in sulfur amino acid
availability can reduce inflammasome activation by mediating p62-independent autophagy
in macrophages. Indeed, the health benefits of methionine restriction (MR), another prolongevity intervention are blocked by cysteine supplementation, suggesting that limited
cysteine availability underlies the benefits of restrictive dietary pro-longevity interventions
(Elshorbagy et al., 2011).
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Importantly, we generated a model of cysteine deficiency to discover that cysteine
availability is required for the defense of core body temperature, and deficiency of cysteine
drives unchecked thermogenesis to the point of mortality. Thermogenesis is activated
through increased sympathetic signaling that drives lipolysis and UCP1 to generate heat.
We discovered that ablation of CSE together with dietary restriction of cysteine in mice
causes a complete transformation of the white adipose tissues into a thermogenic brownlike depot. This process involved increased mobilization of adipocyte progenitors and loss
of monocyte-derived macrophages. Concurrently, tissue resident macrophages were
enriched, with reduced expression of catecholamine degradation enzymes such as COMT,
which increases norepinephrine availability to drive adipose tissue browning. While two
other groups have previously investigated Cth-/- mice in the context of low cysteine diets
(Ishii et al., 2010; Mani et al., 2011), we discovered time that cysteine deficiency mobilizes
adipose to generate heat due to increased pressures to defend core body temperature.
This discovery may have therapeutic implications in a few clinical settings. The
inhibition of CSE together with restriction of cysteine using specific prescribed diets can
serve as a therapeutic strategy to activate thermogenesis as a short-term weight loss
intervention in obese patients under a supervised clinical setting. Preliminary experiments
suggest that even in the context of high fat diet, cysteine deficiency causes weight loss in
Cth-/- mice. While long-term cysteine deficiency is not sustainable due to life-threatening
unchecked weight loss, short-term cysteine deficiency through inactivation of the TSP may
allow for quick weight loss in specific situations, such as weight loss for surgery.
Alternatively, cysteine supplementation may help with unwanted weight loss during
specific conditions such as cachexia. The increase in BCAA degradation and threonine in
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adipose tissue suggests that skeletal muscle degradation may provide additional amino acid
sources for mitochondrial respiration in the adipose tissues. Early studies by Droge and
colleagues found that low plasma cystine levels were found in several diseases such as latestage HIV infection, cancer, sepsis, Crohn’s disease, and major injury and trauma and is
associated with skeletal muscle wasting (Droge et al., 1998; Hack et al., 1997). This process
has been described as the “Low CG Syndrome” where plasma cysteine, glutamine, and
glutathione levels are abnormally low. Supplementation of N-acetyl-cysteine has been a
successful therapeutic strategy in the context of HIV (Droge and Holm, 1997; Sekhar et
al., 2015). Cysteine supplementation may thus serve as a mechanism to combat cachexia
in a number of other diseases. Further investigation on how different metabolic organs such
as adipose tissue and skeletal muscle are responding to cysteine deficiency and
communicating with each other may allow for the untangling of fat and lean mass loss to
provide more precise therapeutic targets in the context of weight loss and cachexia.
In conclusion, we discover that maintenance of cysteine metabolism by the TSP is
important for inflammatory and metabolic homeostasis. Further investigation of how
adaptations to cysteine deficiency are integrated in different metabolic organs may allow
for identification of novel therapeutic strategies.
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Chapter 6: Materials and Methods
Human Samples
The participants in this study were part of the CALERIE Phase 2 (Rochon et al., 2011)
study which was a multi-center, parallel-group, randomized controlled trial by recruitment
of non-obese healthy individuals. 238 adults participated at 3 different locations:
Pennington Biomedical Research Center (Baton Rouge, LA), Washington University (St.
Louis, MO) and Tufts University (Boston, MA) (NCT00427193). Duke University,
(Durham, NC) served as a coordinating center. Participants were randomly assigned to of
25% caloric restriction or ad libitum caloric intake for two years. CR group participants
actually reached 14% of CR (Ravussin et al., 2015). Men were between 20 and 50 years
old and women were between 20 and 47 years old. Their body mass index (BMI) was
between 22.0 and 27.9 kg/m2 at the initial visit. Samples were collected at baseline, 1 year,
and 2 years of intervention. Abdominal subcutaneous adipose tissue biopsy was performed
on a portion of CR group participants and used for RNA-sequencing and metabolomics in
this study. Only 8 participants completed all three time points. All studies were performed
under protocol approved by the Pennington institutional review board with informed
consent from participants.

Mice
All mice were on the C57BL/6J (B6) genetic background except methionine restriction
cohorts, which were on a C57BL/6M background from the NIA. B6 mice were purchased
from Jackson Laboratories and maintained in our lab. Cth-/- mice (C57BL/6NTacCthtm1a(EUCOMM)Hmgu/Ieg) were purchased from the European Mouse Mutant Cell Repository.
Breeding these mice to Flipase transgenic mice from Jackson Laboratories generated Cthfl/fl
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mice which were crossed to Adipoq-cre and Albumin-cre, purchased from Jackson
Laboratories. Nlrp3A350VneoR and Tg(CAG-(cre/Esr1*)5Amc (CAG-ERcre) were purchased
from Jackson laboratories and crossed to generate MWS model mice. Ucp1-/- mice were
purchased from Jackson laboratories and crossed to Cth-/- mice. Fgf21-/- mice were kindly
provided by Dr. Steven Kliewer (UT Southwestern) as described previously (Potthoff et
al., 2009), and crossed to Cth-/- mice. 17-18 month animals were provided by the NIA. All
mice used in this study were housed in specific pathogen-free facilities in ventilated cage
racks that deliver HEPA-filtered air to each cage with free access to sterile water through
a Hydropac system at Yale School of Medicine. Mice were fed a standard vivarium chow
(Harlan 2018s) unless special diet was provided, and housed under 12 h light/dark cycles.
All experiments and animal use were approved by the Institutional Animal Care and Use
Committee (IACUC) at Yale University.

Diet studies
For methionine restriction (MR) studies, diets were purchased from Dyets (Appendix 1).
C57BL/6M mice were started on control or MR diets at 8wks old or 17-18 months old and
were kept on diet for 3 months. For LPS studies, adult C57BL/6J were maintained on
control or MR diet for 3 months.
Mice were acutely injected with LPS (Sigma) i.p. at a dose of 2mg/kg for 4 hours. Blood
glucose (Breeze) and rectal core body temperature (Physitemp) were measured before and
after injection.

126

Nlrp3A350VneoR CAG-ERcre mice were fed control or MR diet for 1 week prior to i.p.
injection of tamoxifen (Sigma). Tamoxifen was injected for 2 consecutive days at 50mg/kg
per day while being maintained on diet.
Adipose samples from protein restricted (PR) mice were kindly provided by Dr.
Christopher Morrison (Pennington University). Control and PR diets were produced by
Research diets, and were designed to be isocaloric by equaling varying protein and
carbohydrate, while keeping fat constant. Control diet contained 20% casein by weight,
while PR diet contained 5% casein. Mice were maintained on diet ad libitum for 6 months.
For cysteine deficiency and leucine deficiency studies, mice were fed special amino acid
diets: control diet, CysF diet, or LeuF diet purchased from Dyets (Appendix 2), for 6 days
unless specified otherwise. Prior to amino acid diets, mice were fed standard vivarium
chow (Harlan 2018s). Mice were started on amino acid diets between 3-6 months of age.
For pair feeding studies, mice were provided with either ad libitum or 2.22-2.27g of diet
daily.

Cell culture
All steps were performed using sterile technique. To prepare BMDMs, femurs and tibias
were collected in RPMI (Life Technologies) + 10% FBS (Omega Scientific). Both ends
of the femur were then cut and the femur was flushed with RPMI. The bone marrow was
centrifuge at 450 g for 5 min, the supernatant was decanted and red blood cells were lysed
using ACK lysis buffer (Quality Biological). After neutralization, bone marrow cells were
centrifuged, resuspended in 10 ml of RPMI and placed into one well of a 6 well plate. Nonadherent cells were collected the following morning.
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The non-adherent cells were

resuspended in media consisting of 10 ml supernatant of non-adherent cells, 14.4 ml L929
conditioned media, 13.6 ml RPMI and MCSF (10ng/ml). An additional 2 ml of fresh media
was added 4 d after isolation. Non-adherent cells were collected on day 7 and resuspended
at 1x106 cells/ml and allowed to adhere overnight.
For M1 polarization, cells were treated with LPS at 1ug/ml + recombinant IFNg
(Ebioscience) at 20ng/ml for 24 hours. For M2 polarization, cells were treated with
recombinant IL-4 (BD) for 24 hours. For inflammasome activation, cells were treated with
ultrapure LPS (Sigma) at 1ug/ml for 4 hours alone or subsequently with 5mM ATP (Sigma)
for one hour. For hydrogen sulfide treatment experiments, cells were treated with sodium
hydrosulfide (Sigma) at 0-100uM at the time of LPS treatment. For methionine and
cysteine restricted experiments, before LPS treatment, cells were washed in PBS and
switched to DMEM lacking methionine and cysteine and glutamine. Glutamine () was
added at 2.5mM, and L-methionine (Sigma) and L-cysteine (Sigma) were each added at
200uM per well. 3-methyladenine (Sigma) was treated at 5mM at the time of LPS
treatment. LysM-cre p62fl/fl femurs were kindly provided by Dr. Michael Karin, and were
received overnight in RPMI. All following steps were done identically as described above.
BMDMs from Nlrp3A350VneoR mice were prepared as described above. The day before
inflammasome activation, the cells were treated with 4-hydroxy-tamoxifen (4-OHT) at
0.25mM.

Potassium efflux assay
On the day before inflammasome activation, cells were plated 100,000 cells per well of a
96 well plate in 200ul. Conditions were consistent as above. After all cell treatments, media
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was changed to fresh media and Asante potassium green 2 (APG4) (Abcam) was added at
5uM and incubated at 37C for 30min. After 2 washes in PBS, the plate was read in 50ul of
PBS according to manufacturer’s directions.

Thioglycolate
Mice were injected with a one-time 1ml intraperitoneal injection of 3% thioglycolate
medium (BD). 4 days later, peritoneal cells were collected by peritoneal lavage.

Western blot analysis
Cell lysates were prepared using RIPA buffer and optionally frozen and stored at -80°C.
Samples were left on ice, vortexing every ten min for 30 min. For tissue samples, snap
frozen tissues were ground by mortar and pestle in liquid nitrogen and resuspended in RIPA
buffer with protease and phosphatase inhibitors. Samples were centrifuged at 14,000g for
15min and the supernatant was collected protein concentration was determined using the
DC Protein Assay (Bio-Rad) and transferred to a nitrocellulose membrane. The following
antibodies (and source) were used to measure protein expression: IL-1β (Genetex), NLRP3
(Adipogen), β-Actin (Cell Signaling), pHSL p660 (Cell Signaling), ATGL (Cell
Signaling), UCP1 (Abcam), CSE (Novus), Caspase-1 (generously provided by Genentech),
Tubulin (Sigma), HSL (Cell Signaling), COMT (Biorad), MAOA (Abcam), TH (Cell
Signaling); followed by incubation with appropriate HRP-conjugated secondary antibodies
(Thermo).
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Gene expression analysis
Cells or ground tissue (described above) were collected in STAT-60 (). RNA from cells
were extracted using Qiagen RNeasy micro kits following manufacturer’s instructions. For
tissue samples, RNA was extracted using Zymo mini kits following manufacturer’s
instructions. During RNA extraction, DNA was digested using RNase free DNase set
(Qiagen). Synthesis of cDNA was performed using iScript cDNA synthesis kit (Bio-Rad)
and real time quantitative PCR (Q-PCR) was conducted using Power SYBR Green
detection reagent (Thermo Fischer Scientific) on a Light Cycler 480 II (Roche). Primers
used for qPCR are described in Appendix 3.

Glucose tolerance tests/ Insulin tolerance test
Mice were fasted 14hr prior to glucose tolerance test. Glucose was given by i.p. injection
based on body weight (0.4g/kg). For insulin tolerance test, mice were fasted for 4 hours
and insulin was given by i.p. injection based on body weight (0.8U/kg). Blood glucose
levels were measured by handheld glucometer (Breeze, Bayer Health Care).

Multiplex
Serum was prepared by collecting blood and allowing to clot at room temperature for 2
hours. Samples were then centrifuged for 20 min at 4°C and stored at -80°C until analysis.
Inflammatory cytokines, IL-6, MCP-1, IL-1β, and TNFa, were measured in the serum using
custom Procartaplex kit (Life Technologies), and measured on a Luminex 200 analyzer.
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Flow Cytometry
Intravascular labeling was performed by iv injection of 2.5ug CD45.2-FITC diluted in
100ul PBS. Mice were euthanized exactly 3 minutes after injection for tissue collection.
Adipose tissue was digested in HBSS (Life Technologies) + 0.1% collagenase I or II
(Worthington Biochemicals). The stromal vascular fraction was collected by
centrifugation, and washed and filtered using 100um and 70um strainers. Cells were
stained with LIVE/DEAD™ Fixable Aqua Dead Cell Stain Kit (Thermo Fisher Scientific)
and then for surface markers including CD45, CD3, B220, CD11b, F4/80, Ly6G, Siglec F,
CD163 and all antibodies were purchased from eBioscience or Biolegend. Cells were fixed
in 2% PFA. Samples were acquired on a custom LSR II and data was analyzed in FlowJo.

Single-cell RNA sequencing
For stromal vascular fraction, female Cth+/+ and Cth-/- mice were fed CTRL of CysF diet
for 4 days. SFAT was collected, with lymph nodes removed, pooled, and digested. For
myeloid cells, Cth+/+ and Cth-/- mice were fed CTRL of CysF diet for 3 days. Intravascular
labeling was performed by i.v. injection of 2.5ug CD45.2 diluted in PBS for 3 min. SFAT
was collected, with lymph nodes removed, pooled, digested, and stained for live/dead,
CD11b, CD45, and dump (CD3, B220, Siglec F). Cells were sorted on BD FACSAria, for
CD45+ CD11b+ cells that were negative for CD45.2 and the dump channel. Isolated cells
were subjected to droplet-based 3’ end massively parallel single-cell RNA sequencing
using Chromium Single Cell 3’ Reagent Kits as per manufacturer’s instructions (10x
Genomics). The libraries were sequenced using a HiSeq3000 instrument (Illumina).
Sample demultiplexing, barcode processing, and single-cell 3’ counting was performed
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using the Cell Ranger Single-Cell Software Suite (10x Genomics). Cellranger count was
used to align samples to the reference genome (mm10), quantify reads, and filter reads with
a quality score below 30. The Seurat package in R was used for subsequent analysis (Butler
et al., 2018). Cells with mitochondrial content greater than 0.05 percent were removed and
data was normalized using a scaling factor of 10,000, and nUMI was regressed with a
negative binomial model. Principal component analysis was performed using the top 3000
most variable genes and t-SNE analysis was performed with the top 20 PCAs. Clustering
was performed using a resolution of 0.4. The highly variable genes were selected using the
FindVariableFeatures function with mean greater than 0.0125 or less then 3 and dispersion
greater than 0.5. These genes are used in performing the linear dimensionality reduction.
Principal component analysis was performed prior to clustering and the first 20 PC’s were
used based on the ElbowPlot. Clustering was performed using the FindClusters function
which works on K-nearest neighbor (KNN) graph model with the granularity ranging from
0.1-0.9 and selected 0.4 for the downstream clustering. For identifying the biomarkers for
each cluster, we have performed differential expression between each cluster to all other
clusters identifying positive markers for that cluster. To perform pathway analysis, we
compared differential gene expression parameters (0 fold and threshold of at least 10% of
cells) between samples. Gene-set enrichment analysis (GSEA) was performed using the
FGSEA package in R with the canonical pathways (CP). To understand the trajectory of
the adipocyte progenitors, we used Monocle2 to analyze scRNA-seq data of Clusters 0, 1,
and 2 (Trapnell et al., 2014).
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Whole tissue RNA sequencing and transcriptome Analysis
Snap frozen tissues were ground by mortar and pestle in liquid nitrogen and resuspended
in STAT-60. RNA was extracted using Zymo mini kits. RNA was sequenced on a
HiSeq2500. The quality of raw reads was assessed with FastQC [FastQC]. Raw reads were
mapped to the GENCODE vM9 mouse reference genome [GENCODE] using STAR
aligner [STAR] with the following options: --outFilterMultimapNmax 15 -outFilterMismatchNmax

6

--outSAMstrandField

All

--outSAMtype

BAM

SortedByCoordinate --quantMode TranscriptomeSAM. The quality control of mapped
reads was performed using in-house scripts that employ Picard tools [Picard]. The list of
rRNA genomic intervals that we used for this quality control was prepared on the basis of
UCSC mm10 rRNA annotation file [UCSC] and GENCODE primary assembly annotation
for vM9 [GENCODE]. rRNA intervals from these two annotations were combined and
merged to obtain the final list of rRNA intervals. These intervals were used for the
calculation of the percentage of reads mapped to rRNA genomic loci. Strand specificity of
the RNA-Seq experiment was determined using an in-house script, on the basis of Picard
[Picard] mapping statistics. Expression quantification was performed using RSEM
[RSEM]. For the assessment of expression of mitochondrial genes, we used all genes
annotated on the mitochondrial chromosome in the GENCODE vM9 mouse reference
genome [GENCODE]. PCA was performed in R. For the PCA, donor effect was removed
using the ComBat function from the sva R-package [sva]. Gene differential expression was
calculated using DESeq2 [DESeq2]. ]. Pathway analysis was done using fgsea (fast GSEA)
R-package [fgsea] with the minimum of 15 and maximum of 500 genes in a pathway and
with 1 million of permutations. For the pathway analysis, we used the Canonical Pathways
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from the MSigDB C2 pathway set [MSigDB1, MSigDB2], v6.1. The elimination of
redundant significantly regulated pathways (adjusted p-value < 0.05) was done using an
in-house Python script in the following way. We considered all ordered pairs of pathways,
where the first pathway had normalized enrichment score equal to or greater than the
second pathway. For each ordered pair of pathways, we analyzed the leading gene sets of
these pathways. The leading gene sets were obtained using fgsea [fgsea]. If at least one of
the leading gene sets in a pair of pathways had more than 60% of genes in common with
the other leading gene set, then we eliminated the second pathway in the pair.

GAM-clustering, identifies modules describing dynamic regulation of metabolism and is
based on the previously developed GAM method (Sergushichev et al., 2016). GAMclustering extends the GAM method by setting the task to find not one but several
metabolic modules (connected subnetworks of metabolic network) with the condition that
each of these modules should contain as many metabolic genes with high pairwise
correlation of their expression as possible. The initial approximation of the final set of
modules is carried out by k-medoids clustering of a gene expression matrix for all
metabolic genes of a dataset with some arbitrary k (here we used k=32). Each cluster forms
a corresponding expression pattern which can be determined as averaged value of its znormalized gene expression values. The metabolic network used for further analysis is
presented as a graph where vertices are metabolites and edges are KEGG database reactions
which are mapped with catalyzing them enzymes and corresponding genes. For each
particular pattern edges of this graph are scored (weighted) based on their gene expression
similarity with this pattern and dissimilarity with other patterns.
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For each case of weighted graph, a connected subgraph of maximal weight is found by a
signal GMWCS (generalized maximum weight connected subgraph) solver (Ulland et al.,
2017) (https://github.com/ctlab/sgmwcs-solver) and is called a metabolic module. This
solver uses the IBM ILOG CPLEX library, which efficiently performs many iterations of
this method in a reasonable amount of time. Then, each pattern is updated by replacing it
with an averaged gene expression of the module’s edges with a positive score. If the pattern
is changed, a new score set is calculated and a new iteration is performed. Before moving
to the next iteration, small graphs are eliminated from further analysis so that there are no
graphs with less than five edges and diameter less than four in the output solution. The
algorithm continues until the pattern content stops changing (Gainullina et al., 2020).

Metabolomics and Lipidomics
Metabolite extraction from tissue blocks for metabolome analyses was performed as
described previously (Miyazawa et al., 2017). Briefly, one frozen block together with
internal standard (IS) compounds (see below) was homogenized in ice-cold methanol
(500μl) using a manual homogenizer (Finger Masher (AM79330), Sarstedt), followed by
the addition of an equal volume of chloroform and 0.4 times the volume of ultrapure water
(LC/MS grade, Wako). The suspension was then centrifuged at 15,000 g for 15 min at 4°C.
After centrifugation, the aqueous phase was ultrafiltered using an ultrafiltration tube
(Ultrafree MC-PLHCC, Human Metabolome Technologies). The filtrate was concentrated
with a vacuum concentrator (SpeedVac, Thermo). The concentrated filtrate was dissolved
in 50μl of ultrapure water and used for LC-MS/MS and IC-MS analyses.
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We used both internal (added to the tissue before extraction) and external (used to produce
calibration curves for each compound) standard compounds for concentration calculation.
The detailed method is as follows:
Internal standard (IS) compounds
We used 2-morpholinoethanesulfonic acid (MES) and 1,3,5-benzenetricarboxylic acid
(trimesate) as ISs for anionic metabolites. These compounds are not present in the tissues;
thus, they serve as ideal standards. Loss of endogenous metabolites during sample
preparation was corrected by calculating the recovery rate (%) for each sample
measurement.
External standard (ES) compounds
An external calibration curve was used to calculate the absolute abundance of metabolites.
Before sample measurement, we measured the mixture of authentic compounds of target
metabolites at three different concentrations in ultrapure water to generate calibration
curves. Quantification (amount of metabolites, nmol/mg tissue) was performed by
comparing the IS-normalized peak areas against the calibration curves.
Ion chromatography-tandem mass spectrometry for anionic metabolites
For metabolome analysis focused on glucose metabolic central pathways, namely
glycolysis, TCA-cycle and PPP, those anionic metabolites were measured using an
orbitrap-type MS (Q-Exactive focus, Thermo Fisher Scientific, San Jose, CA), connected
to an high performance ion-chromatography system (ICS-5000+, Thermo Fisher
Scientific) that enables us to perform highly selective and sensitive metabolite
quantification owing to the IC-separation and Fourier Transfer MS principle (Hu et al.,
2015).
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The IC was equipped with an anion electrolytic suppressor (Thermo Scientific Dionex
AERS 500) to convert the potassium hydroxide gradient into pure water before the sample
enters the mass spectrometer. The separation was performed using a Thermo Scientific
Dionex IonPac AS11-HC, 4-μm particle size column. IC flow rate was 0.25 mL/min
supplemented post-column with 0.18 mL/min makeup flow of MeOH. The potassium
hydroxide gradient conditions for IC separation are as follows: from 1 mM to 100 mM (0–
40 min), 100 mM (40–50 min), and 1 mM (50.1–60 min), at a column temperature of 30°C.
The Q Exactive focus mass spectrometer was operated under an ESI negative mode for all
detections. Full mass scan (m/z 70−900) was used at a resolution of 70,000. The automatic
gain control (AGC) target was set at 3 × 106 ions, and maximum ion injection time (IT)
was 100ms. Source ionization parameters were optimized with the spray voltage at 3 kV
and other parameters were as follows: transfer temperature at 320°C, S-Lens level at 50,
heater temperature at 300°C, Sheath gas at 36, and Aux gas at 10.

Liquid chromatography-tandem mass spectrometry for amino acid measurement
The amount of cationic metabolite including amino-acids in the tissues was quantified
using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Briefly, a triplequadrupole mass spectrometer equipped with an electrospray ionization (ESI) ion source
(LCMS-8040, Shimadzu Corporation) was used in the positive and negative-ESI and
multiple reaction monitoring (MRM) modes. The samples were resolved on the Discovery
HS F5-3 column (2.1 mmI.D. x 150 mmL, 3μm particle, Sigma-Aldrich), using a step
gradient with mobile phase A (0.1% formate) and mobile phase B (0.1% acetonitrile) at
ratios of 100:0 (0–5 min), 75:25 (5–11 min), 65:35 (11–15 min), 5:95 (15–20 min) and
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100:0 (20–25 min), at a flow rate of 0.25 mL/min and a column temperature of 40°C. MRM
conditions for each amino acids are listed in Appendix 4.

Liquid chromatography-mass spectrometry for lipid measurement
The amount of lipids in the tissues was measured using an orbitrap-type MS (Q-Exactive
focus, Thermo Fisher Scientific, San Jose, CA) connected to an high performance liquid
chromatography system (UltiMate 3000 RSLC system, Thermo Scientific ).
Briefly, the samples were resolved on the Accucore C18 column (2.1 x 150 mm, 2.6 μm,
Thermo Scientific), using a step gradient with mobile phase A (10 mM HCOONH4 in 50%
ACN (v) + 0.1% HCOOH (v)) and mobile phase B (2 mM HCOONH4 in ACN / IPA /
H2O 10:88:2 (v/v/v) + 0.02% HCOOH (v) ) at ratios of 65:35 (0 min), 40:60 (0–11 min),
15:85 (11–12 min), 0:100 (12–21 min), at a flow rate of 0.4 mL/min and a column
temperature of 35°C.
The Q Exactive focus mass spectrometer was operated under an ESI positive mode for all
detections. Full mass scan (m/z 100−1200) was used at a resolution of 70,000. The
automatic gain control (AGC) target was set at 3 × 106 ions, and maximum ion injection
time (IT) was 100 ms. Source ionization parameters were optimized with the spray voltage
at 3 kV and other parameters were as follows: transfer temperature at 285°C, S-Lens level
at 45, heater temperature at 370°C, Sheath gas at 60, and Aux gas at 20.

Imaging Mass Spectrometry
Tissues were sectioned at 8-µm thick and thaw-mounted on a conductive indium-tin-oxide
(ITO)-coated glass slides (Matsunami Glass Industries, Osaka, Japan). The samples were
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measured by a MALDI-Fourier transformation ion cyclotron resonance (FT-ICR) mass
spectrometer (solariX XR 7T, Bruker Daltonics), or a linear ion trap (LIT) mass
spectrometer (LTQ XL, Thermo Fishcer Scientific). The raster scan pitch was set
depending on the experiment from 30 to 150 µm. Data were acquired from m/z 286.65 to
450.00 (for FT-ICR data) in positive ion mode. For LIT data, signals of 5-HT-DPP (m/z
391 > 232) were monitored with a precursor ion isolation width of 1.0 m/z and a normalized
collision energy of 45%. Ion images were reconstructed with msIQuant 2.0.1.1466,
ImageQuest 1.1.0 software (Thermo Fischer Scientific) the FT-ICR data, and the LIT data,
respectively. After finishing the measurement, the sections were stained by H&E stain to
annotate the regions.

MRI-BIRDS temperature mapping
The animals were anesthetized with isoflurane, first at 3% isoflurane in an induction
chamber and then at 2-3% during surgery. The animal was laid back on a microwaveable
heating pad. Prior to incision, a single dose of bupivacaine was given for analgesia. A 1-2
cm midline incision was made on the neck to expose the jugular vein. Another small
incision (<1 cm) was made at the back of the neck. A sterile polyurethane or silicone
catheter with a metal guide was inserted from the back of the neck, where the vascular port
was fixed to the jugular vein. Prior to implantation the port and the catheter were flushed
with heparinized saline (25 IU/ml). The jugular vein was catheterized toward the heart. The
skin was closed with surgical sutures after application of triple antibiotic ointment and the
vascular port was fixed. The duration of the surgical procedure was 15-20 min.For MR
data acquisition, TmDOTMA- was purchased from Macrocyclics (Plano, TX, USA).
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Temperature mapping with BIRDS was performed on a 9.4T Bruker scanner (Billerica,
MA). The respiration rate was monitored during the entire duration of the experiment. A
200mM TmDOTMA- solution was infused at a rate of 60 to 80 µl/h for 1 to 2 hours. The
infusion rate was adjusted according to animal physiology. The T2 weighted magnetic
resonance (MR) images were acquired with an FOV of 23x23mm2, 128x128 matrix, 23
slices of 0.5mm thickness, TR=3s and TE=9ms. The extremely short T1 and T2 relaxation
times (<5ms) of the TmDOTMA- methyl group allowed ultrafast temperature mapping
with BIRDS using 3D chemical shift imaging (CSI) acquisition with a short TR (10ms)
and wide bandwidths (±150ppm). Temperature mapping with BIRDS was started
immediately after detection of global MR signal of TmDOTMA- methyl group, at about 1
hour after the start of the infusion. The CSI was acquired using a FOV of 23x15x23mm 3,
809 spherical encoding steps, 21min acquisition, and reconstructed to 23x15x23, with a
voxel resolution of 1x1x1mm3. Selective excitation of the TmDOTMA- methyl group was
achieved using a single band 200µs Shinnar-Le Roux (SLR) RF pulse. The MR spectrum
in each voxel was line broadened (200 Hz) and phased (zero-order) in Matlab (MathWorks
Inc., MA, USA), and the corresponding temperature Tc was calculated from the chemical
shift  CH3 of the TmDOTMA- methyl group according to
Tc = a 0 + a 1 ( CH3 −  0 ) + a 2 ( CH 3 −  0 ) 2

where d0 = -103.0 ppm and the coefficients a0 = 34.45 ± 0.01, a1 = 1.460 ± 0.003 and a2 =
0.0152 ± 0.0009 were calculated from the linear least-squares fit of temperature as a
function of chemical shift  CH3 (Coman et al., 2010).

140

Temperature Loggers
Animals were anesthetized with isoflurane, first at a rate of 2-3% and maintained at 0.52% in oxygen during surgery. Mice were kept on a heating pad throughout surgery. Mice
were injected with buprenorphine and bupivacaine as pre-emptive analgesia. A small
ventral incision of 1cm was made after clipping hair and disinfection with betadine and
70% ethanol. DST nano-T temperature loggers (Star Oddi) were placed in the peritoneal
cavity, and abdominal muscle and skin were sutured closed. Post-surgery, mice were singly
housed and provided with Meloixcam for 48 hours. After 7 days, sutures were removed.
10 days after surgery, mice were started on CTRL or CysF diet, and loggers were removed
for data collection after euthanization. Loggers were programmed to take temperature
readings every 30 minutes.

Metabolic cages
The energy expenditure (EE), respiratory exchange ratio (RER), activity, food intake and
water consumption of mice were monitored using the TSE PhenoMaster System (V3.0.3)
Indirect Calorimetry System. Each mouse was located in individual chambers for 3 days
for acclimation, and switched to experimental diet for 6 days. Each parameter was
measured every 30 min. EE and RER were calculated based on the oxygen consumption
(O2) and carbon dioxide production (CO2). Mouse activity was detected by infrared
sensors, and food intake and water consumption were measured via weight sensors on food
and water dispensers located in the cage.
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EchoMRI
The parameters of body composition were measured in vivo by magnetic resonance
imaging (EchoMRI; Echo Medical Systems). The amount of fat mass, lean mass and free
water were measured by the analysis. For the analysis, each mouse was placed in an acrylic
tube with breathing holes and the tube was inserted in the MRI machine. The analysis per
mouse takes approximately 90 sec and automatically calculated numerical results were
analyzed.

Climate chambers
Mice were acclimated in climate chambers at either 30°C or 22°C, with humidity
maintained at 50% under 12 h light/dark cycles. After one week acclimation, mice were
switched to custom amino acid diets, either CTRL or CysF diet for 6 days, while
maintained in the climate chambers. Mice were handled daily to measure body weight.

Histology
Tissues were collected in 10% formalin, embedded in paraffin and sectioned into 5um thick
sections. Tissues were stained with hematoxylin and eosin (H&E), or stained for UCP1
(Abcam) and Goat anti-rabbit HRP (DAKO) and developed for color using Abcam DAB
substrate kit.

Quantification and statistical analysis
Statistical differences between groups were calculated by unpaired 2-tailed t-tests. For
comparing groups over time, mice were individually tracked and groups were compared
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using paired 2-way ANOVA with Sidak’s correction for multiple comparisons. For all
experiments a p-value of p≤0.05 was considered significant.
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Appendix 1: Chapter 2 Custom Amino Acid Diets

L-Arginine
Glycine
L-Glutamic Acid
L-Histidine
L-Isoleucine
L-Leucine
L-Lysine-HCl
L-Phenylalanine
L-Threonine
L-Tryptophan
DL-Methionine
L-Valine
L-Cystine
Total L-AA
Cornstarch
Dyetrose
Sucrose
Cellulose
Cornoil
Salt Mix #200000
Vitamin Mix #300050
Choline Bitartrate
Total
% protein
% carbohydrate
% fat

CTRL
MR
Diet # 510027
DYET# 510029
11.2
11.2
23.3
23.3
27
33.88
3.3
3.3
8.2
8.2
11.1
11.1
18
18
11.6
11.6
8.2
8.2
1.8
1.8
8.6
1.72
8.2
8.2
0
0
gm/Kg
kcal/gm
gm/Kg
kcal/gm
140.5
562
140.5
562
432.5
1557
432.5
1557
50
190
50
190
200
800
200
800
50
0
50
0
80
720
80
720
35
16.45
35
16.45
10
38.7
10
38.7
2
0
2
0
1000
3884.15
1000
3884.15
14.5
14.5
67.0
67.0
18.5
18.5
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Appendix 2: Chapter 3 Custom Amino Acid Diets

L-Arginine
Glycine
L-Glutamic Acid
L-Histidine
L-Isoleucine
L-Leucine
L-Lysine-HCl
L-Phenylalanine
L-Threonine
L-Tryptophan
DL-Methionine
L-Valine
L-Cystine
Total L-AA
Cornstarch
Dyetrose
Sucrose
Cellulose
Cornoil
Salt Mix #200000
Vitamin Mix
#300050
Choline Bitartrate
Total
% protein
% carbohydrate
% fat

CTRL
CysF
LeuF
Diet # 511387
Diet # 510027
Diet # 511403
11.2
11.2
11.2
23.3
23.3
23.3
27
27
39.45
3.3
3.3
3.3
8.2
8.2
8.2
11.1
11.1
0
18
18
18
11.6
11.6
11.6
8.2
8.2
8.2
1.8
1.8
1.8
8.6
8.6
8.6
8.2
8.2
8.2
3.9
0
3.9
gm/Kg kcal/gm
gm/Kg kcal/gm
gm/Kg kcal/gm
144.4
577.6
140.5
562 145.75
583
428.6
1543
432.5
1557 427.25
1538
50
190
50
190
50
190
200
800
200
800
200
800
50
0
50
0
50
0
80
720
80
720
80
720
35
16.45
35
16.45
35
16.45
10
2
1000

38.7
0
3886.21
14.9
66.6
18.5

10
2
1000
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38.7
0
3884.15
14.5
67.0
18.5

10
38.7
2
0
1000
3886.75
15.0
66.5
18.5

Appendix 3: qPCR primers
Gene
18S
Il1b
Acadm
Casp1
Cbs
Cidea
Ckmt1
Ckmt2
Cox7a1
Cox8b
Cpt1
Cth
Dio2
Elovl3
Elovl6
Eva1
Gamt
Gatm
Ifng

Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd
Rev
Fwd

Sequence (5'->3')
CCATCCAATCGGTAGTAGCG
AACCCGTTGAACCCCATT
GGTCAAAGGTTTGGAAGCAG
TGTGAAATGCCACCTTTTGA
AGAACCAGACCTACAGTCGC
AGGGCATACTTCGTGGCTTC
GGACCCTCAAGTTTTGCCCT
AGACGTGTACGAGTGGTTGT
ACGAGCAGATCCAATCACGAG
TGCTCACGGGCTGCCACGAA
TGCTCTTCTGTATCGCCCAGT
GCCGTGTTAAGGAATCTGCTG
TGAGGAGACCTATGAGGTATTTGC
TCATCAAAGTAGCCAGAACGGA
GCATGGTGGCTGGTGATGAG
AAACTGCCCGTGAGTAATCTTG
CAG CGT CAT GGT CAG TCT GT
AGAAAACCGTGTGGCAGAGA
GAA CCA TGA AGC CAA CGA CT
GCG AAG TTC ACA GTG GTT CC
GCAAGATAGGCATAAACGCAG
GTCTCCTTTACAGTGTCCATCC
GATGGGGCAAAGCACAGTTT
TTCAGATGCCACCCTCCTGA
CAGTGTGGTGCACGTCTCCAATC
TGAACCAAAGTTGACCACCAG
TCCGCGTTCTCATGTAGGTCT
GGACCTGATGCAACCCTATGA
CAGCAAAGCACCCGAACTA
AGGAGCACAGTGATGTGGTG
GTCCCAACCAGACCATCAAC
CTCCATCTTGCTCTGGAAGC
GCAGCCACATAAGGTTGTTCC
CTCTTCAGACAGCGGGTACG
GACCTGGTCTTGTGCTCTCC
GGGATGACTGGTGTTGGAGG
AACTGGCAAAAGGATGGTGAC
146

Rev
Fwd
Il18
Rev
Fwd
Il6
Rev
Fwd
Maoa
Rev
Fwd
Nlrp3
Rev
Fwd
Otop1
Rev
Fwd
Pm20d1
Rev
Fwd
Ppara
Rev
Fwd
Pparg
Rev
Fwd
Ppargc1a
Rev
Fwd
Prdm16
Rev
Fwd
Slc27a2
Rev
Fwd
Slc6a8
Rev
Fwd
Tnfa
Rev
Fwd
Ucp1
Rev

TTGCTGATGGCCTGATTGTC
GACAGCCTGTGTTCGAGGAT
CAGTCTGGTCTGGGGTTCAC
ACCAGAGGAAATTTTCAATAGGC
TGATGCACTTGCAGAAAACA
GTATGGAAGGGTGATTCGGCA
ACTGCACCTTCCATGTAGCC
GCTAAGAAGGACCAGCCAGA
CAGCAAACCCATCCACTCTT
GACAACCCGATGTCTGGACT
GCCAAAGCAAATTTCCTCCA
TGGAGAATATATCCGCAAAGC
GCCACGACTTCATGTTGGA
GCGTACGGCAATGGCTTTAT
GAACGGCTTCCTCAGGTTCTT
GCCTATGAGCACTTCACAAGAAATT
TGCGAGTGGTCTTCCATCAC
GAAAAGGCCAAACAGAGAGA
GTAAATCACACGGCGCTCTT
CAG CAC GGT GAA GCC ATT C
GCG TGC ATC CGC TTG TG
GCGTGCCTCAACTACAACATT
CCTCCTCCACAGCTTCTTGT
TGCATATCTCCAAGGTGGCAG
CTACAAACTGGCTGTCCAGA
CCACCACGCTCTTCTGTCTAC
AGGGTCTGGGCCATAGAACT
CACCTTCCCGCTGGACACT
CCCTAGGACACCTTTATACCTAATGG
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Appendix 4: MRM conditions for amino acids measurement
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Appendix 5: CL316,243 activated gene set
Zim1
H19
Akr1cl
Prss35
Adam12
Mest
Postn
Peg3
Cyp2f2
Car3
Prkar2b
Gdpd2
Thbs2
Ly6h
Polr3g
Adamts15
H2afv

Gm5617
Vash2
Lypd1
Klhdc9
Cpz
Igfals
S100a4
Col1a1
Cthrc1
Tspan7
Ttyh3
Mdga1
Hsd11b2
Mgmt
Mfap2
Atxn1
Pla2g15

Sort1
Sned1
Cxcl9
Dlk1
Pde3b
Chrna1os
Gstm7
1600014C10Rik
Sfrp2
Mrps6
Rrad
Dnm3os
Vegfb
Lyrm2
Fdxr
Sord
Epb41l1
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Serf1
Slc5a3
Mlst8
Eln
Txndc16
Fam171a2
Pparg
Gpt2
Hmgcs2
Tamm41
Sox4
Selenoh
Gdf11
Marcks
Col3a1
Yipf2
Eef1b2

Gpx7
Gm19739
Col1a2
Csad
Adgrl1
Maged2
Cpxm1
Tomm70a
Lpl
Pld3
Col16a1
Fgfrl1
Olfml2b
Slc7a8
Igfbp4
Gas1
Bgn

Appendix 6: NAM gene signature
Clec12a
F13a1
Ccl12
Bmp2
Cbr2
Ccdc109b
Ccr2
Cd209f
CD63
CD72
Clec10a
Crim1
Egr1
Fcrls
Gas6
Ier2
Ifi27l2a
Lipa
Pdlim1
Plbd1
Pltp
Rnase4
Rtp4
S100a4
Tnfsf9
Xdh
AB124611
Aldoc
Arhgef10l
C130050O18Rik
Sephs2
Stom
Tradd
Abhd14b
Rab19
Sar1b
Ttyh2
Unc119

Card11
Cav2
Ccl7
Ccl9
Cd83
Cib1
Clec4n
Dennd2c
Ecm1
Fam69a
Fbxo4
Gmppb
Ifitm3
Itga6
Ldha
Marcksl1
Mgl2
Ms4a4a
Nedd9
Plxnb2
Pstpip1
Rasgrp4
Slc38a6
Socs3
Spint1
Timd4
Tlr2
Vcam1
Ada
Adamts2
Sft2d2
Susd3
Trim24
Pid1
Rab32
Sash1
Blnk
Bst1

Add3
Akt3
Aldh1a2
Angptl4
Antxr1
Anxa1
Apold1
Arl11
Asap1
atp8b4
Bzw2
C4b
Capn1
Cd200r4
Cd209b
cd93
Cdk14
Cfh
Chst12
Cish
Clec1b
Cnn2
Col14a1
Cp
Cpne8
Csf2rb
Ctnnd2
Dock5
E2f2
Ear2
Slc16a10
Tbc1d23
Trim47
Pkib
Rab37
Scel
Cst3
Cxcr2

Edil3
Ehd4
Eif2b2
Eng
Enpp1
Fam129a
Fcna
Fez2
Fgr
Flna
Folr2
Gas7
Gbp4
Gbp8
Glipr2
Glrx
Gpr34
Gramd4
H2-aa
Hba-a1
Hba-a2
Hbb-bs
Hepacam2
Hes1
Hivep2
Hvcn1
Igfbp4
Il1r2
Il1rl1
Irf8
Slc25a24
Tc2n
Trmt10c
Pnpo
Ralgps2
Sdc3
Fli1
Flnb
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Itgam
Itgb7
Kdelc2
Lilra6
Lrmp
Lsp1
Ly6e
Lyve1
Map4k4
mmp14
Mmp2
Mras
Ms4a7
Naaa
Nlrc3
Npl
Nr1h3
Nrp1
Olfm1
P2ry14
Panx1
Pdk3
Pea15a
Pilra
Pla2g2d
Pla2g7
Pmp22
Pxdc1
Rab34
Rapgef2
Slc35c2
Tex9
Tsta3
Pold4
Rarg
Sdc4
Ifitm6
Il18

Rcn3
Rgs18
Rhoj
Rin3
Ripply3
S100a6
S1pr1
Scarf1
Selm
Sept9
Serpinf1
Sesn1
Sh3d19
Sharpin
Shcbp1
Skint3
Slc12a2
Slc13a3
Slc37a2
Slc9a3r2
Slco3a1
Smagp
Stard8
Steap3
Tiam1
Timp2
Tnip3
Tnni2
Trip6
Tssc4
Slc39a11
Tjp2
Ttc28
Ppp1r12b
Rassf4
Sema4a
Mgst2
Mical1

Vps37b
Wwp1
Abca5
Abcb4
Abcd2
Abcg2
Abcg3
Abi3
Abr
Acss1
Adam28
Adgrl3
Adora3
Aif1
Aifm1
Aldh18a1
Aldoa
Amica1
Anln
Anxa2
Aprt
Arhgap27
Atp6v0e
Atp6v0e2
Bach2
Bco2
Bend6
Bin2
Slfn5
Tln2
Txndc16
Prdm1
Rbpj
Sema6d

C2cd2l
Cadm1
Camk2d
Casp7
Ccdc102a
Ccdc91
Ccl2
Ccl24
Ccl6
Ccna2
Ccnd1
Cd163
Cd164
Cd209a
Cd209g
Cd300a
Cdk2ap2
Cdr2
Cetn2
Clec4a3
Clmn
Clu
Cmah
Colec12
Commd5
Cpne5
Creg1
Csf2rb2
Slfn8
Tmem14c
Vnn3
Prom1
Rell1
Stat4

Cyp51
Cyr61
Cyth4
Dgat2
Dgkd
Dhdh
Dip2c
Dlc1
Dnase1l3
Dpep2
Dusp8
Echdc1
Emilin2
Emp3
Epha2
Ephx1
Epn2
Eps8
Ermap
Esr1
Etv1
Evl
Fads1
Fam111a
Fam117a
Fam43a
Fcgr4
Fcrl1
Slfn9
Tmem245
Wdr46
Prr11
Retnla
Tnfrsf11a

Fmo1
Fnbp1l
Foxp1
Frmd6
Fut8
Galnt7
Gars
Gca
Gde1
Gem
ggta1
Gimap6
Gpr165
Gpr55
Gpr84
Gsto1
havcr2
Hdac10
Hes6
Hk3
Hmgcs1
Hmmr
Hps6
Hsd17b4
Htra2
I830077J02Rik
Ier3
Ifi30
Ssbp2
Tmem254a
Zfp125
Pstpip2
Rexo2
Zmynd15
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Il1f9
Il21r
Impdh1
Ipo13
Itgax
Kazn
Kbtbd11
Kctd12b
Kif11
Kif23
Kitl
Klhl5
Krt80
Lag3
Lat2
Ldlrap1
Lgals9
Lifr
Lonrf1
lpcat2
Lsm1
Ltbp3
Lyl1
Mad2l1
Man1a
Map3k8
Marveld2
Mef2c
St3gal6
Tmem254b
Zfp36l1
Ptgs1
Rims3

Mlkl
Mmd
Mmp13
Mrc1
Msr1
Nav1
Nceh1
Ncf4
Nckap5
Nfkbiz
Nid2
Nlrp1c-ps
Nsdhl
Nt5dc2
Nuak1
Nubp2
Oas2
Olfml3
Pacsin2
Paox
Paqr3
Pcdhga8
Pde1b
Pde4d
Pf4
Pgf
Phactr1
Phf11a
St5
Tmem9b
Zfp599
Ptpn22
Samd9l
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